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Dear colleagues,
During the last two decades, multiple treatment modalities have been tested in
the attempt to improve clinical outcomes from sepsis. During this period we
have consistently observed initially promising results that have gradually faded
in subsequent large clinical trials. Researchers blame this irreproducibility on
slow patient accrual (selection bias), the Hawthorn effect (knowing you are
being watched changes your practice), beta-type errors (false positive), publi-
cation bias and other factors. In a recent publication (Mebazaa et al. Journal of
Intensive Care (2016) 4:24) the authors stated, that the major reasons for lack of
survival in recent sepsis trials are over-estimated treatment effects, suboptimal
pre-clinical models, incorrect treatment targets, and heterogeneity of definitions
and patients. Priorities for future sepsis clinical trials are among others, identi-
fication of responders to treatment, networks of sepsis investigators experienced
in clinical trial conduct, application of the recent S-3 definitions for sepsis and
septic shock, targeted clinical trials in relatively homogeneous groups of
patients, and pre-specified covariate adjustment of the primary endpoint
(heterogeneity) and exclusion of low-risk patients.
The German Sepsis Society (DSG) will address these questions at its 8th
Weimar Sepsis Congress entitled ‘‘Facing the Challenges’’. Why Weimar? Due
to its unique features, the Weimar Sepsis Congress has built up a reputation on a
national and international level: leading experts from all over the world with
excellent publications in basic and clinical research, no parallel sessions—ev-
erything under a single roof—vivid discussions in a smooth and casual
atmosphere.
The 8th Weimar Congress—that will once again take place together with the
9th Congress of the German Society of Intensive Nursing Care—will update you
on the current state of knowledge about how to improve treatment of patients by
adhering to the guidelines but yet in a critical way.
We are looking forward to meeting you!
Kind regards
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Dynamic experimental study of acute kidney failure
pathophysiology in abdominal sepsis
Sydorchuk R (1), Fedoruk O (2), Stepan V (2), Vladychenko K (2),
Sydorchuk L (3), Sydorchuk I (3), Plehutsa O (1), Sydorchuk A (3)
(1) General Surgery Department, Bukovinian State Medical Univer-
sity, (2) Urology Department, Bukovinian State Medical University,
(3) Family Medicine Department, Bukovinian State Medical
University.
Introduction: Multiple organ failure is a hallmark of abdominal
sepsis (AS). Acute kidney dysfunction is a common sequel of sepsis.
Sepsis, which is commonly defined as systemic inflammation process
resulting from an infection, often results in an abrupt decrease in the
kidney’s ability to effectively filter the blood. According to the US
National Kidney Foundation, sepsis is one of the major causes of
acute kidney injury (AKI) and some studies have found that between
32 and 48% of AKI cases were caused by sepsis. It is being suggested
that sepsis-induced kidney failure may have a distinct pathophysiol-
ogy and identity. Particularly complex is AS, which combines
pathogenetic mechanisms common to other forms of sepsis but
aggravated by involvement of kidneys into inflammatory process and
bacterial overload. However, most of the clinical studies of AKI in
sepsis are biased due to interference with treatment, etc.
Objectives: The aim of the study is to study the multimodality
pathophysiological mechanisms of AKI under AS in dynamics of
acute experiment.
Methods: The study is based on acute AS modelled in 38 white
Wistar line rats allowing results standardization excluding treatment
bias. AS modeled via intraperitoneal injection of E. coli O111:B4
endotoxin, (Difco Labs) and 7 lg CFU/ml of live E. coli (clinical
strain). Sepsis proved by means of clin/lab observations and micro-
biological study. Renal dysfunction assessed through set of 50+
variables including absolute and conditional diuresis, ions/creatinine
metabolism and excretion/clearance markers (ENa+, UR+, ER+, Uc,
Pc), filtration/reabsorption values, nitrogen, detox/pH regulation
functions (R H2O%, P Na+, FFNa+, EFNa+, RFNa+, TdNa+, ETA,
NH3, CH, EH+, etc). Data collected during 6, 24, 48, and 72 h of AS
modeling. Bioethical principles strictly obeyed (approval of the local
Bioethics Committee #5 /5.10.2017). Statistica 7.0 (StatSoft Inc)
software used for analysis.
Results: Diuresis and conditional diuresis dropped 4 fold during 6 h
with growing tendencies during 24–72 h. Urine Na+ concentration
and excretion grew 10 and 2 fold (6 h) with further drop of these
markers. In contrast, K+ concentration and excretion grew signifi-
cantly during the course of experiment. Creatinine plasma
concentration grew 1.9–2.65 times with 8.2–10.6 fold decreased urine
concentration and clearance. Urine filtration rate initially dropped
10.1–12.3 times with further partial compensation of 260.96 ± 18.92
at 72 h of experiment vs. 1436.70 ± 73.38 in control (mkl/min
9100g). H2O reabsorption rate changed unreliably providing partial
compensation mechanism. Maximum protein excretion rate observed
during 24 h.
Conclusions: Received data confirms existence of two physiological
periods of AKI in AS. The first one is characterized by stress-related
influence, compensatory hyper activation of adaptive mechanisms.
Second phase is characterized by exhaustion of compensation,
dysadaptation and kidney dysfunction.
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Fast simultaneous assessment of renal and liver function using
polymethine dyes in animal models of chronic and acute organ
injury
Press AT (1,2), Butans M (1,2), Bauer M (1,2), Kortgen A (1,2)
(1) Department of Anesthesiology and Intensive Care Medicine,
Universita¨tsklinikum Jena, (2) Center for Sepsis Control and Care,,
Universita¨tsklinikum Jena.
Introduction: (Multi-)organ dysfunction after systemic infection
defines sepsis and reflects one of the most common causes of death on
intensive care units worldwide. Obvious lack of treatment options
promotes extensive translational research in rodent models in which a
reliable assessment of organ dysfunction is critical. Timely diagnosis of
impaired organ function is crucial in this context. Particularly kidney
and liver dysfunction are of outstanding importance, both leading to
subsequent remote organ impairment due to accumulation of endo- and
xenobiotic substances. However, diagnostic tools for sensitive and fast
detection of organ dysfunction for kidney or liver failure in daily
clinical practice are still scarce. At present, most applied biomarkers
are static plasma or urine parameters such as bilirubin in case of liver
dysfunction or creatinine and urea for kidney failure. These parameters,
however, often lack sensitivity and specificity. Sensitive, fast and
simultaneous assessment of excretory liver and kidney function is still
an unmet need in experimental stress models as well as in critical care.
Objectives: Aim of the study was to characterize polymethin dyes
which can be applied for evaluation of hepatic and renal dysfunction,
based on their physico-chemical properties and their elimination
capacity in vivo.
Methods: Plasma disappearance and elimination rate measurements of
simultaneous injected fluorescent dyes DY-780 (hepato-biliary elimi-
nation) and DY-654 (renal elimination) using catheter techniques and
(confocal) intravital microscopy in animals subjected to different organ
injuries: polymicrobial sepsis by peritoneal contamination and infec-
tion, ischemia- reperfusion injury (70% liver tissue or bilateral
clamping of kidney arteries) and glycerol-induced acute kidney injury
caused by intramuscular glycerol injection. Further assessment of organ
function using clinical parameters (transaminases, bilirubin, urea, cre-
atinine) and mass spectrometry to assess conjugation of bile acids.
Results: DY-780 and DY-654 have organ specific and determined
elimination routes in healthy and diseased animals. They can be
measured simultaneously using (near)infra-red imaging techniques and
spectrophotometry. DY-780 and DY-654 plasma-disappearance rate
indicate hepatic or kidney dysfunction respectively in different animal
models with superior sensitivity than conventional biomarkers. Greatest
impact on liver function was found in animals with polymicrobial
sepsis whereas glomerular filtration damage due to glycerol-induced
kidney injury had strongest impact on DY-654 elimination.
Conclusions: Hepatic elimination and renal filtration can be assessed
in rodents measuring DY-780 and DY-654 plasma-disappearance
rate. Conventional biomarkers correlate with organ dysfunction
assessed by polymethin dyes. Polymethine-dye clearance thereby
allows for the first time point-of-care assessment of both organ
functions simultaneously.
S4 Abstracts
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Experimental study of patients’ status severity scoring systems
use in abdominal sepsis
Sydorchuk R (1), Sydorchuk L (2), Sydorchuk A (2), Plehutsa O (1),
Sydorchuk I (2), Tkachuk O (3), Kyfiak P (3)
(1) General Surgery Department, Bukovinian State Medical Univer-
sity, (2) Family Medicine Department, Bukovinian State Medical
University, (3) Intensive Care Department, Bukovinian State Medical
University.
Introduction: Abdominal sepsis (AS) is almost the heaviest example
of sepsis associated with a large medical and economic burden. Sepsis
understanding switched from ‘bacteremia’ and even SIRS associated
with infection to a multi organ dysfunction caused by an up- and
down-regulated host response to infection. Severity of status assess-
ment is currently standardized in septic patients using multimodal
scoring systems that can more accurately and objectively determine
the status, correct treatment policies, the surgical tactics and outcome.
There are many rating scales and systems for AS, among them SOFA,
qSOFA, MIP, APACHE (I–III), PSS, ASA, which are often not suf-
ficiently consistent and comprehensive. Their scope is constantly
expanding and currently covers the diagnosis, prognosis, treatment,
and surveillance for many diseases and injuries.
Objectives: The aim of the study is to determine the feasibility of
using the most common scoring systems in comparative aspects in
acute standardized experimental conditions.
Methods: Prognostic evaluation of the effectiveness of scoring
pathologic conditions was studied by simulating an acute peritonitis
in 19 inbreed rabbits weighing 5.39 ± 0.47 kg according to self-
developed experimental technique by introducing standardized mix-
ture of museum strains of pathogenic and conditionally pathogenic
microorganisms into peritoneal cavity with the addition of adjuvants,
which allowed simulating different degrees of severity of the patho-
logical process and progress. The functional state of the organism
assessed via heart rate (HR), respiratory rate (RR), arterial blood
oxygenation indices (PaO2), arterial blood pH, ionogramm indicators,
hematocrit, creatinine, peripheral blood WBC count and formula,
morphologic evaluation of the pathological process development and
severity. The study approved by the bioethics commission.
Results: In 6 (31.6%) animals modeled local limited peritonitis (1
group), 7 (36.8%)—diffuse (2 group), and in 6 (31.6%)—general
peritonitis (3rd group). 12 and 24 h after initiation of a pathological
process defined physiological and laboratory parameters and calcu-
lated severity for different systems (APACHE, APACHE II, MIP).
The calculated results are presented in Figs. 1–3. In group 1
APACHE and MIP indices in contrast to APACHE II decreased after
24 h. Predicted mortality among animals of the group 1 was to be 0%
(MIP) or 0–5% (APACHE II and APACHE), 2–29% (MIP) and
5–25% (APACHE II and APACHE). Mortality in group 3 was pre-
dicted to be 100% (MIP) and 25–100% (APACHE II and APACHE).
Actual mortality was in the group 1—0% in 2—28.6%, the 3rd—
83.3%.
Conclusions: The use of scoring systems as prognostic tool is
expedient for practical application in clinical settings. In order to
increase the probability of forecasting and optimization of treatment
strategy it is rational to combine different evaluation scoring systems.
Fig. 1. APACHE values changes in experiment
Fig. 2. APACHE II values changes in experiment
Fig. 3. MIP values changes in experiment
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Comparative analysis of infected and uninfected biliary
peritonitis
Rohovyy Y (1), Bilookiy O (2), Bilookiy V (2), Sydorchuk R (2)
(1) Pathophysiology Department, Bukovinian State Medical Univer-
sity, (2) Surgery Department, Bukovinian State Medical University.
Introduction: Acute biliary peritonitis is a common cause of
abdominal sepsis. While understanding of sepsis require participation
of microbiota and microbial toxins, biliary peritonitis adds another
peculiarities into sepsis pathogenesis through involvement of bile,
liver and kidney dysfunction.
Objectives: The aim of the study was to find the possible influence of
biliary peritonitis on kidney function.
Methods: In experimental studies 110 white mature male rats
weighing 180–200 g underwent a comparative analysis of infected
and uninfected bile peritonitis. Bioethics were strictly obeyed.
Results: In case of non-infected bile peritonitis was negative corre-
lation of distal transport of sodium ions relative reabsorption of water
and glomerular filtration in contrast to infected peritonitis in which
these relationships are positive, which indicates the difference of
mechanisms of development of renal impairment. However, there was
general laws, the manifestation of which are the positive correlation
of relative water reabsorption from the glomerular filtration, absolute
proximal reabsorption of sodium ions. Under the condition of an
infected biliary peritonitis, in contrast to uninfected develops the
syndrome of ‘‘loss’’ ions of sodium, proteinuria, the decline in the
excretion of acids and ammonia from urine. Subject to biliary peri-
tonitis oxidative modification of proteins ends with the formation of
acidic groups of proteins, which is evidence that impaired balance of
pro - and antioxidant system, the changes are most significant in the
case of an infected biliary peritonitis. This increases the oxidative
modification of proteins in 1.3 times in kidney and liver of rats
according to the ratio R/B, which increases in the proximal 1.5 times,
0.7 times distal parts of the nephron, the collecting tubules of the renal
papilla and in the cytoplasm of hepatocytes. For the infected bile
peritonitis found a statistically significant (p\ 0.001) the growth rate.
The sequence distribution of the degree of damage of the investigated
structures of the liver and kidney indicates the greatest sensitivity
determine the degree protein ratio R/B in the proximal nephron and in
the cytoplasm of hepatocytes, compared with intact animals, and the
infected bile peritonitis found a similar pattern in relation to the
uninfected, which confirms the role of infectious factor in the
development of reactions of alteration. In the experiment the optical
density of plasma venous blood, provided the uninfected biliary
peritonitis does not differ significantly from the benchmarks, how-
ever, provided the infected peritonitis parameters increased
statistically significantly (p\ 0.01) rise.
Conclusions: The results of the research showed differences of
uninfected and infected biliary peritonitis, which has important
practical significance to prevent the development of septic infection.
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Protein kinase C as target to resolute excretory liver failure in
sepsis
Martinac P (1), Neugebauer S (2), Kiehntopf M (2), Press AT (1),
Bauer M (1)
(1) Department of Anesthesiology and Intensive Care Medicine, Jena
University Hospital, (2) Department for Clinical chemistry and
Laboratory Medicine, Jena University Hospital.
Introduction: Excretory dysfunction of the liver is an early and
frequent event in sepsis. Different PAMPs but especially cytokines as
well as chemokines from circulating or local recruited as well as
inflammatory cells affect hepatic integrity. This sometimes only
subclinical excretory dysfunction is strongly associated with survival
of the host, both in rodent models and the clinical context, reflecting a
critical condition with lacking effective therapies. The protein kinase
C isoforms are involved in membrane shaping processes, cytoskeletal
remodeling but also cellular polarization, metabolism and many other
essential cellular processes. In hepatocytes protein kinase C isoforms
are recently described to be essential for the anchoring and trafficking
of transporters involved in the basolateral uptake and canalicular
excretion of endo- and xenobiotics.
Objectives: The present study investigates for the first time the
clinical relevance of Go¨6850, a well-established pan-PKC inhibitor
for the treatment of liver dysfunction in a murine model of polymi-
crobial, abdominal sepsis.
Methods: In accordance with Thuringian animal welfare association
sepsis was induced applying the model of peritoneal contamination
and infection (PCI) which lead in this case to a systemic infection
dominated by Escherichia coli. Sham animals were injected
intraperitoneal with sterile saline. Further supportive volume and
antibiotic therapy for 7 days after onset of the infection was applied to
all groups. Different treatment regimens are applied during the first 5
days of the infection, in which phase liver failure determines out-
come. Animals were observed for a total period of 22 days after
infection.
Results: No signs of illness were observed in any treatment or vehicle
control groups in sham. An increased survival during every time-point
of observation resulting in a survival rate of 40% (PCI, treatment
group) versus 18% (PCI, vehicle group) was observed for low doses.
Higher doses are only translated in an increased survival within the
first days but fail to improve 22 days survival significantly. In a
second set of experiments liver tissue was harvested and analyzed for
21 unconjugated and conjugated bile acids (BA) using mass spec-
trometry. An accumulation of unconjugated BA was found in PCI
animals (n = 6) after 24 and 72 h but not in sham vehicle or any sham
Go¨6850 groups. Treating infected animals with higher doses of
Go¨6850 lead to no elevation of BA after 24 or 72 h. Treatments with
low doses Go¨6850 per animal once daily lead to an initial increase of
BA after 24 but dropped to baseline after 72 h.
Conclusions: Treatment of septic cholestasis with Go¨6850 resolute
excretory dysfunction in a dose- and time-dependent manner and
increases survival from systemic infections significantly in a murine
model of sepsis, emphasizing the outstanding importance of protein
kinases in the development of liver failure during infection and gives
for first time an effective treatment targeting cholestasis.
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Underlying pathogen determines characteristics of liver failure in
sepsis
Schaarschmidt B (1,2), Vlaic S (3,4), Medyukinha A (5), Figge MT
(2,5), Nietzsche S (6), Neugebauer S (2,7), Brunke S (8), Kiehntopf M
(2,7), Jacobsen ID (2,9), Bauer M (1,2), Press AT (1,2)
(1) Department for Anesthesiology and Intensive Care Medicine, Jena
University Hospital, (2) Center for Sepsis and Control and Care, Jena
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University Hospital, (3) Research Group Systems Biology/Bioinfor-
matics, Leibniz Institute for Natural Product Research and Infection
Biology (Hans Kno¨ll Institute), (4) Department of Bioinformatics,
Friedrich-Schiller-University, (5) Department of Applied Systems
Biology, Leibniz Institute for Natural Product Research and Infection
Biology (Hans Kno¨ll Institute), (6) Electron Microscopy Center, Jena
University Hospital, (7) Department of Clinical Chemistry and Lab-
oratory Medicine, Jena University Hospital, (8) Department of
Microbial Pathogenicity Mechanisms, Leibniz Institute for Natural
Product Research and Infection Biology (Hans Kno¨ll Institute), (9)
Research Group Microbial Immunology, Leibniz Institute for Natural
Product Research and Infection Biology (Hans Kno¨ll Institute).
Introduction: The development of organ dysfunction discriminates
uncomplicated infection from sepsis. The current concept assumes
that organ dysfunction occurs as a result of inadequate host response
independent of the underlying pathogen. Life-threatening infections
are treated primarily as bacterial infections, resulting in a depletion of
microbiota-derived metabolites, enhancing pathogen susceptibility,
impairing immune homeostasis and promoting fungal infection. For
different gut-derived pathogens the liver is described as a first target
organ, where systemic infection establishes.
Objectives: This study aims to determine whether the hepatic host
response to bacterial and fungal infections differs with a focus on
hepatic metabolism and liver function.
Methods: Murine peritoneal bacterial contamination and infection
(PCI) as well as intraperitoneal and systemic C. albicans infection
models were compared 6 and 24 h post infection (p. i.) to sham
controls. Liver tissue was analyzed regarding protein-protein-inter-
action networks using omic-strategies. Specific readouts such as
intravital microscopy and immunofluorescence microscopy were used
to analyze specific aspects of pathophysiology such as cholestasis.
Results: Transcriptomics revealed similar alterations of hepatic
metabolism in all three infection groups; the degree of regulation
however differed between the infection models and time point. Most
notable, besides the immune response, was the downregulation of
lipid catabolism and bile acid (BA) synthesis already after 6 h in all
groups. Alterations in lipid catabolism were characterized by an
accumulation of long chain acylcarnitines, while short chain fatty
acids showed a more distinct behavior between groups. Defective
beta-oxidation affected the energy metabolism as early as 6 h p. i. as
indicated by reduced hepatic NADH. Intrahepatic BA revealed dif-
ferent conjugation-patterns in PCI vs. Candida infection. While PCI
led to accumulation of unconjugated BA, C. albicans infection caused
accumulation of conjugated BA independent of the route of infection.
Hepatic dye clearance and transporter expression revealed reduced
uptake in fungal infections vs. defects in secretion following bacterial
PCI.
Conclusions: While many aspects of the host response to bacterial
and fungal infections appeared to be conserved, molecular phenotypes
of lipid accumulation and cholestasis allow differentiation between
pathogen and route of infection already at early stages, with possible
diagnostic applications. The consequences for outcome and thera-
peutic approaches yet need to be determined.
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Targeting cholesterol signaling to reduce pneumolysin-induced
cellular injury in hepatocytes and alveolar macrophages
Hoff J (1), Kammann T (1), Deshmukh S (2), Traeger A (3), Schubert
US (3), Maus UA (4), Press AT (1), Bauer M (1)
(1) Department of Anesthesiology and Intensive Care Medicine, Jena
University Hospital, (2) Center for Sepsis Control and Care, Jena
University Hospital, (3) Institute of Organic Chemistry and Macro-
molecular Chemistry, Friedrich Schiller University Jena, (4)
Department of Pulmonary Medicine, Laboratory for Experimental
Lung Research, Hannover School of Medicine.
Introduction: Sepsis reflects a frequent clinical condition charac-
terized by organ failure including hepatic or pulmonary dysfunction.
Underlying infections, such as pneumonia, are often caused by S.
pneumonia, a bacterium producing the cholesterol-dependent cyto-
lysin pneumolysin (PLY). PLY induces cell lysis and thereby triggers
barrier failure allowing bacterial expansion all within and beyond the
lung. The body reacts to PLY via a hepatic remote organ response: An
increase in sterol signaling and particular an upregulated cholesterol-
biosynthesis of unknown signaling origin and biological function.
Objectives: Here we investigated the role of the adaptive hepatic
sterol-response to PLY and whether cholesterol, formulated as
cholesterol-containing particles (CCP), can reduce PLY induced
cellular toxicity by neutralizing.
Methods: Alveolar macrophages (AM) were lavaged from lungs of
FVB/N mice, maintained in tissue culture for 24 h and afterwards
treated with PLY, cholesterol and/or CCPs for 3 and 6 h. Toxicity was
evaluated by LDH-release assay. Same procedure was performed with
hepatocyte carcinoma cells (HepG2). Also RNA was isolated from
treated HepG2 cells to analyze gene expression of specific patterns of
sterol-cholesterol-pathway.
Results: Our results indicate that PLY treatment leads to a concen-
tration-dependent toxicity in both cell-types. However AM are more
sensitive within the used concentrations. Cholesterol treatment
directly before addition of PLY results in both cell-types in decreased
PLY-induced cellular toxicity in a concentration-dependent manner.
In AM this protective effect is present after 3 h as well as after 6 h of
incubation with PLY whereas in HepG2 cells the protective effects
are time-dependent. To employ cholesterol in vivo CCPs with two
diameters (d\200 nm and d[1 lm) were prepared based on various
biodegradable polymers. Treatment with CCPs (but not cholesterol-
free particles) reduces PLY-mediated cell toxicity in both cell-types
in a time-independent manner. Due to previous mouse studies, where
S. pneumonia lung infection leads to a hepatic sterol response, genes
encoding proteins of sterol-biosynthesis (HMGCR, SREBP-1, and
SREBP-2) are therefore up-regulated in HepG2 cells when exposed to
PLY. Further the sterol response was cholesterol-feedback sensitive,
thus supplementation of cholesterol (free and in particles) lowered the
sterol response significantly.
Conclusions: These results demonstrate the protective effects of
cholesterol and CCPs in the light of PLY induced cell damage and
death. Also PLY can directly act on hepatocytes, where it triggers the
activation of sterol-synthesis but not circumventing intrinsic negative
feedback-loops. The adaptive hepatic sterol signaling might therefore
be seen as response to counteract caspase-mediated pro-apoptotic and
inflammatory signaling as well as intrinsic mechanism to inhibit PLY.
Our data further suggest, that the mechanism of cholesterol-dependent
protection counteracting PLY differ between AM and hepatocytes.
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Multispectral optoacoustic tomography to assess liver and kidney
function in Sepsis by measuring dye clearance
Cseresnyes Z (1), Hildebrandt K (2), Press AT (2), Sommerfeld O (2),
Bauer M (2), Kortgen A (2), Figge MT (1)
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(1) Applied Systems Biology, Leibniz Institute for Natural Product
Research and Infection Biology (Hans Kno¨ll Institute), (2) Depart-
ment of Anesthesiology and Intensive Care Medicine, Jena University
Hospital.
Introduction: Sepsis is a life threatening organ dysfunction caused
by a dysregulated host response to infection that is associated with
hospital mortality rates exceeding 40%. Impaired organ function,
induced directly by pathogens or by the immune system (im-
munopathology) determines survival of critically ill septic patients.
As sepsis-induced liver and kidney dysfunction may be unrecognized,
diagnostic methods for early and effective detection of sepsis-asso-
ciated organ dysfunction and damage are essential to initiate
potentially life-saving therapy and/or adequate therapeutic adjust-
ments. Multispectral optoacoustic tomography (MSOT) is a recently
developed sectional imaging modality that allows detection of infra-
red absorbent molecules in a non-invasive manner.
Objectives: It has been shown that Indocyanin green (ICG) and
IRDye800CW (IRD) plasma clearance can be measured by MSOT in
mice. However, data analysis is currently done in a non-systematic
manner, thus leaving the effect of pathological conditions on ICG and
IRD unclear. In this study we aim to develop a systematic image
analysis strategy to characterize spatio-temporal dye-clearance in
health and disease as measured by MSOT.
Methods: Repetitive measurement of organ function by MSOT in
the murine peritoneal contamination and infection model of sepsis
were performed for 28 days. Liver and kidney function was assessed
by using i.v. injection of ICG and IRD, respectively, and MSOT
images were obtained from the organ areas every 15 s for 20 min.
The raw MSOT data were backprojected and unmixed, resulting in
MSOT channels specific for water, oxy- and deoxyhemoglobin, ICG
and IRD. Our custom-written software extracted kinetic information
of ICG and IRD clearance from the liver and the kidneys, respec-
tively. The software used the spinal cord, the aorta and the vena
cava as reference points in order to standardize the spatial coordi-
nate systems temporally, as well as between animals. The typical
kinetic behavior of ICG and IRD were extracted from the MSOT
images using regions of interest (ROI) that covered the corre-
sponding organs. A gold standard was provided by the manual
selection of 2000 and 700 ROI in the liver and kidney areas,
respectively, in a typical image set.
Results: MSOT together with our analysis software allows the
simultaneous assessment of liver and kidney function. We find that
the plasma disappearance rate (PDR) is lower in PCI animals com-
pared to sham for both ICG and IRD. We examine the correlation
between PDR and survival rate in various PCI animals. Finally, we
are aiming to automatically identify and characterize the anatomical
structures based on their pharmacokinetic behavior.
Conclusions: MSOT is a very promising technique to detect early
sepsis-associated liver and kidney impairment by close monitoring of
the organs’ perfusion, oxygenation and function during disease pro-
gression in a longitudinal manner.
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Investigation of the Role of Hepatic Fam 134 isoforms in
Autophagy
Cineus R (1), Martinac P (1), Awis M (2), Press A (1), Hu¨bner C (2),
Bauer M (1)
(1) Department for Anesthesiology and Intensive Care Medicine, Jena
University Hospital, Am Klinikum 1, (2) Institute of Human Genetics,
Jena University Hospital.
Introduction: Autophagy is an important regulator of cellular
responses during sepsis and plays a pivotal role in cell repair,
development, differentiation, as well as immunologic defense.
Macroautophagy (henceforth referred to as autophagy), consists of the
formation of a double-membrane vesicle known as the autophago-
some. The autophagic cascade is mediated by autophagy-related (Atg)
proteins and receptors. The autophagy-related protein 8 (Atg8)
Ubiquitin-like proteins include the LC3 and GABARAP subfamilies,
to which FAM134A, FAM134B and FAM134C can bind to facilitate
ER degradation. Downregulation of FAM134 causes expansion of the
ER, while overexpression causes ER fragmentation and lysosomal
degradation.
Objectives: Here we investigate the role of Fam134 isoforms in
autophagosome maturation and in hepatic ER stress by analyzing the
levels of autophagic markers in primary hepatocytes stimulated with
tunicamycin, LPS, and rapamycin.
Methods: As an ex-vivo sepsis model, primary hepatocytes were
isolated from both knockout and wild-type mice for each isoform, and
treated following an equilibration phase of 24 h with tunicamycin,
lipopolysaccharide (LPS), and rapamycin for 5 h. Proteins were
detected and analyzed by (neoepitope) specific immunoblotting, while
expression analyses were performed by quantitative polymerase chain
reaction and normalized using the Pfaffl method.
Results: The Fam134B +/+ cells demonstrated a marked increase in
the Beclin-1 and XBP1 expression (n = 4, n = 6) when treated with
LPS, tunicamycin, and rapamycin. Intriguingly, Fam134B-/-
showed a significant increase in p62/SQSTM1 expression compared
to Fam134B +/+, indicating that the mutation may have caused
impairment in autophagy that directly influences p62. Similarly,
Fam134B-/- showed a stronger increase in LC3B II than
Fam134B+/+ upon induction of autophagy. Interestingly, a gender-
based difference was observed in the induction of autophagic marker
expression. For example, the Fam134C -/- females showed an
unexpected increase in Beclin-1 and XBP1 protein levels as compared
to the Fam134C+/+ females. Conversely, the Fam134C +/+ males
showed higher levels of Beclin-1 and XBP1 protein as expected. Cells
stimulated with tunicamycin showed a significant (p\0.05) increase
in mRNA levels of BiP and ATF4 haphazard of the mutation. Fur-
thermore, XBP1 splicing was observed in tunicamycin stimulated
cells, indicating that tunicamycin plays a significant role in the
unfolded protein response (UPR) machinery in both wild-type and
knockout cells
Conclusions: LPS, tunicamycin, and rapamycin induced the expres-
sion of different markers involved in autophagosome formation and
maturation. Tunicamycin induced an increase in the mRNA levels of
BiP, ATF4, and spliced XBP1, which play a vital role in hepatic ER
stress. En masse, these findings reveal insights into the processes
underlying the induction of autophagy in sepsis, and how these
pathways could be exploited to design novel therapeutic strategies for
sepsis.
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Matrix metalloproteinase 14 induces Tie2 shedding in
experimental sepsis and human disease
Thamm K (1), Retzlaff J (1), Schrimpf C (2), Ghosh CC (3), Haller H
(1), Parikh SM (3), David S (1)
(1) Medicine; Nephrology and Hypertension, Medical School Han-
nover, (2) Vascular and Endovascular Surgery, Department of Heart,
Transplantation, Thorax and Vascular Surgery, Medical School
Hannover, (3) Center for Vascular Biology Research, Beth Israel
Deaconess Medical Center and Harvard Medical School.
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Introduction: Tie2 is an endothelial tyrosine kinase receptor that
controls vascular quiescence and its response to injury. Besides its
deactivation through antagonistic ligands, Tie2 expression per se
dramatically decreases during sepsis. Experimental reduction of Tie2
recapitulates cardinal features of septic vasculature and increases the
host’s susceptibility to the disease.
Objectives: Here, we investigate the molecular mechanism of Tie2
protein suppression in sepsis in order to develop effective therapeutic
strategies.
Methods: In vitro (stimulated endothelial cells) and in vivo (C57/Bl6
murine cecal ligation and puncture and LPS) models of sepsis plus
retrospective analysis of human septic shock samples (n = 57).
Results: We found that Tie2 was rapidly suppressed both in vitro and
in vivo up to 79.7% within 8 h and 56.6% within 4 h, respectively. We
observed an increase in the extracellular (so-called soluble) Tie2
fragment (75 kDa) cross-species and in different disease models (CLP
and LPS) in the supernatant of challenged endothelial cells (ECs), the
circulation of septic mice (1.07 vs. 1.45 ng/mL, p = 0.001) and the
circulation of septic humans (12.29 vs. 18.77 ng/mL, p \ 0.0001).
In vitro, we identified MMP14-dependent Tie2 ectodomain shedding
as putative underlying mechanism that was protected both after
genetic MMP14 knockdown and pharmacological MMP inhibition.
Consistently, supplementation of recombinant human MMP14 to ECs
increased spontaneous Tie2 shedding. Moreover, experimental
reduction in MMP14 increased protective Tie2 downstream signaling
(pAKT) and improved endothelial barrier function (transendothelial
electrical resistance).
Conclusions: Together, these data indicate that acute changes in Tie2
expression might be regulated via ectodomain shedding in an
MMP14-dependent manner. Therapeutic protection of Tie2 expres-
sion might represent a central way to maintain vascular quiescence.
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Flow-regulated GATA3 Expression Controls Tie2 Transcription
in Sepsis
Thamm K (1), Schrimpf C (2), van Meurs M (3), Ghosh CC (4),
Retzlaff J (1), Haller H (1), Parikh SM (4), David S (1)
(1) Medicine; Nephrology and Hypertension, Medical School Han-
nover, (2) Vascular and Endovascular Surgery, Department of
Cardiothoracic, Transplantation and Vascular Surgery, Medical
School Hannover, (3) Department of Critical Care, University Med-
ical Center Groningen, (4) Center for Vascular Biology Research,
Beth Israel Deaconess Medical Center and Harvard Medical School.
Introduction: Tie2 is a barrier-protective tyrosine kinase receptor
that is almost exclusively expressed by endothelial cells (ECs) and
maintains vascular barrier function and endothelial quiescence. In
systemic inflammation, Tie2 signaling is altered by de-activation of
Tie2 by its antagonistic ligand (termed Angiopoietin-2) and by Tie2
ectodomain shedding. Recently, we have additionally observed an
acute drop in Tie2 transcription upon various models of murine
critical illnesses.
Objectives: We looked for a common chief mechanism of negative
Tie2 mRNA regulation in sepsis leading to a capillary leakage and
multiple organ dysfunction.
Methods: Basic molecular biology methods (qPCR, WB, siRNA,
plasmid transfection) for in vitro (endothelial cells in a microfluidic
chamber to apply flow) analysis and in vivo murine sepsis models
(cecal ligation and puncture (CLP) and endotoxemia (LPS)). Addi-
tionally, qPCR for Tie2 and GATA3 from post mortem kidney
biopsies from septic AKI (acute kidney injury) patients (n = 14).
Results: In murine experimental sepsis, we found a rapid and pro-
found suppression of Tie2 mRNA by [90% in less than 4 h in
different vascular beds. A common denominator of clinical sepsis is
shock leading to microvascular hypoperfusion that led us to investi-
gate flow-regulated endothelial gene responses that could control Tie2
mRNA. In in vitro flow experiments (to model hypotensive shock) we
identified GATA binding protein (GATA) 3 as a potential regulator of
Tie2 transcription. GATA3 was also significantly reduced in different
murine sepsis models (CLP and LPS). Of note, flow dependent
GATA3 induction was required for ECs to increase Tie2 transcription
but GATA3 alone was not sufficient to boost Tie2 transcription.
Importantly, in post mortal human biopsies from septic individuals
Tie2 and GATA3 were also reduced and significantly correlated with
each other highlighting the putative translational relevance of this
finding.
Conclusions: Given that we observed a drop in Tie2 mRNA in var-
ious models of critical illness we believe that the common driver
could be ‘‘shock’’ that leads to reduced microvascular flow thereby
negatively affecting flow-dependent gene responses. Our data indicate
that transcriptional changes of GATA3 might count responsible for
the acute reduction in Tie2 mRNA and vascular destabilization in
sepsis.
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Microbiota of the albino rats colic lumen under abdominal sepsis
Sydorchuk L (1), Sydorchuk I (1), Sydorchuk A (3), Sydorchuk L (3),
Sydorchuk R (2)
(1) Microbiology, Bukovinian State Medical University, (2) General
Surgery Department, Bukovinian State Medical University, (3)
Family Medicine, Bukovinian State Medical University.
Introduction: Abdominal sepsis (AS) continues to occupy a leading
position by the severity of the course, frequency of complications and
mortality among acute surgical pathologies. The main sources of
infection are microorganisms that persist in the lumen and in biotope
of the mucous membrane of the small and large intestine.
Objectives: To study the qualitative and quantitative composition of
the microbiota of the contents of the colic lumen of albino rats with
AS.
Methods: The experiment was conducted on outbred albino rats
(body weight 200–220 g). All animals were quarantined for 10–14
days in vivarium. Ten rats with induced abdominal sepsis were
included in the main group, 15 intact animals formed the control.
Before the study all animals were examined for possible pathology. In
sterile conditions, the abdominal cavity was opened, a portion (1.5–2
cm) of the colon with its contents was taken. A sterile 0.9% sodium
chloride solution was added to the contents. The series of ten-fold
dilutions with a concentration of the initial mixture of 10–2 to 10–10
were prepared. From each test tube 0.01 ml was applied to appropriate
solid nutrient media, which are optimal for microbes.
Results: Bacteroides, Escherichia, Lactobacillus, Proteus, Clostrid-
ium, Bifidobacterium, Peptococcus, Staphylococcus are dominant in
the colon cavity of experimental animals with AS according to
microecological indices (Margalef, Berger-Parker and Simpson indi-
ces). Peptostreptococcus, Klebsiella, Enterobacter and yeast-like
fungi of the genus Candida belong to the additional microflora.
Enterococci, according to their indices, are represented as accidental
microflora, although in intact rats they form a dominant microbiota. In
experimental animals with AS the population level of colony-forming
(viable) Bifidobacteria decreases by 2.06 times, Lactobacilli—by 2.04
times. Also, the population level of Peptostreptococci is reduced by
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50.13%. On the background of a decreased number of anaerobic
functionally significant bacteria, there is an increase in the role of
conditionally pathogenic Bacteroides by 21.04%, Peptococci—by
54.59%, and Clostridia—by 55.64%. In this case, microorganisms
that contaminate the cavity of the colon reach a high (from
4.95 ± 0.18 to 5.93 ± 0.27 lg CFU/g) population level. Aerobic
microorganisms dominated by 36.22% compared with ones in intact
animals, where anaerobic bacteria predominate more than twice.
Conclusions: In the colon cavity of the outbred albino rats with
experimental AS severe disorders of microbiota in comparison with
intact animals are formed. That results in changes of taxonomic
composition and population level of its representatives. According to
the quantitative composition of microorganisms of the colon cavity of
albino rats with AS they are displayed in the following order: bacteria
of genera Escherichia, Bacteroides, Proteus, Clostridium, Lacto-
bacillus, Peptococcus, Bifidobacterium, etc. The quantitative
composition of aerobic microorganisms dominated over anaerobic
bacteria.
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Development of a human gut-on-chip model to study macrophage
dependent inflammatory response
Maurer M (1), Wollny T (2), Berlinghof F (2) Raasch M (1),
Huber O (2), Mosig A (2)
(1) Center for Sepsis Control and Care, Jena University Hospital, (2)
Institute of Biochemistry II, Jena University Hospital.
Introduction: Under normal conditions the intestinal epithelium
forms an essential barrier to prevent translocation of microorganisms,
toxins or other potentially harmful molecules to our body. Especially
dendritic cells in the intestinal epithelium provide important tolerance
signals to intestinal microorganisms which thus do not act as patho-
gens but appear to modulate different physiological, metabolic and
immunological functions of their hosts. Pathophysiological conditions
of sepsis however, are typically accompanied with a disruption of the
epithelial and endothelial gut barrier function allowing access of
pathogens to the circulation and thus to different tissues and organs.
Objectives: In this study we aimed to establish a microfluidically
perfused three-dimensional cell culture system of the human gut to
elucidate the molecular and cellular mechanisms of inflammation-
associated gut barrier breakdown.
Methods: A human gut-on-chip model was developed based on our
previously developed MOTiF (multi organ tissue flow) biochips made
from polystyrol. The biochips are composed of two chambers sepa-
rated by a micro-porous membrane. Each chambers is connected to
inlet and outlet channels allowing independent perfusion of the
individual channels and application of microfluidic shear stress.
Human umbilical vein endothelial cells (HUVECs), tissue resident
macrophages and intestinal epithelial cells (Caco-2) were assembled
on the biochip membrane and grown for 7–14 days.
Results: Within two weeks of perfusion the gut-on-chip models
formed self-organized and well-polarized villus- and crypt-like
structures that resemble essential morphological characteristics of the
human intestine. Integrated human macrophages mimicking dendritic
cells specifically respond to bacterial lipopolysaccharide (LPS)
challenge depending on the side of stimulation. LPS is well-tolerated
at the epithelial side corresponding to the gut lumen without signs of
macrophage activation or a significant release of cytokines. However,
LPS stimulation at the endothelial side of the gut-on-chip model
triggers a pro-inflammatory macrophage activation and the release of
cytokines such as TNF, IL-1b, IL-6 and IL-8.
Conclusions: The gut-on-chip model can be used to gain more detailed
insight into the interplay between commensal bacteria (Lactobacilli,
E. coli and Enterococci) and the human gut. Furthermore, it will be
used to study mechanisms of immune tolerance and host-pathogen
interaction. Therefore, infection models of pathogenic E. coli as well as
Candida albicans are currently established that will be used to explore
mechanisms of gut barrier break-down during sepsis.
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Lung-on-chip model for sepsis research
Rennert K. (1), Nietzsche S. (2), Siwczak F. (3), Mosig A. (3)
(1) Institute of biochemistry II, Jena University Hospital, (2) Center
for Electron Microscopy, Jena University Hospital, (3) Center for
Sepsis Control and Care, Jena University Hospital.
Introduction: To date, the majority of investigations in regard to
microbial infections of the lung rely on animal models such as
rodents. However, lung anatomy and physiology as well as compo-
sition of the immune system significantly differs between rodents and
men. Therefore, considerable advances have been made in the
development of cell culture models as surrogates of human lung tis-
sue. However, human cells commonly fail to maintain differentiation
and expression of lung-specific functions, due to i.e. cancerous origin
of the cells and static mono-cell culture conditions. A human alveo-
lus-model recreating a reactive tissue-tissue interphase between the
vascular endothelium and the airway-facing epithelium is therefore
desirable. It could allow a deeper insight into infection mechanisms of
pathogens and their persistence in human lung tissue.
Objectives: The aim was to establish a human in vitro alveolus model
composed of vascular and epithelial cell structures with integrated
macrophages resembling the human alveolus architecture and func-
tion. The alveolus model should owe a high barrier integrity of the
air-liquid-interphase, that can be maintained for up to 14 days. In
addition, expression and localization of functional cell type-specific
marker and surfactant production should be similar to human lung
tissue. Combining all these characteristics it should be suitable for
infection studies of microbial organisms and their pathogenesis.
Methods: MOTiF biochips were seeded with human endothelial cells
on the vascular site and with epithelial cells and macrophages on the
airway site. This organoid was cultured for up to 14 days with a robust
and stable air-liquid interphase (ALI) under dynamic flow conditions.
Barrier integrity was proven by transepithelial electrical resistance
(TEER) measurements and permeability assays. Expression and
localization of cell-type specific markers and functional proteins was
proven by immunofluorescence.
Results: Dynamic conditions for maintaining ALI allow a
stable barrier with high transepithelial resistance and an intact vas-
cularity. The introduction of macrophages into the model resulted in a
significant increase of barrier integrity proven by TEER measurement
and permeability tests. In addition, epithelial cells show high
expression of tight junction proteins claudin 3 and occludin. Epithelial
cells in the alveolus model are able to produce surfactant (proven by
staining for surfactant protein A), which is important for an adequate
immune response to invading pathogens. Macrophages were
detectable for up to 14 days.
Conclusions: We established a functional, biochip-based human
in vitro alveolus model that could be suitable for infection studies.
Separated airway and vascular chambers allow an infection with a
pathogen from the airway site. Thereby inducing a immune response
it is possible to observe migration of immune cells from the vascular
site into the infected sites.
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SMARTDIAGNOS-Next generation technology for detection of
the pathogens causing sepsis—an EU Horizon 2020 innovation
project
Wolff A (1), Vinayaka AC (2), Shahbazi MA (1), Kant K (1),
Tien NA, Bang DD
(1) DTU Nanotech, Technical University of Denmark, (2) DTU Food,
Technical University of Denmark.
Introduction: Sepsis is a potentially fatal condition arising when the
body’s response to an infection, damages its own tissues and organs.
Sepsis is one of the biggest health issues in the EU and worldwide due
to its high incidence, mortality, and economic cost. Early diagnosis is
crucial, as every hour of delay in appropriate antimicrobial (AM)
therapy increases mortality by 5–10%.
Sepsis diagnosis remains one of the greatest challenges in critical
care. Current laboratory (LAB) methods for detection of the patho-
gens causing sepsis, including blood culture and different nucleic acid
based multiplex amplification technologies, are impaired by the sig-
nificant time-delay of 1–2 days and/or low sensitivity of 30–50%.
Hence there is an urgent need to develop new diagnostic tools that can
provide more accurate and earlier pathogen detection, so that sepsis
patients can be administered with rapid and correct AM treatment.
Objectives: The proposed SMARTDIAGNOS platform will advance
sepsis diagnosis by simplifying clinical sample analysis methods and
integrating the required numerous steps into a streamlined point-of-
care (POC) and a LAB device.
Methods: These objectives will be achieved by combining a number
of innovative technologies: (1) 3-dimensional concentration of
pathogens to process large amount of raw sample (whole blood); (2)
direct PCR in the 3D microstructure to circumvent DNA extraction
step; (3) solid phase PCR (SP-PCR) to achieve unlimited multiplexing
capability and unprecedented selectivity; (4) supercritical angle flu-
orescence (SAF) microlens array for enhanced fluorescence detection
and precise quantification of sepsis-related pathogens; (5) SP-PCR to
identify microRNA (miRNA) as biomarkers for the body’s response
to infection.
Results: In the first year of the project we have: (1) defined user
requirements based on literature; on end-user interviews; expert
interviews, and review of existing commercial products; (2) designed
and fabricated 3-dimensional structures for concentration of patho-
gens; (3) developed reactions to detect 5 and 30 of the most relevant
sepsis pathogen genus and species, respectively, and 6 of the most
relevant AM resistant (AMR) genes by SP-PCR; (4) designed and
fabricated arrays of SAF microlenses which increases fluorescence
sensitivity by 1–2 orders of magnitude; (5) a pilot study resulted in a
potential miRNA profile that could be applied as sepsis biomarkers to
stratify between patients having bacterial sepsis and patients having
non- infectious SIRS. However these results need to be further
validated.
Conclusions: In the expected outcome of the project the SMART-
DIAGNOS system will go beyond the state of the art for shorter time
(1–3 h), higher sensitivity (95%), higher selectivity (99%), multi-
plexing capability, and automation. Fast and correct detection of
sepsis-related pathogens and their AMR genes will improve patient
outcome, shorten intensive care stay and thus reduce health care costs.
Reference: http://www.smartdiagnos.eu
Acknowledgement: Thanks to everyone from the SMARTDIAG-
NOS consortium.
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Infection-on-chip: Staphylococcus aureus infection in a human
liver-on-chip model
Siwczak F (1), Gerstmeier J (2), Werz O (2), Lo¨ffler B (3),
Tuchscherr de Hauschopp L (3), Mosig A (1)
(1) Center for Sepsis Control and Care, Jena University Hospital, (2)
Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Frie-
drich Schiller University Jena, (3) Institute of Medical Microbiology,
Jena University Hospital.
Introduction: Staphylococcus aureus (S. aureus) is an opportunistic
pathogen that can colonize the epithelial surface of many healthy
individuals, but is also one of the most frequent causes of sepsis. To
invade human tissues S. aureus could rely on a wide spectrum of
different virulence factors, but possess also the ability to dynamically
react to environmental changes and adapt to the intracellular milieu
by changing its bacterial phenotype to ‘‘small colony variants’’
(SCVs). SCVs are adapted phenotypes for intracellular persistence in
endothelial and epithelial cells. Tissue macrophages of the liver,
termed Kupffer cells (KC), are critical regulators of host defense
against systemic S. aureus infections by sequestering the majority of
bacteria from the blood stream.
Objectives: The aim was to establish an infection model of S. aureus
for the human liver to specifically elucidate to role of macrophage
polarisation in an adaptive immune response.
Methods: In a microfluidic human liver-on-chip model we investigate
the host–pathogen interaction in the context of a complex liver
microenvironment.
Results: We focus on the immune response to the pathogen and
analyze how different KC activation stages could influence SCV
formation and bacterial persistence during the course of infection. In
addition, resolvins and lipoxins as pro-resolving lipid mediators
secreted by macrophages are characterized for their potential to
ameliorate infection associated tissue damage in the context of an
adapted immune response.
Conclusions: Revealing the mechanisms of S. aureus which allow
bacteria to hide within the host and circumvent the host´s defense
system is the prerequisite to develop new therapeutic strategies for
treatment of S. aureus infection-related sepsis and its long term
sequelae.
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Hemolysis and glucose metabolism during systemic inflammation:
responses to intravenous glucose infusions
Ja¨gers J (1), Brauckmann S (2), Kirsch M (1),
Effenberger-Neidnicht K (1)
(1) Institute of Physiological Chemistry, University Hospital Essen,
(2) Clinic for Anesthesiology and Intensive Care, University Hospital
Essen.
Introduction: Systemic inflammation alters glucose metabolism
resulting in early hyperglycemia, temporary euglycemia and finally
hypoglycemia (1). Severe disorders of glucose metabolism are asso-
ciated with an increased risk of death (2, 3). A sufficient blood
glucose level is particularly important for the CNS, but even more
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important for the erythrocytes. Damage of the red blood cells leads to
massive hemolysis- and cell-free hemoglobin appears to be an
important predictor of survival in sepsis (4, 5).
Objectives: The impact of intravenous glucose infusion on the
alterations in glucose metabolism and the release of cell-free hemo-
globin during systemic inflammation were investigated in male
Wistar rats.
Methods: Sham control group rats (SHAM) received Ringer´s solu-
tion at a rate of 7 ml/kg h over a total period of 300 min. Systemic
inflammation was accomplished by continuous lipopolysaccharide
infusion (1 mg LPS in Ringer´s solution/kg h). Glucose was supplied
either moderately or excessively during systemic inflammation.
During moderate glucose supply, rats received 1 mg LPS in a 1%
solution of glucose/kg h (LPS + GLC1%). During excessive glucose
supply, rats received 1 mg LPS in a 3% solution of glucose/kg h (LPS
+ GLC3%). Systemic and vital parameters (e.g., systemic blood
pressure) as well as blood and plasma parameters (e.g., concentrations
of glucose, lactate and cell-free hemoglobin; activity of lactate
dehydrogenase) were measured hourly.
Results: Continuous infusion of LPS led to an early hyperglycemic
pre-shock state followed by a later hypoglycemic shock state. It
induced severe functional impairment and tissue injury such as
metabolic acidosis, electrolyte disturbances, and massive hemolysis
(increases in plasma cell-free hemoglobin). Excessive but not mod-
erate glucose supply increased LPS-related early hyperglycemia.
Later hypoglycemia was improved by excessive glucose supply (only
slightly by moderate glucose supply). Both moderate and excessive
glucose supply reduced hemolysis during systemic inflammation.
Excessive but not moderate glucose supply enhanced LPS-induced
tissue injury measured as an increase in lactate dehydrogenase
activity.
Conclusions: Final hypoglycemia during systemic inflammation can
be reduced by intravenous glucose infusion. In accord, excessive
glucose supply causes an increase in early hyperglycemia (6). More
interestingly, however, is the observation that even moderate glu-
cose supply can reduce the LPS-induced release of cell-free
hemoglobin—what is known to be an amplifier of LPS biological
activity (7). At present, further studies are underway know, to verify
whether the decrease of hemolysis is directly attributable to the
changes in blood glucose as the sole source of energy for the ery-
throcytes or is due to the modulatory role of glucose in the
inflammation-related activation of coagulation (8). The latter was
identified recently as one possible mechanism to induce hemolysis
during systemic inflammation (9).
Reference: (1) Maitra SR, Wojnar MM and Lang CH. Shock 2000,
13: 379. (2) Hammer MJ, Casper C, Gooley TA, et al. Biol Blood
Marrow Transplant 2009; 15: 344. (3) Krinsley JS. Mayo Clin Proc
2003; 78: 1471. (4) Adamzik M, Hamburger T, Petrat F, et al. Crit
Care 2012; 16: R125. (5) Janz DR, Bastarache JA, Peterson JF, et al.
Crit Care Med 2013; 41: 784. (6) Michie HR. World J Surg 1996; 20:
460. (7) Kaca W, Roth RI, Levin J. J Biol Chem 1994; 269: 25078. (8)
Levi M, Nieuwdorp M, van der Poll T, Stroes E. Sem Thromb Hemost
2008; 34: 26. (9) Brauckmann S, Effenberger-Neidnicht K, Nagel M,
Mayer C, Peters J, Hartmann M. Anesthesiology 2017; submitted.
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Dampening inflammation: Co2+-loaded block copolymer micelles
as novel tools to trigger anti-inflammatory macrophage
polarization
Raasch M (1), Meˇrkova` V (2), Ro¨ssel C (2), Schacher FH (2),
Mosig A (1)
(1) Center for Sepsis Control and Care, Jena University Hospital, (2)
Laboratory of Organic and Macromolecular Chemistry, Friedrich-
Schiller-University Jena.
Introduction: Sepsis is associated with an overwhelming immune
response and pro-inflammatory activation of macrophages (Mph)
triggered by pathogen-associated molecular patterns (PAMPs). Mph
are important regulators of the immune response and could mediate
pro-inflammatory but also anti-inflammatory processes during acute
phase infection and tissue regeneration, respectively. During acute
phase of sepsis, pro-inflammatory cytokines are abundantly released
by pro-inflammatory M1 polarized Mph that contribute to inflam-
mation-associated tissue damage. On the other hand, anti-
inflammatory M2 polarized Mph contribute to tissue remodeling and
repair after initial acute phase reaction to infection.
Objectives: Cobalt 2+ (Co2+) ions have been described to specifi-
cally modulate Mph activation through induction of the regenerative
M2 polarization state. Nevertheless, free Co2+ is toxic. We therefore
synthesized triblock terpolymer micelles for Mph-specific intracel-
lular delivery of Co2+.
Methods: Co2+ loaded micelles were tested for their ability to
modulate polarisation state in human primary macrophages in vitro.
Results: We characterized the micelles with respect to size, effective
Co2+ loading and impact on cellular viability. Plain and cobalt-loa-
ded micelles with sizes ranging from 15–30 nm were taken up in a
concentration-dependent manner through Mph without detrimentally
affecting cell vitality. Micelle uptake was found to be independent
from active receptor-mediated endocytosis and likely occurred by
fusion with the cellular membrane. Co2+-loaded but not plain micelle
uptake by non-activated Mph lead to concentration-dependent release
of IL-10 with no detectable secretion of TNF or IL-1b. In LPS-acti-
vated Mph Co2+ delivery mediated a significant reduction of pro-
inflammatory cytokines (TNF, IL1b, IL-8 and IL-6) and a 200-fold
increased release of IL-10 compared to unloaded control vehicles. In
addition, dampened inflammation was associated with increased
expression of M2 polarization markers CD163 and CD206.
Conclusions: In conclusion, Co2+ delivery to LPS activated Mph by
triblock terpolymer micelles prevented a pro-inflammatory immune
response by inducing an anti-inflammatory M2 phenotype. Co2+-
loaded micelles might represent a novel tool to specifically induce
M2-Mph polarization also in in vitro tissue cultures. In addition,
triblock terpolymer micelles might also be an interesting delivery
vehicle for Co2+ to prevent macrophage-dependent tissue damage
in vivo.
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Macrophages and monocytes as regulators of tissue damage and
repair in a human liver-on-chip model
Groeger M (1), Rennert K (2), Hartfiel S (1), Bauer M (1), Huber O
(2), Mosig A (1)
(1) Center for Sepsis Control and Care, Jena University Hospital, (2)
Institute of Biochemistry II, Jena University Hospital.
Introduction: Tissue resident macrophages are important mediators
of inflammation. The liver harbors *80% of all body macrophages
which underscores the central immunological role of this organ,
especially during sepsis. In adapting their phenotype, Kupffer cells
cell can either contribute to inflammatory progress (M1-polarization)
or trigger tissue-regeneration and -repair (M2-polarization). This
switch is critically regulated via cytokine signaling and mainly driven
by circulating blood cells, like monocytes.
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Objectives: Based on our recently established human liver-on-chip
model we investigated the hepatic dysregulation in respect to mac-
rophage polarization and elucidated the role of circulating monocytes
during this inflammatory process. Further, we identified possible
regulators of the macrophage polarization switch.
Methods: The microfluidically perfused liver-on-chip model, which
includes all major cell types of the liver was challenged with
lipopolysaccharide (LPS) to induce inflammation. Pro-inflammatory
cytokines (IL-6, TNF and IL1b) as well as anti-inflammatory
cytokines were measured in the vascular compartment. Hepatic
damage and function was assessed through measurement of clinically
relevant parameters. Furthermore, immunofluorescence microscopy
as well as celltype-dependent markers were used to determine mac-
rophage polarization state.
Results: Challenge of the liver-on-chip model with LPS led to a pro-
inflammatory phenotype of the tissue resident macrophages together
with an upregulation of CD197 and HiF-1a, representing an M1-like
phenotype. Integration of circulating monocytes prevented hepatic
damage. This was most likely associated with an M2-like phenotypic
transition of tissue resident macrophages and a higher release of the
anti-inflammatory cytokine IL-10.
Conclusions: Our study demonstrates the critical role of tissue-resi-
dent macrophages and invading monocytes during hepatic
inflammation in a complex microenvironment. Furthermore, it was
shown that macrophage polarization critically determines tissue
damage and as well as tissue-repair in a human liver-on-chip model.
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CAAP48—a new sepsis biomarker that has an active role in the
pathophysiology of sepsis
Blaurock N (1), Schmerler D (1), Hu¨nniger K (3), Gro¨ger M (2),
Kurzai O (2,3), Mosig AS (2), Kiehntopf M (1,2)
(1) Department of Clinical Chemistry and Laboratory Medicine, Jena
University Hospital, (2) Integrated Research and Treatment Center
for Sepsis Control and Care (CSCC), Jena University Hospital, (3)
Institute for Hygiene and Microbiology, University of Wu¨rzburg.
Introduction: Sepsis is a life threatening condition and the leading
cause of death in intensive care units. For significant reduction of
sepsis mortality a very early diagnosis and identification of high-risk
patients as well as a fast and targeted therapy is mandatory. Therefore,
identification of reliable biomarkers, facilitating sepsis diagnosis, is
still necessary.
Objectives: Using mass spectrometry we identified a C-terminal
fragment of alpha-1-antitrypsin, designated CAAP48 (C-terminal
peptide of alpha-1-antitrypsin with a mass of 4.8 kDa), that we found
to be elevated in septic patients. Furthermore, we could show that this
proteolytic fragment acts pro-inflammatory and influences the
homeostasis of immune cells as well as endothelial cells and
hepatocytes.
Methods: CAAP48 concentrations were determined in plasma sam-
ples of sepsis patients and in the time course of sepsis by LC-MS/MS.
To examine the effect of CAAP48 on immune cells fresh isolated
PMN/monocytes were incubated with different concentrations of
synthetic CAAP48 and several control peptides. The expression of
activation markers was analyzed by flow cytometry. The chemotactic
response was examined using disposable Boyden chambers. The
viability was determined based on Annexin V/propidium iodide
staining. To analyze the pathophysiological function of CAAP48 on
human endothelial cells and hepatocytes we used a microfluidic-
perfused in vitro organoid model of the human liver sinusoid that
allows studies under physiological conditions. Immunofluorescence
staining was done with antibodies against: MRP2, VE-cadherin and
F-actin. Secreted cytokines were measured in collected supernatants
using a commercially available cytometric bead array.
Results: CAAP48 was observed to be present in 3-4 fold higher
concentrations in sepsis patients than in controls with sterile systemic
inflammation. The peptide has been found to highly activate PMN and
monocytes, to induce pro-inflammatory cytokine release, to stimulate
migration and to reduce cell viability. Furthermore, CAAP48-treat-
ment leads to similar pathological changes, which are described for
sepsis-induced cholestasis, e.g. down-regulation of the hepatic
transport protein MRP2 and a diminished expression of endothelial
VE-cadherin and F-actin, which results in a loss of barrier function.
Conclusions: Based on our previous results we propose that CAAP48
is a promising sepsis biomarker that has an active role in the patho-
physiology of sepsis. However, the importance of CAAP48 as sepsis
biomarker has to be further evaluated in prospectively collected
patient cohorts with defined bacterial infections, different foci of
infection and in the time course of sepsis to clarify and validate the
role of CAAP48 in early identification of patients at risk and timely
initiation of appropriate antibiotic therapy. Furthermore, studies in
progress will evaluate the underlying molecular mechanisms of
CAAP48 uptake, receptor binding and signal transduction.
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Comparison of three different animal models for systemic
inflammation
Seemann S (1), Zohles F (1), Lupp A (1)
(1) Institute of Pharmacology and Toxicology, Jena University
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Introduction: Different rodent models have been developed to
investigate new drug candidates and to mimic systemic inflammation
in humans.
Objectives: Since these models are still discussed controversially, we
aimed to comparatively evaluate the most widely used models with
respect to the systemic effects, the influence on organ functions and to
the underlying pathophysiological processes.
Methods: Systemic inflammation was induced in C57BL/6N mice
with lipopolysaccharide (LPS) treatment, peritoneal contamination
and infection (PCI), or cecal ligation and puncture (CLP). Since we
were interested in the natural course of the disease and since we
induced a mid-grade systemic inflammation making acute lethality
very unlikely, in none of the three animal sepsis models antibiotic
therapy or fluid resuscitation was given. 0, 2, 4, 6, 12, 24, 48 and 72 h
after inflammation onset, mice were sacrificed and blood was
obtained for TNF alpha, IL-6, IL-10, IFN gamma, CXCL12, ALAT
and blood glucose evaluation. Oxidative stress in the brains, kidneys,
livers, lungs and spleens was assessed and liver biotransformation
capacity was determined. Finally, we utilized immunohistochemistry
in liver and spleen tissue to determine cluster of differentiation 3
(CD3), CD8, CD68, CXCL12, CXCR4, cleaved caspase-3 and TNF
alpha expression patterns, and to assess the presence of various
markers for oxidative stress.
Results: Treating mice with LPS and PCI caused a very similar
course of the inflammation; however, LPS treatment elicited a
stronger response. We observed a rapid increase of pro-inflammatory
cytokine levels, an early onset of oxidative stress in the organs, an
early decrease in blood glucose values and in biotransformation
capacity, a pronounced immigration of inflammatory cell populations
from the blood in the liver and spleen and apoptosis in the spleen
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tissue. Mice exposed to either LPS or PCI recovered after 72 h. In
contrast, CLP treatment induced comparatively fewer effects, but a
more protracted course of inflammation.
Conclusions: All in all, the LPS model of systemic inflammation
revealed to be most suitable when being interested in the impact of
new therapies for acute inflammation, as the effects are clearly visible
and the model exerts several methodical advantages. When inducing
inflammation by CLP to mimic human sepsis more closely, the time
period has to be chosen long enough as the treatment induces a
delayed course of the inflammation. Finally, the parameters to be
investigated have to be chosen very carefully in dependence of the
aim of the study.
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Modeling the metabolic reprogramming of macrophage
activation
Ho¨rhold F (1,2), Oswald M (1,2), Eisel D (3), Kolte A (1,2),
Eichmu¨ller S (3), Ko¨nig R (1,2)
(1) Center for Sepsis Control and Care, University Hospital Jena, (2)
Associated Group of Network Modeling, Leibniz Institute for Natural
Product Research and Infection Biology - Hans Kno¨ll Institute, (3)
GMP and T Cell Therapy Unit, German Cancer Research Center
(DKFZ).
Introduction: Bacterial infections can get systemic leading to sepsis,
i.e. organ failure caused by an unbound immune response, and often
death. Resting macrophages can polarize mainly into two distinct
phenotypes: M1 (classical activation e.g. by microbial products or
IFN-g) or M2 macrophages (alternative activation e.g. by IL-4). M1
macrophages can produce pro-inflammatory mediators such as TNF-
a, IL-1 and nitric oxide [3] and can mediate an inflammatory response
leading to a cytokine storm triggering sepsis. In contrast, M2 mac-
rophages show a rather immunosuppressive behavior during sepsis
[5].
Objectives: Hence, a central aim of critical care is to reduce M1 and
induce M2 activation during the acute phase of sepsis. A metabolic
switch of M1 to M2 macrophages had been described by upregulation
of aconitate decarboxylase in M1 macrophages, which synthesizes
itaconate from cis-aconitate [1], M1 macrophages modulate the
citrate cycle such that nitric oxide is produced in the urea cycle [1],
and other studies showed that a transition of M1 to M2 macrophages
can be induced by IL-4 [4,6], which, takes days [4] making it
unattractive for therapy of acute sepsis.
Methods: To understand the switch in regulation of metabolism, we
investigate gene regulation using our previously published tool [7].
Simultaneously, we predict metabolic fluxes with our newly devel-
oped method based on mixed-integer-linear programming integrating
gene expression data into flux balance models. Moreover, it contains a
method to remove thermodynamically infeasible loops.
Results: Comparing the predicted metabolic fluxes in M1 to M2
macrophages, we have a model that reflects M1 macrophages
upregulation of energy production by converting glucose to lactate
(Warburg effect) while M2 macrophages increase flux for nucleotide
biosynthesis.
Conclusions: Our study reveals promising results elucidating the
metabolic and transcriptional reprogramming of M1 and M2 macro-
phages after bacterial activation paving the way for identifying
therapeutic targets to reprogram M1 macrophages into a latent state.
References: [1] Jha, A.K., Huang, S. C.-C., Sergushichev, A.,
Lampropoulou, V., Ivanova Y., et al (2015). Network Integration of
Parallel Metabolic and Transcriptional Data Reveals Metabolic
Modules that Regulate Macrophage Polarization. Immunity, 42,
419-430. doi:10.1016/j.immuni.2015.02.005.
[2] Schellenberger, J., Lewis N. E., and Palsson, B. Ø (2011).
Elimination of Thermodynamically Infeasible Loops in Steady-State
Metabolic Models. Biophysical Journal, 100, 544-553. doi:
10.1016/j.bpj.2010.12.3707 .
[3] Stearns-Kurosawa, D.J., Osuchowski, M.F., Valentine, C., Kuro-
sawa, S., Remick, D.G. (2011). Pathology in Sepsis. Annual review of
pathology: mechanisms of disease. 6, 19-48. doi:
10.1146/annurev-pathol-011110-130327.
[4] Spiller, K.L., Nassiri, S., Witherel, C.E., Anfang R.R., Ng, J., et al
(2015). Sequential delivery of immunomodulatory cytokines to
facilitate the M1-to-M2 transition of the macrophages and enhance
vascularization of bone scaffolds. Biomaterials, 37, 194-207. doi:
10.1016/j.biomaterials.2014.10.017.
[5] Wynn, T.A., Chawla, A, Pollard, J.W. (2013). Macrophage biol-
ogy in development, homeostasis and disease. Nature, 496, 445-455.
doi:10.1038/nature12034.
[6] Zheng, X.-F., Hong, Y.-X., Feng, G.-J., Zhang, G.-F., Rogers, H.
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cans Mediated Up-regulation of EBI3 Expression. PLoS ONE, 8,
e63967. doi:10.1371/journal.pone.0063967.
[7] Poos AM, Maicher A, Dieckmann AK, Oswald M, Eils R, Kupiec
M, Luke B, Ko¨nig R (2016). Mixed Integer Linear Programming
based machine learning approach identifies regulators of telomerase
in yeast, Nucleic Acids Research, 44, e93.
[8] Bordbar, A., Mo, M.L., Nakayasu, E.S., Schrimpe-Rutledge, A.C.,
Palsson B.O., et al (2012). Model-driven multi-omic data analysis
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Predicting Nutritional Uptakes of Bacillus subtilis By Integrating
Gene Expression Profiles Into Metabolic Constrained-Based
Models
Thanamit K (1), Ho¨rhold F (1,2), Oswald M (1,2), Ko¨nig R (1,2)
(1) Network Modeling, Leibniz Institute for Natural Product Research
and Infection Biology-Hans Kno¨ll Institute (HKI), (2) Center for
Sepsis control and Care (CSCC), Jena University Hospital.
Introduction: Finding drug targets for antimicrobial treatment is a
central focus in biomedical research. To discover new drug targets,
we are interested in finding out which nutritional needs are important
for pathogenic microorganisms in the host or under specific circum-
stances. Besides this, metabolic fluxes have been successfully
constructed and predictions used by employing flux balance analysis
(FBA) using constrained based modeling (Orth et al., Nat Biotechnol,
2010, Sharma et al., Semin Cancer Biol, 2013, Lewis et al., Nat
Biotechnol, 2010).
Objectives: We develop FBA models using the stoichiometric
knowledge of the metabolic reactions of a cell and combine this with
experimental data, particularly gene expression profiles to identify
drug targets being essential for nutritional uptake in the metabolic
network of pathogenic microorganisms.
Methods: We implemented our method by using data from B. subtilis
as a case study. We used a metabolic model (Oh et al., J Biol Chem,
2007), gene expression data (Nicolas et al., Science, 2012) and 13C
experimental data (Chubukov et al., Mol Syst Biol, 2013). The data
comprises of 13C labelling experiments based flux data and gene
expression data for B. subtilis grown on 8 different carbon sources.
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We developed a method based on mixed-integer linear programming
(MIP) and trained the model with gene expression data. A further new
method was added to reduce thermodynamically infeasible loops
(TIL) to improve prediction results. Validation was performed by
comparing predicted flux values with the fluxes from the 13C label-
ling experiments.
Results: We started feeding the model with gene expression data of
each of the 8 carbon sources at a time and predicted the fluxes. By
employing our method, our trained model could identify the correct
major carbon sources based on gene expression profiles. We found
improved flux predictions when compared to models not employing
our new method of deleting TILs.
Conclusions: Our method is promising and can well predict flux
predictions in the metabolic network of B. subtilis. This can be
adapted to pathogenic microorganisms, like e.g. S. aureus to study
metabolic networks and find interesting candidates as drug targets to
be validated for in vitro experiments.
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(1,2), Horn P (1,5)
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Introduction: Skeletal muscle (SM) wasting occurs early in the
course of critical illness and impairs prognosis in affected patients [1;
2]. Key metabolic signaling pathways like insulin signaling have been
shown to be involved in pathogenesis of this phenomenon [2].
The endoplasmic reticulum (ER)-stress-signaling pathway is an
important regulator of metabolism and inflammation. Activation of
this pathway can both be detrimental or adaptive by promoting
metabolic dysregulation and apoptosis or cellular homeostasis,
respectively [3]. However, ER stress signaling in SM has not been
studied in critically ill patients and particularly in sepsis.
Objectives: To describe ER-stress-signaling and activation of apop-
tosis in SM of mice and patients suffering from peritoneal sepsis (PS).
Methods: We analyzed SM from 20 patients undergoing therapeutic
laparotomy, among them ten patients suffering from PS and ten
control patients with absence of high-grade systemic inflammation. In
a corresponding peritoneal contamination and infection (PCI) mouse
model, we isolated samples of gastrocnemius muscle from PS and
control mice. The mRNA expression of ATF4, ATF6, CD68, XBP1u,
XBP1s, CASP12, CHOP and BAX [4] was measured using qPCR in
both cohorts.
In a subset of patients, presence of CD68+ cells and nuclear XBP1
translocation were assessed by immunohistochemistry (IHC) and
apoptotic cells were stained using TUNEL assay.
Results: We found increased SM inflammation as assessed by sig-
nificantly increased CD68+ macrophage infiltration and significantly
increased CD68 mRNA expression in SM from both patients (p \
0.05) and mice (p \ 0.05) suffering from PS compared to control
individuals. In both human and murine SM, XBP1u and XBP1s
mRNA as components of the IRE-1 branch of ER-stress were sig-
nificantly upregulated in PS (p \ 0.05). There were no significant
differences in ATF4 and ATF6 mRNA expression in human SM (p[
0.05), indicating that the PERK and ATF6 branch of the UPR were
not involved in early onset PS. Though we found increased mRNA
expression of XBP1u and XBP1s, we were not able to detect
increased protein or nuclear translocation of XBP in IHC. Enhanced
SM mRNA expression of the apoptosis regulator BAX was found
both in human and mouse PS compared to controls (p\0.05). While
CHOP and CASP12 as specific mediators of ER-stress initiated
apoptosis were not upregulated, TUNEL staining revealed signifi-
cantly increased apoptosis in human SM (8/8 positive in PS vs 2/6
positive in non-PS controls; v2-test, p\ 0.05).
Conclusions: Sepsis leads to increased inflammation and pro-apop-
totic signaling in SM. This is accompanied by transcriptional up
regulation of IRE-1 branch of ER-stress pathway. Whether ER-stress
promotes tissue damage or is protective should be focus of further
investigations regarding critical illness myopathy.
References: [1] Schweickert WD1, Hall J. ICU-acquired weakness.
Chest. 2007 May;131(5):1541-9.
[2] Puthucheary ZA et al. Acute skeletal muscle wasting in critical
illness. JAMA. 2013 Oct 16;310(15):1591-600.
[3] Jiang D, Niwa M, Koong AC. Targeting the IRE1a-XBP1 branch
of the unfolded protein response in human diseases. Semin Cancer
Biol. 2015 Aug;33:48-56.
[4] activation transcription factor 4 (ATF4), activation transcription
factor 6 (ATF6), cluster of differentiation 68 (CD68), X-box binding
protein 1 (XBP1u), X-box binding protein 1 spliced variant (XBP1s),
Caspase 12 (CASP12), C/EBP homologous protein (CHOP), Bcl-2-
associated X protein (BAX)
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Hemoperfusion for rapid reduction of bacteria load: a non-
pharmaceutical approach for treating drug-resistant bacteremia
Ward R (1), McCrea K (1), White K (1), Van Zandt K (2), Bresler H
(2), Judd A (2)
(1) Research, ExThera Medical, (2), Battelle Columbus.
Introduction: Multidrug-resistant (MDR) pathogens threaten global
health, and increase interest in-non-pharmaceutical therapies. (1) The
WHO has identified 12 bacteria that pose the greatest threat, (2)
including MDR Acinetobacter, Pseudomonas, and Enterobacteri-
aceae. Rapid administration of effective antimicrobial therapy is
essential for improved outcomes (3) which correlate with reduction in
both bacterial load and duration of bacteremia (4).
Objectives: In vitro and large-animal testing of ‘Seraph’, a broad-
spectrum, biomimetic hemoperfusion device, have shown that it can
quickly remove drug-resistant bacteria from whole blood. Seraph 100
is a filter containing high-capacity ‘adsorbent media’ that mimics
heparan sulfate binding sites on cell surfaces. Oligomeric heparin is
permanently attached to the beads with a covalent bond creating a
‘brush-type’ molecular architecture that allows the entire heparin
chain to be accessible to molecular and cellular adsorbates. Seraph
200 also contains a ‘supplemental adsorbent’ that removes
endotoxins.
Methods: In vitro testing: 2.5 mL filter syringes were filled with
sterilized heparin-functional media. Two mL of pathogen-containing
blood at ca. 105 CFU/mL were passed through the syringes and pre-
and post-concentrations were enumerated. Microbiology testing was
performed at Microchem Laboratories, Texas, USA. In vivo testing:
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Drug-resistant pathogen challenges of Seraph 200 by Battelle used a
swine model. Bacteria were infused continuously at concentrations
between 400 and 3100 CFU/mL into a prototype extracorporeal
hemoperfusion circuit. Blood samples were collected contempora-
neously before and after Seraph to quantify bacteria removal by the
device.
Results: In vitro results demonstrated efficient single-pass removal of
drug-resistant bacteria strains: MRSA (92%), MRSE (66%), CRE
E. coli (99.9%), CRE K. pneumoniae (99.9%), VRE E. faecalis
(91%), and ESBL K. pneumoniae (39%). The Battelle porcine model
demonstrated that Seraph 200 could continuously remove MRSA
(78–88%), MDR (79%), MDR P. aeruginosa (83%), and MDR K.
pneumoniae (35%).
Conclusions: In vivo pre-clinical feasibility studies have been con-
firmed in an ongoing German clinical trial using Seraph in a 4-h
therapy during hemodialysis. Human and pre-clinical animal testing
support the use of Seraph therapy as an adjunctive tool to improve the
therapeutic efficiency of currently available drugs, or when no
effective antimicrobial drugs are available.
References: 1. Opal, Steven M. 2016, Critical Care, Vol. 20, 397.
2. E. Tacconelli, et al. Global Priority List of Antibiotic-Resistant
Bacteria to Guide Research, Discovery, and Development of New
Antibiotics. s.l. : World Health Organization, 2017.
3. Seymour, C W, et al. 23, 2017, The New England Journal of
Medicine, Vol. 376, 2235-2244.
4. Kirkbright. 2011, Emergence Medicine Australasia, Vol. 23, 502.
066
Infection 2017
Survival and function in rats with genetic predisposition for high
or low exercise capacity
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Department of Molecular and Integrative Physiology, Department of
Anesthesiology, The University of Michigan.
Introduction: Sepsis may lead to multiple organ failure and death.
Sepsis-induced cardiac dysfunction represents one of several possible
complications and is co-responsible for the high mortality typical for
sepsis. It is accepted that physical fitness as well as high intrinsic
exercise capacity positively influences cardiovascular health. How-
ever, less is known about the impact of these factors on cardiac
performance and metabolism in sepsis.
Objectives: We aimed to identify the effect of sepsis on cardiac
function, metabolism and insulin responsiveness in rats differing in
their genetic predisposition for either high or low inborn exercise
capacity.
Methods: Sepsis was induced in 15-week old rats with high (HCR) or
low (LCR) intrinsic running capacity by intraperitoneal injection of a
human fecal suspension. The Clinical Severity Score (CSS) was
determined to assess sepsis severity 6 and 24 h later. At 1 and 5
weeks, hearts from sepsis survivors were excised and prepared as
isolated working hearts. Cardiac function, substrate oxidation and
response to insulin were measured using radioactive tracer
technology.
Results: The two groups did not differ in their CSS scores at 6 and
24 h and survival was poor with 33% (HCR) and 38% (LCR) sur-
vivors at 72 h. After 5 weeks, septic animals displayed substantial
reductions of cardiac power (Control vs 5w of sepsis: 45.6 ± 2.9 vs.
37.6 ± 1.5, p\ 0.05 mW/g dry). This reduction in power was not
associated with sepsis-induced alterations in glucose oxidation
(0.33 ± 0.06 vs. 0.30 ± 0.05 lmol/min/g dry, n.s.) or fatty acid
oxidation (0.67 ± 0.08 vs. 0.70 ± 0.05 lmol/min/g dry, n.s.). How-
ever, when relating substrate oxidation to cardiac power as a measure
of substrate efficacy, there was an increase in substrate used per force.
Insulin response was increased in HCR only (change of glucose
oxidation: +0.32 ± 0.08 vs. +0.39 ± 0.07 and +0.16 ± 0.04 vs.
+0.51 ± 0.11 lmol/min/g dry, p\ 0.05).
Conclusions: The detrimental effects of sepsis on survival in rats are
not affected by their genetically determined exercise capacity. Sepsis
causes significant mortality and contractile dysfunction in survivors.
This dysfunction was accompanied by maintained glucose and fatty
acid oxidation suggesting significantly decreased efficiency of sub-
strate use.
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Microbiota of the albino rats ileum lumen under abdominal sepsis
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Introduction: Microflora of the distal part of ileum plays a separate
role in formation of abdominal sepsis (AS) and is characterized by
enhanced vascularization and localization of mucous-associated
lymphoid clusters, which provides a significant ability to resorption
of antigens in comparison with other parts of the gastrointestinal
tract.
Objectives: To study the qualitative and quantitative composition of
the microbiota of the ileum lumen of albino rats with AS.
Methods: A bacteriological method was used in 25 white rats
(200–220 g). All animals were quarantined for 10–14 days. Ten rats
with induced AS concluded the main group, 15 intact animals formed
the control. Before the study all animals were examined for possible
pathology. In sterile conditions, the abdominal cavity was opened, a
portion (1.5–2 cm) of the distal part of ileum with its contents was
taken. Pure cultures were identified by morphological, tinctorial,
cultural and biochemical properties.
Results: In animals with experimental AS the dominant microflora of
ileum lumen consists of obligate anaerobic bacteria of the genera
Bacteroides, Bifidobacterium, Lactobacillus, Peptostreptococcus,
facultative anaerobic and aerobic opportunistic enterobacteria: E. coli
and Proteus; additional microflora is formed by the bacteria of the
genus Enterococcus and accidental—by Peptococcus and Klebsiella.
Also, it should be noticed the elimination of the genera Bifidobac-
terium and Lactobacillus from the iliac lumen in 20.0% of the animals
and the contamination and colonization of the biotope with the con-
ditionally pathogenic enterobacteria of the genera Klebsiella and
Proteus. The results of the bacteriological study confirm the moderate
deficiency of the most important for composition of the intestinal
microbiocenosis and multifunctional role in maintaining the microe-
cological homeostasis bacteria of the genus Bifidobacterium
(reduction by 33.91%) and Lactobacillus (reduction by 27.53%), as
well as a less significant decrease in the population level of bacteria of
genera Bacteroides (19.85%), Peptostreptococcus (13.88%), Escher-
ichia (8.97%), Enterococcus (8.97%) etc. The number of Proteus in
the microbiocenosis is increased by 10.33%; Klebsiella reached a
moderate population level. Changes of the population level of bac-
teria of different taxons lead to an imbalance of microbiocenosis of
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the ileum lumen, which is more clearly indicated by other analytical
indices. Thus, in Bifidobacterium the quantitative dominance is
reduced by 44.88%, participation in the formation of microbiocenosis
of the biotope by 50.98%; in Lactobacilli by 37.02 and 36.01%
respectively, in Enterococci—by 3.5 times and 4.51 times respec-
tively. The quantitative dominance and participation in the formation
of the microbiocenosis of opportunistic enterobacteria increased by
32.37 and 57.96%.
Conclusions: AS leads to deficiency and in some cases (20.0%) to
elimination of Bifidobacterium, Lactobacillus and contamination and
colonization of the ileum lumen with opportunistic enterobacteria
(Klebsiella, Proteus).
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Introduction: The systemic inflammatory response syndrome (SIRS)
is characterised by endothelial and microvascular dysfunction
resulting in decreased organ perfusion and subsequent development of
organ failure. The energy-sensing enzyme AMP-activated kinase
(AMPK), a crucial regulator of cell metabolism and homeostasis, is
thought to play an important role in inflammatory processes. It exerts
significant anti-inflammatory and antioxidant effects in a variety of
cell types, in part by inhibiting the pro-inflammatory NFjB pathway.
Objectives: We hypothesised that AMPK may control SIRS and limit
inflammatory responses of the endothelium thereby protecting against
vascular dysfunction.
Methods: Experiments were performed in wild type (WT) mice and
in mice, in which the catalytic subunit AMPKa1 was knocked out
(KO). SIRS was induced by intraperitoneal injection of LPS (10 lg/g
body weight). To investigate differences in WT and KO mice, plasma
cytokine levels and markers of cellular damage as well as cytokine
levels in the liver were analysed. To characterise the influence of
AMPK on endothelial permeability in vivo, a vascular leakage assay
employing Evans Blue was performed. In vitro experiments were
performed in human umbilical vein endothelial cells, which were
stimulated with cytokines (IL-1b, TNF-a) and/or LPS and analysed
for permeability (ECIS) and adhesion molecule expression (flow
cytometry). AICAR and A769662 were used to activate AMPK in
these experiments.
Results: Female WT mice showed a higher survival compared to
male WT mice in response to LPS. Knockout of AMPKa1 reduced
survival in female mice but had no effect on mortality in male mice.
In line with this, higher plasma cytokine levels (IL1b, TNFa) and
increased plasma markers of cellular damage (lactate dehydrogenase)
were observed in female AMPKa1 KO mice indicating protection
from systemic inflammation by AMPKa1.
6 h after LPS injection, a significant vascular leakage as monitored
with Evans Blue was seen in organs including liver. Here, no
gender difference was observed. LPS-induced vascular leakage in
liver was clearly higher in AMPKa1 KO mice compared to WT
mice. In parallel, cytokine levels (IL-1b, TNF-a) in liver and
plasma markers of hepatocellular damage (alanine aminotrans-
ferase, aspartate aminotransferase) were increased in AMPKa1 KO
animals. These data indicate that AMPKa1 protects from vascular
leakage and liver inflammation during SIRS. This may be in part
due to endothelial barrier stabilisation and prevention of leukocyte
immigration into the tissue. Accordingly, pharmacological activa-
tion of AMPK in cultured endothelial cells led to a significant
decrease of cytokine-induced endothelial permeability and adhe-
sion molecule expression.
Conclusions: Taken together, these data underline the importance of
AMPK as an anti-inflammatory molecule in the context of systemic
and local inflammation. AMPK may represent a pharmacological
target to prevent or ameliorate inflammatory responses during SIRS.
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Introduction: The early recognition of potentially pathogenic
microorganisms is the essential step before mechanisms of innate and
adaptive immune responses are initiated. The evolutionary battle
between host and pathogens lead to the development of the Toll-like
receptor system for the recognition of bacterial, fungal and viral
components of very different chemical composition. Bacterial and
fungal cell wall components, proteins, toxins and nucleic acids belong
to those molecules and the binding of the so-called pathogen-asso-
ciated molecular patterns (PAMPs) to Toll-like receptors (TLRs)
provokes a signaling cascade resulting in recruitment of the tran-
scription factor NF-jB. NF-jB binds to certain NF-jB response
elements in the promotor region of genes involved in inflammation
and immunity and activates their transcription. The recognition pro-
cess takes place soon after microorganisms overcome the barriers of
skin and mucosa by tissue resident immune cells carrying TLRs and
also other immune receptors.
Objectives: We generated a TLR expression based cellular assay to
detect bacterial ligands in liquid samples. Our intention is to use
reporter cell lines to measure the activation and signalling of certain
Toll-like receptors to evaluate blood plasma samples from septic
patients.
Methods: We generated stable isogenic cell lines expressing single
TLRs (e.g. TLR5) or combinations of TLRs and cofactors (e.g.
TLR4). The cells are seeded in 96 well plates and stimulated after
14–16 h of adherence. The cells were stimulated with soluble ligands,
heat-inactivated bacteria and more complex samples e.g. spiked
plasma samples and blood plasma from septic patients.
Results: Cells expressing TLR2, TLR2/TLR1, TLR2/TLR6, TLR4-
CD14-MD2 or TLR5 were dose-dependently activated by the
according ligands lipoteichoic acid, Pam3Csk4, Fsl-1, LPS and
Flagellin as well as by heat-inactivated bacteria and spiked human
plasma samples. Septic plasma samples activated several TLR-ex-
pressing cell lines according to the causing microorganism.
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Conclusions: An optimized version of the system may potentially be
used as a biosensor system for bacterial components in the context of
diagnostic procedures.
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Staphylococcus aureus pathogenesis: The role of different host cell
types during the passage from sepsis to chronic osteomyelitis
Garcia Moreno M (1,2), Siwczak F (2,3), Lo¨ffler B (1,2), Mosig A
(2,3), Tuchscherr L (1,2)
(1) Medical Microbiology, Jena University Hospital, (2) Center for
Sepsis Control and Care (CSCC), Jena University Hospital, (3)
Biochemistry II, Jena University Hospital.
Introduction: Staphylococcus aureus is an opportunistic pathogen
and a frequent cause of infection. A dreaded complication of sepsis is
metastatic infection of different organs, such as osteomyelitis, which
is longsome and difficult to treat and often requires surgical inter-
ventions. The ability of S. aureus to establish chronic infections most
likely originates in the complex interaction of the bacteria with bone
tissue that is not fully understood. It includes invasion of S. aureus in
professional and non-professional phagocytes, expression of cytotoxic
and proinflammatory factors and bacterial persistence within the
intracellular location for long time periods.
Objectives: We established a mouse and human biochip organoid to
analyse the bacterial localization and the bacterial-host cell commu-
nication that might trigger bacterial adaptation processes in bone
tissue. We focused on non-phagocytic bone cells like osteoblasts and
osteocytes
Methods: Mouse bone biochip was established by seeding MC3T3-
E1 osteoblast and MLO-Y4 osteocyte murine cell lines with different
coatings and orientations. Those last ones were treated under miner-
alising conditions to induce the development of matrix. The human
bone biochip was developed using SaOS2 osteoblastic cell line, as a
human osteocytes cell line is not available; we used an already
published method where SaOS2 human osteosarcoma cells can dif-
ferentiate into osteocyte-like cells. The differentiation cell process
was analysed by fluorescence microscopy during 21 days. Cells were
fixed in PFA 4% and stained with Phaollidin-AF633 and DAPI
Results: Mice and human bone biochips were established. Providing
the appropriate mineralising conditions MLO-Y4 and SaOS2 cells
synthesised a mineralised matrix and acquired a characteristic
osteocytes dendritic morphology over the time, which was success-
fully measured by AlizarinRed. After 7 days under differentiating
conditions, the presence of calcium was observed indicating the
beginning of the mineralising process. Highly mineralised cultures
were observed after 21 days. Osteoblasts and osteocytes were able to
be seeded in both orientations. Both biochips presented differentiated
cells and mineralised matrix as it was observed
Conclusions: The knowledge about the localization of S. aureus
during infection is very important in order to design novel regimes to
prevent and treat chronic infections. This is difficult to be analysed
and all tries in animal models have failed up to now due to the fact
that systemic and localized infections cannot be determined via visual
observation. The biochip-organoid bone is an alternative model to
study the localisation of S. aureus during infection by closely simu-
lating the in vivo disease. This alternative ex vivo model will provide
critical real-time information needed for developing novel therapeu-
tics and investigate possible effective antimicrobial treatments for
chronic infections
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Chemerin as an effector of transactivation of hepatic stellate cells
Kammeyer C (1), Galler K (2,3), Schleser F (1), Neugebauer U (2,3),
Horn P (2,4), Claus RA (1,2)
(1) Department of Anesthesiology and Intensive Care, Jena Univer-
sity Hospital, Jena, (2) Center for Sepsis Control and Care, Jena
University Hospital, Jena, (3) Jena, Leibniz Institute of Photonic
Technolgy, (4) Department of Internal Medicine IV (Gastroenterol-
ogy, Hepatology, Infectious Diseases), Jena University Hospital,
Jena.
Introduction: Hepatic stellate cells (HSC) have been identified as
key mediators of hepatic fibrosis, a pathophysiological response of the
tissue towards acute or chronic stress. Once activated by cytokines,
viral infection, ethanol or other toxic agents, HSC lose vitamin A,
synthesize extracellular matrix components and thus transform into
contractile myofibroblasts. Adipokines such as leptin or adiponectin
are also known mediators of hepatic fibrosis. Chemerin is a novel
adipokine acting mainly via its own G-coupled receptor CMKLR1,
playing a role in type 2 diabetes, psoriasis and rheumatoid arthritis.
Interestingly, serum concentration was found elevated in patients
affected by peritoneal sepsis [1]. We therefore investigated whether
chemerin has an impact on the HSC-mediated liver fibrosis in an in-
vitro model.
Objectives: to investigate the impact of chemerin on transactivation
of immortalized human LX-2 cells monitoring intracellular signalling
events and functional activity (migration, contractility and loss of
vitamin A)
Methods: Experiments were performed on LX-2 cells following time
and concentration dependent stimulation: (1) qPCR analyses of
established marker genes of hepatic fibrosis, (2) migration assay using
ThinCertTM inserts, (3) contractility assay was carried out by
embedding LX-2 cells into a collagen matrix and measuring the time-
dependent collagen gel size change (4) mobilisation of Vitamin A
storage via Raman spectroscopy [2] (5) presence of CMKLR1 on LX-
2 cells by immunoblotting, also following of sub-cellular
fractionation.
Results: As a result of the pilot study, both CMKLR1 mRNA as well
as the protein content were detected in (stimulated) LX-2 cells at high
levels via qRT-PCR and immunoblotting. Surprisingly, chemerin
failed to induce any change in the synthesis of molecular markers of
activation of LX-2 cells as a surrogate of cellular transactivation.
While chemerin had also no impact on the contractility, migration
was inhibited in a dose dependent manner. Furthermore, chemerin
induced loss of vitamin-A was observed in LX-2 cells as a cell
specific marker of cellular stress. However, subsequent sub-cellular
fractionation revealed lack of CMKLR1 protein in the membrane
fraction.
Conclusions: Though CMKLR1 is not present on the surface of LX-2
cells, chemerin effectively and dose-dependently inhibited the
migration of LX-2 cells and lead to the loss of vitamin A. As selective
receptor signalling properties have recently been described for GPR1
[3], one can assume that the chemerin-induced activation of LX-2
cells is based on alternative, CMKLR1-independent pathways. Since
both migration as well as loss of vitamin A are hallmarks of trans-
activation of LX-2 cells, we suggest that chemerin plays a role in the
development of hepatic fibrosis. However, further experiments with
primary hepatic stellate cells or animal models are needed. Further-
more, the results of this study reveal the need of extended research
regarding the molecular mechanisms of chemerin.
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Reference: [1] Horn P, Metzing UB, Steidl R, Romeike B, Rauchfuß
F, Sponholz C, Thomas-Ru¨ddel D, Ludewig K, Birkenfeld AL,
Settmacher U, Bauer M, Claus RA, von Loeffelholz C (2016) Che-
merin in peritoneal sepsis and its associations with glucose
metabolism and prognosis: a translational cross-sectional study. Crit
Care 20:39.
[2] Galler K, Fro¨hlich E, Kortgen A, Bauer M, Popp J, Neugebauer U
(2016) Hepatic cirrhosis and recovery as reflected by Raman spec-
troscopy: information revealed by statistical analysis might lead to a
prognostic biomarker. Anal Bioanal Chem. 408:8053-8063.
[3] De Henau O, Degroot GN, Imbault V, Robert V, De Poorter C,
Mcheik S, Gale´s C, Parmentier M, Springael JY(2016)
Signaling Properties of Chemerin Receptors CMKLR1, GPR1 and
CCRL2. PLoS One 11:e0164179.
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An immunoproteomic approach to identify protein candidates for
pathogen detection and risk stratification in sepsis patients
Normann N (1), Scharf C (2), Schmidt F (3), Steil L (3), Gru¨ndling M
(4), Vo¨lker U (3), Bro¨ker B (1)
(1) Department of Immunology, University Medicine Greifswald, (2)
Department of Ear, Nose and Throat Diseases, and Head and Neck
Surgery, University Medicine Greifswald, (3) Interfaculty Institute of
Genetics and Functional Genomics, University Medicine Greifswald,
(4) Clinic of Anaesthesiology and Critical Care Medicine, University
Medicine Greifswald, (5) Medical Microbiology, University Medical
Center Utrecht, (6) Friedrich Loeffler Institute of Medical Microbi-
ology, University Medicine Greifswald, (7) Institute of Clinical
Chemistry and Laboratory Medicine, University Medicine
Greifswald.
Introduction: Sepsis, ‘‘as life-threatening organ dysfunction caused
by a dysregulated host response to infection’’ (Singer 2016), is the
third leading cause of death in hospitalized patients in Germany. Due
to an alarming increase of antibiotic resistant bacteria rapid microbial
diagnosis is needed to ensure the most appropriate antibiotic is cho-
sen. Blood culture, the gold standard of pathogen detection, is positive
in less than half of the cases of clinical sepsis. In contrast, PCR-based
methods promise to be faster, but carry a risk of false positive results.
Objectives: To complement conventional microbiological diagnosis,
we plan to develop a multiplex immunoassay. This assay will be
based on the quantification of the antibody binding kinetics to several
bacterial proteins simultaneously.
Methods: In a prospective clinical trial (IMI_Sep, BB020/13) we
collected plasma samples of sepsis patients before the onset of sepsis,
at diagnosis and during the infection. The most frequent sepsis
pathogens isolated from blood cultures or microbiological samples of
the septic focus were S. aureus, S. epidermidis, E. coli, E. faecium, P.
aeruginosa, S. marcescens and K. pneumoniae. The bacteria were
cultivated until stationary growth phase and extracellular proteins
were precipitated from the supernatants. Patient plasma antibody
binding to the extracellular proteins of the corresponding infectious
agent were quantified by using a Simple Western Assay
(ProteinSimple). Patients with an increase of antibody binding
during infection by at least a factor of two were defined as patients
with an informative course of disease. Extracellular proteins of sepsis
pathogens from patients with an informative course of disease were
separated by 2D gel electrophoresis, transferred to a PVDF membrane
and incubated with plasma. Total antibody binding was detected by
using chemiluminescence.
Results: For each patient, two 2D immunoblots were performed to
compare antibodies in plasma taken before sepsis onset with those in
plasma obtained at a later time point. During the disease course, often
new spots appeared on the 2D immunoblots and intensities of other
spots increased. For each of the six bacterial species at least five
immunogenic proteins were identified. These proteins will now be
cloned, recombinantly expressed and included in a multiplex assay.
Conclusions: This multiplex immunoassay may complement the
microbiological and sequence-based diagnosis of sepsis-pathogens
with information about the specific immune response. This promises
new insights into the role of the adaptive immune response in
infection control. The assay may also be suitable for stratification of
patients according to their risk of infection or complications of
infection, such as sepsis. Finally, the assay might support the diag-
nosis of chronic implant-associated infections.
Acknowledgement: Darm K2, Ku¨hn A4, Fuchs C4, Kolata J5, Tietz
G1, Balau V6, Schulz K6, Steinmetz I6, Nauck M7, Meissner K4
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Characterisation of two different preclinical murine models of
haemolytic uraemic syndrome
Pirschel W (1,2), Dennhardt S (1,2,3), Wissuwa B (1,2), Daniel C (4),
Gunzer F (5), Lindig S (1), Rudolph WW (5), Amann K (4),
Coldewey SM (1,2,3)
(1) Department of Anaesthesiology and Intensive Care Medicine,
Jena University Hospital, (2) Septomics Research Center, Jena
University Hospital, (3) Center for Sepsis Care and Control, Jena
University Hospital, (4) Department of Nephropathology, Friedrich-
Alexander University Erlangen-Nu¨rnberg, (5) Institute of Medical
Microbiology and Hygiene, Dresden University of Technology.
Introduction: Diarrhea-positive haemolytic uraemic syndrome
(HUS) is a rare kidney disorder most frequently caused by infections
with enterohaemorrhagic Escherichia coli (EHEC). Clinically, it is
characterised by a triad of microangiopathic haemolytic anaemia,
thrombocytopenia and acute kidney injury (AKI). Shiga toxins (Stxs),
particularly Stx2, as key virulence factors of EHEC play a predomi-
nant role in HUS development. Studying renal endothelial damage in
infection-associated HUS will allow us to gain fundamental insights
into pathophysiological principles of disturbed microcirculation and
thrombosis—a hallmark of HUS and septic shock.
Objectives: Specific prognosis-improving treatable targets in EHEC-
associated HUS are currently not available. In this study, we aimed to
establish and characterise an appropriate murine in vivo model to
elucidate molecular mechanisms underlying HUS pathogenesis and
perform pharmacologic intervention studies.
Methods: 10-16 week-old male C57BL/6J wild-type mice obtained
either a single high dose of Stx2 (acute model) or three low doses on
days 0, 3 and 6 (subacute model) accompanied by volume resusci-
tation. Disease progression was monitored. Kidney dysfunction and
damage were characterised by analysis of plasma urea and creatinine,
histological evaluation and detection of specific immunohistochemi-
cal targets for kidney and endothelial damage, apoptosis,
proliferation, complement activation and immune cell invasion. Dif-
ferences in gene expression patterns were examined using
microarrays.
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Results: Plasma creatinine and urea were significantly increased in
Stx2-challenged mice in both models, indicating kidney dysfunction.
Histological and immunohistochemical investigation of renal sections
revealed significant kidney damage accompanied by loss of
endothelial cells and thrombotic microangiopathy as hallmarks of
human HUS in both the acute and subacute model. In contrast,
complement activation, immune cell invasion and higher levels of
apoptosis as well as proliferation were observed only in the subacute
HUS model. Microarray analysis of both models showed 91 over-
lapping genes regulated by Stx2-challenge.
Conclusions: We established and characterised two distinct preclin-
ical models of HUS. Our results indicate that the subacute model
better reflects human HUS by presentation of kidney dysfunction,
thrombotic microangiopathy and endothelial damage but also com-
plement activation accompanied by immune cell invasion. The
models allow further pathophysiological characterisation and subse-
quent pharmacological studies in HUS and related conditions
associated with impaired microcirculation in the kidney.
W.P. and S.D. contributed equally
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Influence of Mitochondrial Function on Sepsis Severity and
Outcome
Schrepper A (1), Kynast S (1), Schwarzer M (1), Doenst T (1)
Department of Cardiothoracic Surgery, University Hospital Jena.
Introduction: Sepsis is associated with cardiomyopathy and mito-
chondrial dysfunction, which may predict sepsis mortality. However,
a temporal relation between cardiac and mitochondrial function has
not been investigated yet.
Objectives: The objective of this study was to evaluate the influence
of sepsis on cardiac and mitochondrial function in a time dependent
manner.
Methods: Sepsis was induced by intraperitoneal injection of human
feces (peritoneal contamination and infection model - PCI) in wild
type and transgenic mice. After 6, 24 and 72 h, sepsis severity and
cardiac function were assessed. Furthermore, mitochondrial function
of heart, skeletal muscle and liver was investigated at these three time
points. Mice without PCI served as a control.
Results: In wild types, PCI resulted in severe sepsis within the first
24h with elevated clinical severity score (basal vs. 24 h: 4 ± 0 vs.
11.5 ± 1.1), reduction of body weight and mortality rates of 0% after
6h, 62% after 24 h and 90% after 72h. Six hours after the septic insult
diastolic dysfunction (E/DT basal vs. 6h: 30.3 ± 1.8 vs. 19.5 ± 1.7;
p B 0.5), cardiac output reduction (17.3 ± 1.0 vs. 11.9 ± 0.8;
p B 0.5) and heart rate elevation (453 ± 11 vs. 516 ± 14; p B 0.5)
was measured, with no impairment of ejection fraction (53.8 ± 1.8
vs. 56.6 ± 1.9). Changes in cardiac function recovered slightly after
24 h and fully after 72 h in the survivors. At 6 h, there was no
difference in any echocardiographic parameter between the 24
h-survivors and the non-survivors, making a selection bias unlikely.
In contrast, cardiac state 3 respiration remained unchanged until 6 h
but was significantly decreased after 24h and even more so after 72 h
(basal-6 h-24 h-72 h:304 ± 44 vs. 276 ± 58 vs. 224 ± 36 vs.
116 ± 28 natomsO/min/mg). Therefore, we analyzed mice with a
moderate overexpression of SirT1, an activator of mitochondrial
biogenesis. Cardiac state 3 respiration was higher at baseline in
transgenic mice and was not affected by sepsis (basal-6 h-24 h-72 h:
457 ± 60 vs. 545 ± 46 vs. 460 ± 27 vs. 530 ± 59natomsO/min/
mg). Furthermore, cardiac function was less impaired with sepsis
(cardiac output: basal vs. 6h: 19.1 ± 1.0 vs. 15.3 ± 0.8; p B 0.5).
However, despite protected mitochondrial function, sepsis mortality
rate and sepsis severity were not improved.
Conclusions: Our data indicate, that there is no causal relation
between mitochondrial function and sepsis severity.
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QUANTIM—quantification of the innate immune function in
whole-blood infection assays
Leonhardt I (1), Lehnert T (2), Hu¨nniger K (4), Thomas-Ru¨ddel D (3),
Figge MT (2), Kurzai O (4)
(1) Fungal Septomics, Leibniz Institute for Natural Product Research
and Infection Biology, Hans Kno¨ll Institute, (2) Applied Systems
Biology, Leibniz Institute for Natural Product Research and Infection
Biology, Hans Kno¨ll Institute, (3) Department of Anesthesiology and
Intensive Care Medicine, University Hospital Jena, (4) Institute for
Hygiene and Microbiology, University of Wu¨rzburg.
Introduction: Despite the availability of the wide range of data on
cellular and molecular processes involved in systemic inflammation,
little progress has been made in pharmacologically modulating the
inflammatory dysregulation that occurs in sepsis. A major reason for
this is the heterogeneity of sepsis as a clinical syndrome, resulting
from highly diverse pathological conditions and showing variable
disease kinetics in individual patients. Therefore, it is of importance
to develop tools that enable categorization of septic patients and
predict the efficacies of tailor-made therapeutic interventions.
Objectives: Within this project, we use a human whole-blood assay
of infection combined with advanced mathematical modeling to
answer the two following questions:
Are there pathogen-specific patterns of immune activation during
whole blood infection?
Are there immune effector functions that allow stratification of sepsis
patients?
Methods: Blood samples taken from healthy donors and patients
were inoculated with the two model pathogens S. aureus and C.
albicans. After a 4 h time course immune cell activation and the
association of the pathogens with different immune cells were
determined using differential FACS staining. Based on time course
data on pathogen distribution to different immune cells a virtual
infection model was used to perform detailed and quantitative pre-
dictions on the dynamics of host-pathogen interaction.
Results: First, the infected blood samples from healthy donors pro-
vide a comparative analysis of the regulatory networks governing
inflammation and pathogen elimination. We found clear differences in
the immune response, e.g. the rates of immune cell reaction differ
considerably for infection with S. aureus and C. albicans. Thereafter,
the whole-blood assay was performed with a more homogeneous
population than septic patients. Within a pilot study, blood samples
from patients who underwent cardiac surgery with extracorporeal
circulation were examined. This surgery provides an inflammatory
stimulus that is both time-defined and relatively homogeneous. With
the ability to investigate the blood of the same patient at defined time
points before and after extracorporeal circulation, inter-individual
differences and the effects of inflammation can be clearly distin-
guished. The analysis of three patients displayed an increase in white
blood cell count after surgery as well as variations in immune cell
reaction rates and immune cell activation. Moreover, pathogen
specific pattern could be detected for the immune responses before
and after surgery.
Conclusions: Once optimized, analyses of blood samples from sepsis
patients and patients who have survived severe sepsis will follow.
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This will allow identifying patterns of the dysregulated immune
homeostasis providing functional classifiers for the differentiation of
sepsis patients, thereby forming a basis for future patient
stratification.
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Caspofungin modulates ryanodine receptor-mediated calcium
release in human cardiac myocytes
Jersch J (1), Henrich M (2), Markmann M (1), Sander M (1), Koch C
(1)
(1) Department of Anaesthesiology and Intensive Care Medicine,
University Hospital of Giessen and Marburg, 35392 Giessen, Ger-
many, (2) Department of Anaesthesiology and Intensive Care
Medicine, Vidia St. Vincentius-Hospital Karlsruhe, 76135 Karlsruhe,
Germany.
Introduction: Caspofungin (CAS) is known as an effective and safe
antifungal agent for the prophylaxis and treatment of different cohorts
of patients (1). Recent studies revealed that CAS might alter cardiac
function (2,3,4). Especially critically ill patients might be at risk for
hemodynamic impairment during CAS therapy.
Objectives: Based on our previous studies of cardiac impairment
after CAS application in endotoxemic rats and isolated rat cardiac
myocytes, the aim of our present study was to examine the mecha-
nisms behind CAS induced cardiac alterations.
Methods: For this purpose human cardiac myocytes (HCM, Promo-
cell, Heidelberg, Germany) were incubated with different doses of
CAS (75, 100, 130, 140, 150, 200 lg/ml) for 30 min. We performed
cytosolic calcium imaging using 2.5 lM Fura-2 in calcium-containing
and calcium-free media and measured the intracellular calcium con-
centration ([Ca2+]i) by detecting the changes in 340/380nm Fura-2
fluorescence intensity ratio as described before (5). Furthermore, we
recorded the oscillation frequency (s-1) in CAS (12.5, 25, 50, 100,
200 lg/ml) treated adult rat cardiac myocytes compared to untreated
controls. Intracellular [Ca2+] storages were depleted using 30 mM
caffeine (CAF). Ryanodine receptors were inhibited using 40 lM
ryanodine (Ry).
Results: Caspofungin treatment in HCM caused a dose dependent
increase in [Ca2+]i. The CAS dependent [Ca2+]i increase was also
found in experiments in calcium-free buffer medium (nCTRL = 20;
nCAS = 30-50 per group; (p\ 0.01) of [Ca2+]i with CAS[100lg/
ml and increased [Ca2+]i between 2.6 and 4.5 fold (control\2 fold)).
The dose-effect analysis revealed ED50 = 146.7 [lg/ml] and
ED50 = 113.2 [lg/ml] within calcium-containing medium or cal-
cium-free medium, respectively.
Regarding oscillation frequency (s-1) measurements in adult rat
myocytes, we found significantly (p\ 0.01) elevated mean values
among experimental groups with CAS [25 [lg/ml] compared to
untreated controls (nCTRL = 24; nCAS = 10-22 per group, 12.5 lg/
ml: FC = 1.13, p = 0.05; 25 lg/ml: FC = 1.11, p = 0.02, 50 lg/ml:
FC = 1.60, p\ 0.001, 100 lg/ml: FC = 2.28, p\ 0.001; 200 lg/ml:
FC = 2.74, p\ 0.001).
CAS [140lg/ml] induced liberation of Ca2+ was significantly
reduced in the presence of CAF [nCTRL = 20, nEffect = 40; CAF+
vs. CAF-: FC = 1.04, p = 0.7] or Ry [nCTR = 20, nEffect = 40;
RYN+ vs. RYN-: FC = 1.15, p = 0.06].
Conclusions: In our study, we found a dose dependent increase in
[Ca2+]i after CAS treatment. Ca2+ ions were found to be released
from intracellular caffeine sensitive stores most probably via activa-
tion of ryanodine receptors. Further studies are needed to explore the
underlying mechanism how CAS activates ryanodine receptors.
References: 1. Kett DH, Azoulay E, Echeverria PM, Vincent J. C (2).
2011;39(4):22–4.
2. Koch C, Wolff M, Henrich M, Weigand MA, Lichtenstern C.
Cardiac Effects of Echinocandins in Endotoxemic Rats.
2016;60(1):301–6.
3. Stover KR, Farley JM, Kyle PB, Cleary JD. Cardiac toxicity of
some echinocandin antifungals. Expert Opin Drug Saf [Internet].
2014;13(1):5–14. Available from: http://www.ncbi.nlm.nih.gov/
pubmed/24047086
4. Cleary JD, Stover KR. Antifungal-Associated Drug-Induced Car-
diac Disease.Clin Infect Dis. 2015 Dec 1;61 Suppl 6:S662-8. doi:
10.1093/cid/civ739.
5. Grynkiewicz G, Poenie M, Tsienb RY. A New Generation of Ca2 +
Indicators with Greatly Improved Fluorescence Properties .
1985;260(6):3440–50.
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Differentiation of the small colony variant phenotype of
Staphylococcus aureus from the wild type using Raman
spectroscopy
Gladigau F (1), Ebert C (1), Tuchscherr L (2), Lo¨ffler B (2), Popp J
(3), Neugebauer U (1)
(1) CSCC, Jena University Hospital, (2) Institute for Medical
Microbiology, Jena University Hospital, (3), Leibniz Institute of
Photonic Technology.
Introduction: Staphylococcus aureus is one of the most common
Gram positive bacteria found in case of sepsis [1]. Furthermore these
bacteria are able to cause relapsing infections by persisting intracel-
lularly [2]. Characteristic for this behaviour is the phenotypical switch
between wildtype and the small colony variant (SCV) phenotype.
SCVs are adapted to the intracellular milieu by having a reduced
metabolism, slow growth and a decreased exotoxin secretion. In this
intracellular location the bacteria are well protected against the host
immune system and antimicrobial treatments and might be a reservoir
for chronic infections [2].
The common method to differentiate between wildtype and SCV is to
isolate the bacteria from the tissue and plate them on blood agar. As
the SCV’s grow very slowly, this will take 48–72 h before the
colonies are visible.
Objectives: In our experiments we want to introduce Raman spec-
troscopy as a fast, label-free and non-invasive method for
differentiating wildtype and SCV phenotypes.
Methods: Raman spectroscopy measures the inelastic scattering of
light. The sample is irradiated with monochromatic laser light and the
so formed spectra contain fingerprint-like information. These can be
analyzed using statistical methods such as principal component
analysis (PCA) and linear discriminant analysis (LDA). Recently we
could demonstrate that this technique allows the identification of S.
aureus directly inside endothelial cells [3].
In our case we gathered the spectra for 18 strains of S. aureus. Five
pairs of wildtype and the corresponding stable SCV were used as
training data to build a classification model. Five strains of
stable SCV’s gathered from patients with chronic infections were
used as independent test data. Furthermore three standard wildtype
strains were used for the validation of the model.
Results: The training data have been analyzed using PCA and LDA,
revealing the most significant differences in the spectra of the two
phenotypes. The test data could then be differentiated with an accu-
racy of 97.4%.
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Conclusions: The characteristic variances between wildtype and SCV
could now be used as marker bands to identify the phenotype of
intracellular bacteria in further experiments.
Reference: [1] Bone RC (1994) Gram-positive organisms and sepsis.
Arch Intern Med 154:26-34
[2] Tuchscherr L, Medina E, Hussain M, Vo¨lker W, Heitmann V,
Niemann S, Holzinger D, Roth J, Proctor R, Becker K, Peters G,
Lo¨ffler B (2011) Staphylococcus aureus phenotype switching: an
effective bacterial strategy to escape host immune response and
establish a chronic infection. EMBO Mol Med 3: 129–141
[3] Große C, Bergner N, Dellith J, Heller R, Bauer M, Mellmann A,
Popp J, Neugebauer U (2015) Label-Free Imaging and Spectroscopic
Analysis of Intracellular Bacterial Infections. Anal. Chem. 87:
2137–2142
Acknowledgement: Financial support from the BMBF via the CSCC
(FKZ 01EO1502) and the EU via EFRE (FKZ 2015 FGI 0011) is
highly acknowledged.
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In depth localization of Staphylococcus aureus in a hematogenous
bone infection mouse model using two-photon microscopy
Ebert C (1), Po¨llath C (1), Hoerr V (3), Ozegowski Y (3),
Tuchscherr L (3), Lo¨ffler B (3), Neugebauer U (2)
(1) Center for Sepsis Control and Care, Jena University Hospital, (2),
Leibniz Institute of Photonic Technology, (3) Institute for Medical
Microbiology, Jena University Hospital.
Introduction: Staphylococcus aureus is one of the most frequent
pathogens found in osteomyelitis with around 80% of cases.
Hematogenous osteomyelitis results from bacteria spread through the
bloodstream into the bone and can occur as a sequela of sepsis. The
bacteria are able to adapt to several kinds of host tissues through
different virulence mechanisms such as sigB (1). They also adapt to
the bone and can persist there leading to chronic osteomyelitis. This
disease is associated with severe, painful bone deformations and is
difficult to treat with antimicrobial substances.
Objectives: We want to use advanced imaging techniques to study
the pathogenesis of S. aureus-mediated hematogenous osteomyelitis
in an established mouse model. Thereby we aim to identify the host
cells and parts of the bone where the bacteria establish their niches.
Methods: Mice were infected with S. aureus strain 6850 as described
in (1). The mice were sacrificed after 1 week (acute osteomyelitis)
and after 6 weeks (chronic osteomyelitis). Isolated bones from legs
were fixed in 4% paraformaldehyde and decalcified with 14% EDTA
for 7 weeks. Thereafter, thick cryosections of 100 lm were generated
and stained by immunofluorescence labelling of S. aureus using an
adapted protocol of (2). Cell nuclei were counterstained with DAPI.
Labelled, mounted sections were scanned by two-photon microscopy
using a Ti:sapphire laser (Coherent, Germany) coupled to an LSM780
microscope (Zeiss, Germany). A 63x C-Apochromat/NA 1.15 long
working distance objective (Zeiss, Germany) was used for optimal
resolution.
Results: S. aureus could be successfully detected with two-photon-
microscopy in several lm depths of the section. Compared with
normal laser scanning microscopy, the signal-to-noise-ratio and
contrast was much better using the two-photon excitation. We were
able to detect S. aureus in different parts of the bone mainly located
around cell nuclei which suggests intracellular state in both acute and
chronic infection. Deformation of bones in chronic osteomyelitis was
clearly visualized by X-ray imaging and correlated to the fluorescence
images obtained from the bone sections. In those regions high
numbers of bacteria in the connective tissue as well as in the hard
bone were found in specific clustering areas.
Conclusions: We could demonstrate that two-photon microscopy is a
superior tool for giving high contrast and resolution images of the
small bacteria in deep layers in thick tissue sections. Further studies
using labelling of different bone markers will provide information
about the intracellular location, the dynamics of bacteria movement
and adaptation from acute to chronic osteomyelitis.
Reference: (1) Tuchscherr et al., 2015, PLOS Pathogens, doi.org/
10.1371/journal.ppat.1004870
(2) Horst et al., 2012, Am J Path 181 (4). 1206-1214
(3) Zukor et al., 2010, Dev Dynamics 239, 3048-3057
Acknowledgement: Financial support from the BMBF (FKZ
01EO1502) is highly acknowledged.
101
Infection 2017
Synaptic dysfunction and long-term cognitive deficits in a mouse
model of polymicrobial sepsis
Gru¨newald B (1), Ho¨hold F (2), Rupp H (2), Zermann J (1), Claus RA
(4), Ko¨nig R (1), Geis C (1)
(1) Integrated Research and Treatment Center, Center for Sepsis
Control and Care (CSCC), Jena University Hospital, (2) Hans-Berger
Department of Neurology, Jena University Hospital, (3) Network
Modeling, Leibniz Institute for Natural Product Research and Infec-
tion Biology, Hans Kno¨ll Institute, (4) Department of Anesthesiology
and Intensive Care, Jena University Hospital.
Introduction: Sepsis survivors often suffer from prolonged cognitive
impairment and deficits in executive function. Due to the continuous
improvement in intensive care and the resulting higher surviving rate
of patients this cluster of symptoms will be of increasing economic
relevance in the future. To date an effective treatment is lacking and
the underlying pathomechnisms are unknown.
Objectives: Aim of the study was the analysis of cognitive impair-
ments and correlating abnormalities in neuronal function and
plasticity in a mouse model of long-term survival of sepsis. Further,
we tried to elucidate abnormalities in the cellular pathways to identify
potential therapeutic targets.
Methods: A modified peritoneal contamination and infection model
(PCI) was used as a model for polymicrobial infection. 6–8 weeks
after PCI-induction surviving animals were subjected to serveral
multidimensional behavioral tasks test to analyze basic health
parameters, locomotion, anxiety-related behavior, and spatial learn-
ing. Synaptic function and plasticity were analyzed in acute
hippocampal brain slices by field potential recording and induction of
long-term potentiation, as well as whole-cell patch-clamp recordings.
Unbiased gene expression analysis and elaborated network modeling
was used to identify cellular pathways
Results: We found no obvious abnormalities in surviving mice after
recovery of 6 weeks by a standard phenotypic screen. Further, there
were no signs of ongoing inflammation detectable. Animals of the
PCI group showed significant reduced performance in the Morris
water maze and in the Barnes maze in comparison to sham treated
animals. Further, mice after PCI had increased level of fear-related
behavior. The cognitive impairment correlated with the strength of
the initial disease course after PCI. Synaptic plasticity in the Schaffer-
collateral CA1 pathway was impaired and spine density was reduced
in the PCI-group. Additionally, signaling cascades involved in
synaptic plasticity were affected in PCI animals as revealed by
western blot and unbiased gene expression study. These impairments
were reversible by enriched environment.
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Conclusions: Strong peripheral polymicrobial infection induces long-
lasting cellular and synaptic changes in CNS neurons leading to
cognitive impairments which are reversible by enriched enviroment.
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Characterization of an sphingosine 1-phosphate (S1P)-
neutralizing L-aptamer (Spiegelmer) and its application in a
mouse model of septic shock
He X (2), Gra¨ler MH (1)
(1) Department of Anesthesiology and Intensive Care Medicine,
Center for Sepsis Control and Care (CSCC), Center for Molecular
Biomedicine (CMB), University Hospital Jena, (2) Department of
Anesthesiology and Intensive Care Medicine,Center for Sepsis Con-
trol and Care (CSCC), University Hospital Jena.
Introduction: S1P is a lipid metabolite which can activate five G
protein-coupled receptors designated S1P receptors type 1–5 (S1P1-
5). Dysfunction of the endothelial barrier is a major cause of car-
diovascular collapse and resulting in hypoperfusion. We hypothesize
that blocking S1P and/or its leakage from circulation in the acute
phase of sepsis may offer a first and new treatment option in septic
shock.
Objectives: NOX-S93 is characterized by its S1P binding and
blocking capabilities in cell culture experiments and in the mouse
model of septic shock.
Methods: Polymicrobial sepsis is induced by peritoneal contamina-
tion and infection (PCI) in mice. Changes in body temperature,
hemolysis level, plasma albumin, S1P levels in blood, cytokines, and
parameters of vital organ function were analyzed. Meanwhile, the
effects of NOX-S93 to extract S1P from the outer RBC membrane, to
prevent S1P-induced receptor internalization and to prevent S1P from
dephosphorylation were investigated in cell culture experiments.
Results: 6 h after sepsis induction, NOX-S93 treated mice showed a
reduced temperature drop compared to untreated PCI mice. Injection
of 11.4 mg/kg NOX-S93 revealed an increase of 0.5 lM, and 57 mg/
kg NOX-S93 resulted in an increase of 4 lM in plasma S1P levels
compared to vehicle controls. Hemolysis and cytokines, such as
interleukin (IL)-1 and IL-6 increased in PCI mice (p\ 0.05), with no
statistically significant difference between NOX-S93 treated and
untreated PCI mice. PCI mice had lower albumin levels in plasma
compared to control mice (p\ 0.05), which was inhibited by treat-
ment with 57 mg/kg NOX-S93. No statistically significant differences
in parameters of organ functions, for example, blood urea nitrogen
were found among control mice, NOX-S93 treated and untreated PCI
mice. However, there was a tendency to higher levels of parameters of
clinical chemistry of organ dysfunction in PCI mice compared to
control mice and NOX-S93 treated PCI mice.
After 2 h incubation with red blood cells (RBC), we found that 10 lM
NOX-S93 can extract 8 lM S1P from RBC. In hemagglutinin (HA)
epitope-tagged S1P1 (S1P1-HA) rat hepatoma HTC4 cells, we found
that 5 lM NOX-S93 was able to block all the S1P1 internalization
caused by 0.5 lM S1P. In HTC4 wild type cells after overnight
incubation with 1 lM NOX-S93 and 1 lM S1P, we observed that 1
lM NOX-S93 can protect about 400 nM S1P from degradation.
Conclusions: Based on our current data, NOX-S93 treated PCI mice
had alleviated body temperature and higher plasma albumin, indi-
cating a better endothelial barrier function, compared to untreated PCI
mice. NOX-S93 was able to extract S1P from the outer RBC mem-
brane at an equimolar ratio and can prevent S1P-induced receptor
internalization and extracellular dephosphorylation of S1P.
Acknowledgement: This study is financed by China Scholarship
Council (CSC) and Center for Sepsis Control and Care (CSCC).
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The protective role of sphingosine 1-phosphate in genotoxic stress
induced DNA damage response in inflammation
Schro¨der NH (1), Weigel C (2), Gra¨ler MH (3)
(1) Department of Anesthesiology and Intensive Care Medicine,
University Hospital Jena, (2) Department of Anesthesiology and
Intensive Care Medicine; Leibniz Institute on Ageing, University
Hospital Jena; Fritz Lipmann Institute, (3) Department of Anesthe-
siology and Intensive Care Medicine, Center for Sepsis Control and
Care (CSCC), Center for Molecular Biomedicine (CMB), University
Hospital Jena.
Introduction: The DNA damage response (DDR) is an important
cellular mechanism induced by several internal and external stimuli.
Depending on the extent of damage, the cell initiates cellular mech-
anisms, like apoptosis and autophagy, which influence the cell fate.
Related to this, the sphingolipid rheostat emphasizes that sphingosine
1-phosphate (S1P) is able to protect cells from apoptosis while its
related metabolite ceramide induce predominately apoptosis. The fact
that low-dose genotoxic stress was shown to attenuate experimental
sepsis via the induction of the DDR and autophagy in peripheral
tissue cells suggests that the sphingolipid rheostat is involved in that
regulation. We postulate that low-dose genotoxic stress stimulates the
activation of the DDR and anti-apoptotic S1P-mediated pathways.
Objectives: Our aim is to define the role of S1P in cellular adaptions
responsible for the protective effect of low-dose genotoxic stress in
inflammatory responses. In particular we identified the activation of
the DDR by low-dose genotoxic stress and a potential role of S1P.
Methods: Dose-dependent effects of epirubicin- induced genotoxic
stress were evaluated in lung epithelial cells in cell culture experi-
ments upon lipopolysaccharide (LPS) stimulation. Additionally, these
cells were stimulated with S1P. The activation of the DDR was
investigated by Western-blot and immunofluorescence microscopy. In
particular we analyzed the members of the Mre11-Rad50-Nbs1
(MRN) complex as part of the double strand break response mecha-
nism, the Ataxia-telangiectasia mutated (ATM) kinase and ataxia
telangiectasia and Rad3 related (ATR) protein as central players of
the DDR, as well as the DNA damage marker gamma H2AX
(phospho S139). To detect the extent of DNA fragmentation, Comet
assay and TUNEL assay were performed.
Results: We demonstrate that the DDR is activated after stimulation
with low doses of epirubicin and S1P, and/or under inflammatory
conditions. We show a dose dependent activation of the protein
kinases ATM and ATR. Only low doses of epirubicin and S1P under
inflammatory conditions show less activation of ATM. Furthermore
we indicated that only low doses of epirubicin and S1P originate
under inflammatory conditions a cytoplasmic occurrence of ATM.
Concurrently the DNA damage marker gamma H2AX showed less
activation to low doses and S1P stimulation, which implies less DNA
damage. Similar to low doses of epirubicin, S1P stimulated cells
showed also lower extent of DNA fragmentation indicating also
reduced cellular damage. The members of the MRN complex are
constantly expressed independent from the stimulation. Only under
inflammatory conditions we identified a higher expression.
Conclusions: We demonstrate that the DDR activated by S1P shows
the same protective effect like the low-dose genotoxic stress induced
DDR. Furthermore the activation of the DDR and its members by S1P
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stimulation indicates S1P as a potential therapeutic target to increase
the cell survival under inflammatory conditions.
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Signaling dynamics and function of sphingosine 1-phosphate
(S1P) receptors
Hofmann S (1), Gra¨ler MH (2)
(1) Department of Anesthesiology and Intensive Care Medicine,
University Hospital Jena, (2) Department of Anesthesiology and
Intensive Care Medicine, Center for Sepsis Control and Care
(CSCC), Center for Molecular Biomedicine (CMB), University
Hospital Jena.
Introduction: Sphingosine 1-phosphate (S1P) is a signaling phos-
pholipid. It is a ligand specific for five G-protein-coupled cell surface
receptors designated as S1P1-5. S1P regulates pathophysiological
processes involved in sepsis progression, including endothelial per-
meability, cytokine release and vascular tone. The maintenance of
endothelial cell (EC) barrier is dependent on the S1P1 activation
through S1P (Gi coupled signaling pathway) while high S1P con-
centrations leads to S1P1 internalization and destabilize the EC
barrier. FTY720-P, a S1P agonist, also internalizes the S1P1 but it
does not compromise the EC barrier.
Objectives: In this study we will define how S1P and its synthetic
agonist, FTY720 differs in post translational S1P1 and S1P3 receptor
regulation and signaling. On the other hand we will also investigate
the receptor dimerization and clustering of S1P1 with other S1P
receptors.
Methods: In order to investigate S1P1 receptor regulation in more
detail, fusion proteins consisting of fluorescence proteins (mCherry/
eGFP) combined with S1P1 and S1P3 are generated. These constructs
will be used for overexpression predominantly in endothelial cells,
particularly in the endothelial cell line EA.hy926. Protein-protein
interactions (e.g. receptor dimerization and clustering) will be
investigated with Fo¨rster resonance energy transfer (FRET) analysis.
To study the function of transfected plasmids and potential clusters of
different S1P receptors will be tested by intracellular calcium (Ca2+)
flux experiments. Then the cellular trafficking and expression of S1P
receptors will be determined by flow cytometry and fluorescence
microscopy.
Results: Initial experiments with EA.hy926-wildtype and—
HAS1PR1 transfected cells in Ca2+-measurements indicates different
signaling from S1P and FTY720-P through S1P1/S1P3. S1P activates
Gi via S1P1 but Gq via S1P3 which leads in a higher Ca2+-signal. In
contrast FTY720 activates Gi in both receptors which results in a low
Ca2+ response. FTY720 not only activates Gi via S1P3 may also
stabilize EC barrier function which is normally mediated via S1P1.
These preliminary barrier studies were performed by Electric Cell-
substrate Impedance Sensing (ECIS). Further experiments will be
done using the fusion proteins generated for FRET to analyze protein-
protein-interactions e.g. receptor dimerization and clustering.
Conclusions: FTY720 not only internalize S1P1 but on the other
hand it could also stabilize EC barrier via Gi S1P3 on comparing with
S1P. Because of this FTY720 could be a valuable target for phar-
macological interventions in the treatment of sepsis to maintain EC
barrier.
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To good for the bin—data mining for secondary analysis of
(pre)clinical research
Effenberger-Neidnicht K, Neidnicht M
Institute of Physiological Chemistry, University Hospital Essen.
Introduction: Normally data acquisition starts based on a hypothesis.
If it does not confirm, the supposed useless data end up in the bin.
However, numerical algorithms without any bias may not only help
finding new questions from existing data but even derive strongly
advising hints for unexpected associations. Every (in)conceivable
combination of data—without any limits to size—should be treated as
if it were the hypothesis. This particular approach to analyze big data
is called non-real-time data mining.
Objectives: The aim of the project was to create a mathematically
clean, unbiased and highly automated approach—tailored for the
needs of secondary analysis of (pre)clinical research, including the
possibility of non-linear functional relationship which could not be
found in traditional correlation. It was intended to reveal (un)known
markers for systemic inflammation.
Methods: The prerequisite for each data mining is the existence of an
almost homogeneous data base. In our example it was formed by
overall 45 parameters (vital, blood and plasma parameters) measured
in 12 individual experimental studies using 57 rats without and 63 rats
with systemic inflammation following lipopolysaccharide infusion.
Data were collected in an unsorted, partly incomplete and equally
weighted manner. For each rat 4 classifiers (study, group, survival,
time) were used to get valid samples by a later filtering of the sta-
tistical base. Any information about the hypothesis leading to the
respective studies was suppressed. In order to assess whether a sta-
tistical relationship exists, a total of 6 different functional prototypes
were postulated and examined for their regression. For each param-
eter combination, the best function type was selected. Thus,
regression quality, correlation and significance were obtained in form
of matrices, which can be used directly either individually or in
combination for visualization or for answering complex questions.
Results: In our example, ultimately 425,250 regressions were opti-
mized, automatically evaluated and filtered. Calculation time was
about 1 h for each time point. The algorithm suggested 41 parameter
combinations with the most obvious context in a first step, which were
prepared for manual reading to decide whether they are nonsense,
trivial, known or even new.
Conclusions: The developed algorithm is able to reveal statistical
relationships from a nearly crude data base with low effort by sys-
tematic and unbiased analysis. The finding of well-known correlations
proves its reliability, whose validity could be increased by clean
aggregation of different studies. In addition, new interesting hints for
future research could be gained. Thus, unknown markers could be
found which are associated with an increased risk of death during
systemic inflammation. A further development of the program is
planned including multiple regressions (more than two parameters
could be related to each other) or cluster analysis.
Reference: (1) Nelder JA and Mead R. A simplex method for
function minimization. Comput J 1965, 7: 308. (2) Iavindrasana J,
Cohen G, Depeursinge A, Mu¨ller H, Meyer R and Geissbuhler A.
Clinical data mining: a review. Yearb Med Inform 2009, 121. (3)
Binder H and Blettner M. Big data in medical science—a biostatis-
tical view. Dtsch Arztebl Int 2015, 112: 137. (4) Deuel JW, Schaer
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CA, Boretti FS, Opitz L et al. Hemoglobinuria-related acute kidney
injury is driven by intrarenal oxidative reactions triggering a heme
toxicity response. Cell Death Dis 2016, 7: e2064.
Acknowledgement: Data preparation was done in Excel, computa-
tion in C and visualization using MATLAB.
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Sphingolipid metabolism as a trigger for age-related sepsis
susceptibility
Ma¨rtz KB (1), Weigel C (2), Gra¨ler MH (3)
(1) Department of Anesthesiology and Intensive Care Medicine,
University Hospital Jena, (2) (1) Department of Anesthesiology and
Intensive Care Medicine (2) Leibniz Institute on Aging, (1) University
Hospital Jena (2) Fritz Lipmann Institute, (3) Department of Anes-
thesiology and Intensive Care Medicine, Center for Sepsis Control
and Care (CSCC), Center for Molecular Biomedicine (CMB),
University Hospital Jena.
Introduction: Sphingolipids have an important role in cell metabo-
lism and intracellular/extracellular signaling. Some components of the
sphingolipid-metabolism, especially ceramides, sphingosine and
sphingosine 1-phosphate (S1P), can trigger cellular differentiation,
apoptosis, proliferation, cell-cycle arrest, and also inflammation. A
dysregulated sphingolipid metabolism and signaling also affect sep-
sis, amongst other diseases. Sepsis is a life-threatening organ
dysfunction caused by a dysregulated host response to infection.
Sphingolipids are involved in the pathogenesis of sepsis by regulating
antigen presentation, lymphocyte egress, and maintenance of vascular
integrity. Clinical studies have proven that there is an age-related
increase of sepsis hospitalization and an increasing incidence of
severe sepsis, especially in patients over 65 years of age.
Objectives: There is a lack of knowledge about age-related differ-
ences in the sphingolipid metabolism and/or signaling and the effect
of these differences on sepsis susceptibility. This study addresses the
question if the sphingolipid metabolism can influence the suscepti-
bility to sepsis, based on age-related differences in the sphingolipid
metabolism of young and aged mice.
Methods: We analyzed gene expression and protein levels of
enzymes involved in sphingolipid metabolism and signaling in liver
samples of young and aged mice with qPCR and Western blot. Fur-
ther we characterized metabolites of sphingolipids by liquid
chromatography coupled to triple-quadrupole mass spectrometry (LC-
MS/MS) in plasma samples.
In addition we isolated primary mouse hepatocytes from young and
old wild type mice as well as from knock-out models of sphingolipid
metabolizing enzymes. We performed two metabolic assays in vitro
[MTT and neutral red uptake (NRU)] under lipopolysaccharide (LPS)
stimulation and pharmacological manipulation of the sphingolipid
metabolism and signaling.
Results: In liver samples from young and aged mice we found
changes on mRNA as well as on protein levels of the two S1P-
generating sphingosine kinases (SphKs). In addition we observed
down-regulation of the S1P receptor type 3 (S1P3), which is one the
five G-protein-coupled S1P receptors. Further we found reduced S1P
levels in plasma of aged mice compared to young ones. In addition we
observed in first experiments altered responses of primary hepatocytes
from aged mice in comparison to young ones after stimulation with
lipopolysaccharide in viability.
Conclusions: With additional analysis of primary hepatocytes from
knockout-mice for specific genes of the sphingolipid metabolism or
signaling, and with pharmacological manipulation of the sphingolipid
pathways in this cells we will be able to draw a well-founded con-
clusion about the role of S1P signaling and/or metabolism in age-
related phenotypes of the liver.
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Complement, Immunoglobulins and Sepsis
Machel AC (1), Gockel U (1), Hartung A (2), Makarewicz O (2)
(1) Biotest AG, Dreieich, Germany, (2) Center for Intectious Diseases
and Infection Control, University Hospital Jena, Germany.
Introduction: The complement system plays a key role in severe
diseases such as sepsis, biofilm associated inflammation, multiple
sclerosis, and cancer. Increased activity of the complement factors is
associated with the uncontrolled inflammation leading to tissue
damages and organ failure. The most potent immunoregulatory
complement factors are anaphylatoxins, which excessive release
induces chemotaxis of immune cells and increases endothelial per-
meability affecting adversely patient’s outcome. Immunoglobulins
(Igs) act as major regulators of the complement. In this regard, IgM
activates the classical cascade but also enhances the scavenging of
membrane-bound complement factors down-regulating the comple-
ment activity.
Objectives: The evidence of therapeutic impact of Igs in complement
regulation addressing its role on various diseases such as sepsis,
cancer, and multiple sclerosis, and experimental evaluation of the
effect of two approved Ig-products (Pentaglobin and Intratect) on
bacterial of S. aureus and E. coli, both are associated with bacteremia,
chronical diseases and sepsis.
Methods: An extensive analysis of publications to support the
hypothesis that complement is regulated by Igs, thereby modulating
the inflammatory response and outcome in different diseases has been
performed. In in vitro experiments, the effect of Pentaglobin (Ig-
mixture with enriched IgM) and Intratect in clearance of biofilm-
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embedded bacteria by leukocytes has been investigated by determi-
nation of the viable bacteria (CFU/mL) and the immune-response
after different treatments. Additionally, synergism with colistin,
which seems to have an anti-biofilm activity was analyzed.
Results: The therapeutic use of Igs improved the outcome for patients
with severe sepsis, transplant rejection, multiple sclerosis and cancer.
In in vitro experiments, Pentaglobin reduced the biofilm-embedded S.
aureus by 90%, whereas Intratect led to a reduction by 30–50%. Both
Ig-products showed less effect on clearance of E. coli. The analysis of
the cytokines levels is ongoing and will be presented at the confer-
ence. Colistin showed an antagonistic effect in combination with the
Igs.
Conclusions: There is a strong evidence, that IgM has a beneficial
effect on patient’s outcome in severe disease with are associated with
tissue damages due to undamped inflammation as observed in sepsis.
S. aureus bacteremia which often results in sepsis and death might be
triggered by cell debris resulting from S. aureus toxins. To overcome
the undamped inflammation, IgM might be adminitred in addition to
the anti-microbial treatment. Thereby, the antagonism with the
antibiotics should be known. In case of colistin, we hypothesize that
its inhibits the leukocytes. To sum up, the therapeutic efficiency of
polyclonal and monoclonal antibodies needs to be further evaluated.
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Integration of natural killer cells in a microfluidically perfused
liver biochip
Gro¨ger M, Mosig A
Center for Sepsis Control and Care (CSCC), University Hospital
Jena.
Introduction: Natural killer (NK) cells are the main lymphocyte
population in the human liver with up to 50% of the lymphocyte
population. The liver acts as an innate immunity-dominant organ and
NK cells therefore provide the first line of defense against pathogens
and infections. NK cells highly express purinergic receptors which are
activated by extracellular nucleotides (e.g. ATP, adenosine).
Objectives: The major aim of this study was to integrate NK cells
into an existing microfluidically perfused liver biochip. Furthermore,
isolated NK cells were investigated regarding purinergic receptors.
Methods: NK cells from human blood and liver specimen were
isolated by an already established Biocoll/Percoll separation method
and subsequently magnetic cell separation (MACS). Further assess-
ment of purinergic receptors was performed by PCR analysis. Hepatic
and blood derived NK cells were analysed by FACS. In a microflu-
idically supported liver biochip, comprising human cells, isolated NK
cells were inserted and investigated under static or perfused condition
for 48h.
Results: NK cells were successfully isolated with high purity from
blood and liver specimen assessed by FACS analysis. In hepatic NK
cells several purinergic receptors were identified (P2X4, P2X5, P2X7,
P2Y1, P2Y4, P2Y8, P2Y13). After 48h under static and perfused
conditions NK cells are still detectable within the biochip, without
changes regarding CD16 and TRAIL status.
Conclusions: NK cells were successfully isolated and inserted into
the existing microfluidically perfused liver biochip. NK cells attached
and remained in the perfused in vitro model of the liver sinusoid.
Several purinergic receptors were detectable on isolated hepatic NK
cells. Further experiments to evaluate the influence of purinergic
signaling are planned.
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Role of Autophagic Lysosome Reformation (ALR) during
inflammatory stress
Afzal MA (1,2), Tuchscherr L (3), Hu¨bner C (1)
(1) Institute of Human Genetics, Universita¨tsklinikum Jena, (2)
Center for Sepsis Control and Care, Universita¨tsklinikum Jena, (3)
Institute of Medical Microbiology, Universita¨tsklinikum Jena.
Introduction: Autophagy is an evolutionarily conserved lysosome-
dependent degradation pathway, which can be induced by extrinsic
and intrinsic stressors in living systems to adapt to fluctuating
environmental conditions. In the context of inflammatory stress
autophagy contributes to the elimination of invading pathogens, the
regulation of innate and adaptive immune mechanisms, and regu-
lation of inflammasome activity as well as tissue damage repair.
Recently it was shown that lysosomes can be recycled from
autophagy, a process also known as autophagic lysosome refor-
mation (ALR). Thus ALR contributes to the replenishment of
lysosomes that are available for fusion with autophagosomes
in situations of increased autophagic turnover for instance during
inflammatory stress or sepsis. Previously, our group and others
could show that ALR is impaired in cells devoid of Spatacsin
(SPG11) or Spastizin (SPG15).
Objectives: We aim to identify the effects of inflammatory stress on
the lysosomal system, autophagy and ALR. For this purpose we will
assess how different inflammatory mediators impact on the lysosomal
system and in-vitro infection models.
Methods: Bone marrow derived macrophages (BMDMs) were iso-
lated from wild-type mice and Spatacsin (Spg11-/-) knockout mice.
BMDMs and Mouse Embryonic Fibroblasts (MEFs) were treated with
200 ng/ml of LPS for 14 h then fixed and stained with p62 and Lamp1
antibodies. Images were taken with Leica confocal microscope and
the quantification of autolysosomes and lysosomes was done with
ImageJ. Wild-type MEFs and Spg11-/- MEFs were infected with
Staphylococcus aureus and multiplication of infection (MOI) used
was 10. After 4 h of infection, cells were visually assessed for via-
bility and images were taken under Olympus CKX53 inverted
microscope.
Results: Prolonged starvation of wild-type MEFs pretreated with LPS
induced a significant increase in autolysosomes as compared to
starved untreated MEFs, while the number of lysosomes was dimin-
ished (n = 45 cells per group from 3 independent experiments,
**P\ 0.01). Similar results were obtained for BMDMs after LPS
treatment as compared to control (n = 45 cells per group from 3
independent experiments, ***P\ 0.001).
In-vitro infection of MEFs with Staphylococcus aureus showed a
marked decrease of cell viability in ALR deficient Spatacsin knockout
(Spg11-/-) MEFs as compared to wild-type.
Conclusions: Significantly increased autolysosome numbers together
with decreased lysosome number after LPS treatment is consistent
with a defect of ALR in response to LPS. Suggesting that ALR is
important for the defense of invading pathogens e.g. S. aureus, we
observed a marked increase of cell death in an in-vitro infection
model in cells with compromised ALR.
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Room-temperature transpulmonary thermodilution (TPTD) with
increased indicator volume of 20 ml compared to standard TPTD
with 15 ml of iced saline
Maendl E (1), Haller B (2), Wenzel P (1), Huber W (1)
(1) Klinikum rechts der Isar, Technical University of Munich, (2)
Institute of Medical Statistics and Epidemiology, Technical University
of Munich.
Introduction: Due to the frequent haemodynamic instability in septic
patients, haemodynamic monitoring including TPTD is frequently
used to monitor cardiac index (CI), global end-diastolic volume index
(GEDVI) and extravascular lung-water index (EVLWI). Current
practice is to perform TPTD with iced saline boluses. However, this
method can be cumbersome in daily routine, e.g. in the OR. A recent
study (1) investigated TPTD using 15 ml room-temperature saline.
The results of this study were not completely satisfactory for use in
daily routine, though.
Objectives: This study aims to improve accuracy and precision of
TPTD by using room-temperature saline by increasing the indicator
volume.
Methods: 407 sets of TPTDs were performed in 60 patients moni-
tored by the PiCCO-2 device. Each dataset consisted of four TPTDs,
two with 20 ml room-temperature saline and two with 15 ml iced
(4 C) saline.
Results: Patients characteristics: 33 male, 27 female; APACHE II score
25 ± 8; height 171 ± 8 cm; weight 73 ± 14 kg; diagnosis 40% sepsis.
TPTD with 15 ml of iced saline vs. TPTD with 20 ml of room-
temperature saline:
Compared to TPTD with iced saline the parameters derived from
room-temperature injectate TPTD were slightly, but significantly
higher for CI (3.96 ± 1.00 vs. 4.02 ± 1.06 l/min/m2; p\ 0.001),
GEDVI (789 ± 159 vs. 793 ± 163 ml/m2; p = 0.013) and EVLWI
(11.1 ± 4.2 vs. 11.7 ± 4.5 ml/kg; p\ 0.001). These differences
resulted in acceptable values for mean bias and percentage error (PE)
of 0.06 ± 0.35 l/min/m2 and 17.4% for CI, 3.94 ± 77.60 ml/m2 and
19.2% for GEDVI, 0.58 ± 1.20 ml/kg and 20.7% for EVLWI.
Influence of CVC position: Femoral CVC room-temperature indicator
injection resulted in a slightly lower bias of GEDVI compared to
jugular indicator injection (-4.97 ± 76.50 vs. 17.15 ± 77.55 ml/m2;
p = 0.005). The mean biases of CI (femoral: 0.03 ± 0.39 vs. jugular:
0.10 ± 0.29 l/min/m2; p = 0.110) and EVLWI (femoral: 0.65 ± 1.22
vs. jugular: 0.49 ± 1.17 ml/kg; p = 0.328) did not differ for different
CVC positions.
Comparison of 20 ml with 15 ml room-temperature injectate [original
data from previous study (1)]:
CI (0.06 ± 0.35 vs. 0.15 ± 0.52 l/min/m2; p = 0.003) and GEDVI
(3.94 ± 77.60 vs. 30.47 ± 144.62 ml/m2; p\ 0.001) showed a sig-
nificantly improved bias for 20 ml compared to 15 ml room-
temperature injectate. Regarding EVLWI no difference could be
shown (20 ml: 0.58 ± 1.20 vs. 15 ml: 0.59 ± 2.11 ml/kg;
p = 0.054). PE was lower in all three variables for 20 ml injectate
(CI: 17.4 vs. 21.9%, GEDVI: 19.2 vs. 29.2%, EVLWI: 20.7 vs.
29.3%).
Conclusions: TPTD with 20 ml of room-temperature saline showed
acceptable bias and PE compared to TPTD with 15 ml of iced saline.
TPTD with 20 ml of room-temperature saline showed better results
than TPTD with 15 ml of room-temperature saline. Results so far
suggest TPTD with 20 ml of room-temperature saline is applicable in
practice.
References: (1) Huber, W., Kraski, T., Haller, B., Mair, S., Saugel,
B., Beitz, A., Schmid, R. M., Malbrain, M. L. N. G. (2014). Room-
temperature vs iced saline indicator injection for transpulmonary
thermodilution. Journal of Critical Care, 29(6), 1133.e1137–
1133.e1114. doi:10.1016/j.jcrc.2014.08.005
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Linezolid pharmacokinetics in liver failure: Exploring the
maximal liver function capacity (LiMAx) test
Kaffarnik M (1), Alraish R (1), Frey OR (3), Roehr A (3), Pratschke J
(1), Stockmann M (1), Wuensch T (1), Wicha SG (2)
(1) Chirurgische Klinik, Campus Mitte/Virchow Klinikum, Charite´ -
Universita¨tsmedizin Berlin, (2) Institut fu¨r Pharmakologie, Univer-
sita¨t Hamburg, (3) Klinische Pharmakologie, Klinikum Heidenheim.
Introduction: Patients in the intensive care unit frequently require
antibiotic treatment. Dose finding studies are usually performed in
healthy volunteers or patients who are not critically ill. Extrapolation
of the dosage recommendations to critically ill patients may not be
reasonable due to pathophysiologic changes in this specific popula-
tion. In addition, liver impairment possesses substantial challenges for
dose selection in these patients.
Objectives: The aim of the present pilot study was to assess the novel
maximal liver function capacity (LiMAx test) in comparison to
conventional liver function markers as covariates of drug elimination
in liver failure using linezolid as model drug. Therefor linezolid
trough serum concentrations were prospectively evaluated in patients
with or without liver dysfunction.
Methods: 28 patients with different degrees of liver failure were
recruited and LiMAx test, plasma, dialysis and urine sampling was
performed under linezolid steady-state therapy (600 mg BID).
According to their LiMAx result at the respective measure point,
parameters of each time point were matched into one of the following
groups: (A) LiMAx\100 lg/kg/h (n = 11); (B) LiMAx 100–199 lg/
kg/h (n = 14); (C) LiMAx 200–299 lg/kg/h (n = 9); (D) LiMAx
C300 lg/kg/h (n = 17). NONMEM was used for the pharmaco-
metric analysis, in which the different clearance routes of linezolid
were elucidated
Results: Linezolid pharmacokinetics were highly variable in patients
with liver failure. The LiMAx score displayed the strongest associa-
tion with CLnon-renal (=4.46•(WT/57.9)•(LiMAx/221.5)0.388 L/h),
which reduced interindividual variability in CLnon-renal from 46.6 to
33.6%, thereby being superior over other common markers of liver
function (INR, c-GT, bilirubin, thrombocytes, ALT, AST). For
LiMAx\100 lg/kg/h, 64% of linezolid trough concentrations were
above the recommended trough concentration of 8 mg/L and the
majority of patients with LiMAx [300 lg/kg/h revealed trough
concentrations below 2 mg/L.
Conclusions: The study presents the first application of the LiMAx
test to quantify the effect of liver dysfunction on the pharmacokinetics
of linezolid. Thereby, the LiMAx test was superior over all other
markers of liver dysfunction. Clinicians should be particularly
watchful in patients with LiMAx\100 and[300 lg/kg/h and con-
sider therapeutic drug monitoring with potential dose adaption of
linezolid to avoid potential toxicity or therapeutic failure.
Acknowledgements: The study was funded by research grants of the
Charite´ University Hospital, Berlin, Germany. No funds were
obtained for payment of the authors. The authors would like to thank
the team of the Surgical Intensive Care Unit of the Charite´ for sup-
porting our study. We would also like to thank the team of the
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Pharmacokinetics of tigecycline in liver impairment:
quantification of liver function with maximal liver function
capacity test (LiMAx)
Kaffarnik M (1), Alraish R (1), Frey OR (3), Roehr A (3), Wuensch T
(1), Pratschke J (1), Stockmann M (1), Wicha SG (2)
(1) Chirurgische Klinik, Campus Mitte/Virchow Klinikum, Charite´ -
Univerista¨tsmedizin Berlin, (2) Institut fu¨r Pharmakologie, Univer-
sita¨t Hamburg, (3) Klinische Pharmakologie, Klinikum Heidenheim.
Introduction: Tigecycline (TGC), the first-in-class glycylcycline, is
an important therapeutic option in critically ill patients due to its
efficacy against (multiresistent) grampositive and gramnegative bac-
terias in the treatment of complicated intra-abdominal and
complicated skin and skin-structure infections (1-2). Since TGC is
metabolized and eliminated predominantly by the liver, critical illness
induced liver failure may have a profound impact on the pharma-
cokinetic of TGC.
Objectives: The aim of the study was to establish a link between the
degree of liver dysfunction and serum concentration of TGC over a
quantitative measurement of liver function using the dynamic LiMAx
test and a parallel determination of TGC serum concentration.
Methods: This prospective study includes 20 patients received TGC.
Patients were treated with TGC by intermittent bolus administration
of 100 or 50 mg every 12 h after a 100mg loading dose. TGC con-
centrations in serum and bile were obtained by collecting blood
samples at 0.3, 2, 5, 8 and 11.5 h post dose for each patient after at
least 36 h of therapy and were analyzed by means of a (HPLC
method. Within the same day LiMAx test was carried out and routine
blood parameters were measured. In addition we measured three
patients in different dosage conditions: (1) directly after 100mg
loading dose (2) in 100mg steady state (3) in 50mg steady state.
Results: Peak serum TGC concentrations (0.3 h after end of 50 mg
dosage) were significantly higher in patients with severe liver failure
(LiMAx \100lg/kg/h) than in patients with normal liver function
(LiMAx [300lg/kg/h) (Fig 1). Pharmacokinetic curves showed
higher values in severe liver failure at any measure point (Fig. 2).
Serum concentrations in 100mg steady state were higher than in 50mg
steady state, whilst serum levels after 100mg loading dose were lower
than in 50mg steady state concentrations. TGC concentration in the
bile duct were up to 50 times higher than in serum. TGC bile duct
levels showed (Fig 3).
Conclusions: The study demonstrates a correlation between LiMAx
test and TGC serum concentration. This qualifies LiMAx as a reliable
index of the degree of liver function impairment and its drug-me-
tabolizing ability, which is required in dosage adjustments in order to
achieve maximum efficacy with minimum toxicity for an effective
antibiotic therapy in the management of infection in critical illness.
Acknowledgement: The study was funded by research grants of the
Charite´ University Hospital, Berlin, Germany. No funds were
obtained for payment of the authors. The authors would like to thank
the team of the Surgical Intensive Care Unit of the Charite´ for sup-
porting our study. We would also like to thank the team of the
‘‘workgroup for the liver’’ for their valuable comments on planning
and designing the study.
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Pathogen concentration integrated molecular analysis for
SMARTDIAGNOS: the next generation sepsis diagnosis
VINAYAKA AC (1), Mohammad-Ali S (2), Dave VP (1), Tien AN
(1), Anders W (2), Bang DD (1)
(1) Research Group for Analytical and Predictive Microbiology,
National Food Institute, Technical University of Denmark, (2)
Department of Micro and Nanotechnology, Technical University of
Denmark.
Introduction: Sepsis is a potential life threatening complication with
the mortality rate ranging from 18–50% of the encountered cases.
Each hour of delayed diagnosis and therapy will increase the risk of
death by approximately 8%. In the European Union, overall mortality
was 27–36% imposing an economical burden of approximately 7–21
B€ per year. The major limitation of sepsis diagnosis is the require-
ment of more than 48 h for the specific identification of causative
pathogen due to the requirement of pathogen enrichment and cul-
turing steps.
Objectives: Combination of pathogen pre-concentration with rapid
molecular diagnosis is the main objective of the present work in order
to overcome the present challenge of sepsis diagnosis: low pathogen
concentration (5–10 CFU/mL blood) and to improve the current limit
of detection by 1–2 orders of magnitude.
Methods: Staphylococcus aureus was selected as a model pathogen
due to its predominance in sepsis complications. Anti-lipoteichoic
acid antibody was immobilized on protein AG attached magnetic
beads and used as capturing ligands. Staphylococcus aureus cells in a
range *105 to 101 cfu in 1 mL of 1X PBS were incubated with the
antibody immobilized beads (*106 beads) at 37 C for 30 min. The
beads were washed and the captured pathogens were detected by PCR
targeting Thermonuclease gene of Staphylococcus aureus . To mimic
bloodstream infection, Staphylococcus aureus spiked volunteer
human blood was used. The spiked blood was lysed with 2% saponin
before incubating with antibody immobilized beads and analyzed as
mentioned above.
Results: The Immuno-magnetic beads could efficiently concentrate
Staphylococcus aureus at a low concentration of 102 cfu/mL from
PBS and *103 cfu/mL from the spiked blood. Due to the highly
viscous blood matrix, dilution of the blood had a direct influence on
the immuno-capturing efficiency and dilution of 50% gave optimum
results. The use of protein AG, as a bio-adaptor, provided unidirec-
tional orientation to the immobilized antibodies thereby resulting in a
long term antibody-bead conjugate stability with higher efficiency.
Integration of a direct PCR using a phusion hot start DNA polymerase
overcome the possible PCR inhibitors and excluded cumbersome
DNA extraction steps thereby reducing the duration of analysis to less
than 3 h.
Conclusions: The magnetic bead-based pathogen pre-concentration is
efficient and versatile method to overcome the greatest challenges in
sepsis diagnosis: low pathogen counts and complexity of blood
matrix. Combination of the immuno-magnetic bead and the direct
PCR reduces the sepsis diagnosis time significantly. This approach
may lay a future platform technology for rapid detection of the
pathogens causing sepsis.
Acknowledgement: This research financially supported by
‘‘SMARTDIAGNOS Next generation sepsis diagnosis technology’’
an EU Horizon-2020 project, Grant Agreement No.: 687697.
Abstracts S29
123
009
Infection 2017
Diagnostic value of midregional proAdrenomedullin (MR-
proADM) and interleukin (IL)-17A for the detection of fungal
infections in patients with septic shock—a prospective, single-
center, observational study
Decker SO (1), Sigl A (1), Uhle F (1), Lichtenstern C (1),
Heininger A (2), Weigand MA (1), Hofer S (3), Brenner T (1)
(1) Department of Anesthesiology, Heidelberg University Hospital,
Germany, (2) Department of Infectious Diseases, Medical Microbi-
ology and Hygiene, Heidelberg University Hospital, Germany, (3)
Department of Anesthesiology, Westpfalzklinikum Kaiserslautern,
Germany.
Introduction: Bacterial infections are the most common cause of
sepsis. Although fungemia can only be observed in 3% of unselected
septic patients, fungi are one of the most frequently isolated species in
abdominal or respiratory tract specimens.
Objectives: The aims of this study were therefore twofold, (1.) to
evaluate the prevalence of fungal colonization as well as infection in
patients with septic shock and (2) to assess the diagnostic value of
midregional proAdrenomedullin (MR-proADM) and interleukin (IL)-
17A for the detection of fungal infections in these patients.
Methods: In total, 50 patients with septic shock were enrolled in this
observational, prospective cohort study from 11/2013 to 01/2015.
Fungal findings as well as corresponding plasma levels of MR-
proADM and IL 17A-values were evaluated at 6 consecutive time
points within 28 days after sepsis onset. Candida species (C. spec.) in
the respiratory tract or in fluids from drainages were classified as
colonization. Positive results in blood cultures, intraoperative swabs
and Aspergillus species in deep respiratory tract specimens with
accompanying pulmonary infiltrates were classified as infection.
Results: Within the 28-day observation period, 22% (n = 11) of
patients suffered from a fungal infection. In contrast, 78% (n = 39) of
patients were shown to be non-infected and either presented without
any fungal findings (34%/n = 17) or were colonized with C. spec. in
the different specimens (44%/n = 22).
In patients suffering from a fungal infection, plasma levels of MR-
proADM were shown to be significantly increased at all timepoints in
comparison to colonized patients as well as patients without any
fungal findings. Accordingly, MR-proADM was shown to be a suit-
able tool for the identification of patients with a fungal infection as
assessed by a receiver operating characteristic (ROC)-analyses (ROC-
area under the curve (AUC) for patients with a fungal infection vs.
non-infected patients e.g. at t0: 0.738; Cut-Off: 6,99nmol/l -[ Sens.
0.727; 1-Spec. 0.333, t1: 0.755; Cut-Off: 8.53nmol/l -[Sens. 0.727;
1-Spec. 0.212, t2: 0.774; Cut-Off 5.10nmol/l -[Sens. 0.818; 1-Spec.
0.273, etc.).
IL-17A was also shown to be significantly increased in septic
patients suffering from a fungal infection in comparison to septic
patients with a fungal colonization or without any fungal findings
within the first 7 days after sepsis onset. Therefore, IL-17A was also
found to be a suitable tool for the identification of patients with a
fungal infection as assessed by ROC-analysis (ROC-AUC for patients
with a fungal infection vs. non-infected patients e.g. at t0: 0.714; Cut-
Off 14.165pg/ml -[ Sens. 0.818; 1-Spec. 0.323, t1: 0.776; Cut-Off:
14.22pg/ml -[Sens. 0.818; 1-Spec. 0.29, t2: 0.865 Cut-Off 15.00pg/
ml -[ Sens. 0.818; 1-Spec. 0.194, etc.).
Conclusions: Due to the diagnostic value for the detection of fungal
infections in patients with septic shock, implementation of MR-
proADM as well as IL-17A measurements in routine diagnostics
should be taken into account.
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The clinical study of respiratory functional tests in abdominal
sepsis
Sydorchuk L (1), Sydorchuk A (1), Sydorchuk I (1), Plehutsa O (2),
Stepan V (2), Sydorchuk R (2)
(1) Family Medicine Department, Bukovinian State Medical Univer-
sity, (2) General Surgery Department, Bukovinian State Medical
University.
Introduction: Multiple organ failure is a hallmark of abdominal
sepsis (AS) being a leading immediate cause for sepsis-related mor-
tality. Pulmonary dysfunction is a common sequel of sepsis, lungs are
particularly vulnerable to the generalized inflammatory response, and
sepsis is the cause of death in about 40% of all patients with acute
respiratory failure. However, in about 50–60% cases it remains
undiagnosed and untreated. Acute respiratory distress syndrome is the
most common mechanism for pulmonary dysfunction, while SIRS,
immunological reactions or direct pulmonary injury by microorgan-
isms and toxins are rare. While many mechanisms of respiratory
system involvement into sepsis pathogenesis are clear, the role of
airways is not considered as a possible treatment target.
Objectives: The aim of the study is to determine changes of pul-
monary function under AS to distinguish them from surgery-
associated influences.
Methods: The study includes clinical observations of 7 AS patients
(1st group), 9 patients who underwent uncomplicated minor elective
surgery not related to abdominal pathologies (2nd group), and prac-
tically healthy individuals (3rd group—control). Computer assisted
spirometry, simplified breathing retention tests, pO2 and pCO2 at rest
and during oxygen test performed on 3rd day after surgery; con-
traindications and bioethics were strictly obeyed. Post-bronchodilator
test was not performed.
Results: The max breath holding on inhalation phase in groups was as
follows (sec): 12.85 ± 3.81 (group 1), 29.36 ± 1.24 (group 2) and
39.08 ± 3.65 (group 3), respectively (p\ 0.05); max breath holding
on exhalation phase was (sec): 8.93 ± 0.53 (1), 21.38 ± 2.84 (2) and
25.63 ± 3.73 (3), respectively (p\ 0.05). pO2 at rest 53.64 ± 3.28
(1), 69.04 ± 5.02 (2), and 73.51 ± 2.67 (3), respectively; pCO2 at
rest 30.63 ± 2.70 (1), 49.26 ± 3.07 (2), and 40.47 ± 1.68 (3),
respectively. pO2 after pure oxygen supply—64.32 ± 1.94 (1),
70.37 ± 3.75 (2), and 75.76 ± 1.52 (3), respectively; pCO2 after
pure oxygen supply—31.66 ± 2.58 (1), 41.26 ± 3.89 (2), and
38.35 ± 1.73 (3), respectively. Computed spirometry aborted in all
patients of group 1 (AS group) due to very low figures (less than 6 s
FVC test), discomfort and difficulties.
Conclusions: While this study has multiple limitations and possible
errata, received data confirms existence of respiratory insufficiency in
abdominal sepsis. Moreover, in addition to known mechanisms,
possible involvement of airways is currently underestimated in
treatment protocols. It is still unclear whether it is determined by
anesthesia or immune misbalance, requiring further studies.
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Introduction: Multiple organ failure is a hallmark of abdominal
sepsis (AS) being a leading immediate cause for sepsis-related mor-
tality. Pulmonary dysfunction is a common sequel of sepsis, lungs are
particularly vulnerable to the generalized inflammatory response, and
sepsis is the cause of death in about 40% of all patients with acute
respiratory failure. However, in about 50–60% cases it remains
undiagnosed and untreated. Acute respiratory distress syndrome is the
most common mechanism for pulmonary dysfunction, while SIRS,
immunological reactions or direct pulmonary injury by microorgan-
isms and toxins are rare. While many mechanisms of respiratory
system involvement into sepsis pathogenesis are clear, the role of
airways is not considered as a possible treatment target.
Objectives: The aim of the study is to determine changes of pul-
monary function under AS to distinguish them from surgery-
associated influences.
Methods: The study includes clinical observations of 7 AS patients
(1st group), 9 patients who underwent uncomplicated minor elective
surgery not related to abdominal pathologies (2nd group), and prac-
tically healthy individuals (3rd group—control). Computer assisted
spirometry, simplified breathing retention tests, pO2 and pCO2 at rest
and during oxygen test performed on 3rd day after surgery; con-
traindications and bioethics were strictly obeyed. Post-bronchodilator
test was not performed.
Results: The max breath holding on inhalation phase in groups was as
follows (sec): 12.85 ± 3.81 (group 1), 29.36 ± 1.24 (group 2) and
39.08 ± 3.65 (group 3), respectively (p\ 0.05); max breath holding
on exhalation phase was (sec): 8.93 ± 0.53 (1), 21.38 ± 2.84 (2) and
25.63 ± 3.73 (3), respectively (p\ 0.05). pO2 at rest 53.64 ± 3.28
(1), 69.04 ± 5.02 (2), and 73.51 ± 2.67 (3), respectively; pCO2 at
rest 30.63 ± 2.70 (1), 49.26 ± 3.07 (2), and 40.47 ± 1.68 (3),
respectively. pO2 after pure oxygen supply—64.32 ± 1.94 (1),
70.37 ± 3.75 (2), and 75.76 ± 1.52 (3), respectively; pCO2 after
pure oxygen supply—31.66 ± 2.58 (1), 41.26 ± 3.89 (2), and
38.35 ± 1.73 (3), respectively. Computed spirometry aborted in all
patients of group 1 (AS group) due to very low figures (less than 6 s
FVC test), discomfort and difficulties.
Conclusions: While this study has multiple limitations and possible
errata, received data confirms existence of respiratory insufficiency in
abdominal sepsis. Moreover, in addition to known mechanisms,
possible involvement of airways is currently underestimated in
treatment protocols. It is still unclear whether it is determined by
anesthesia or immune misbalance, requiring further studies.
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Changes of cardiovascular system functional state in abdominal
sepsis
Sydorchuk R (1), Shaprinskiy V (2), Khimich S (2), Sydorchuk I (3),
Sydorchuk L (3), Sydorchuk A (3), Plehutsa O (1)
(1) General Surgery Department, Bukovinian State Medical Univer-
sity, (2) Surgery Department, Vinnytsia National Medical University,
(3) Family Medicine Department, Bukovinian State Medical
University.
Introduction: Cardiovascular system is a primary targeted organ in
sepsis causing about half of all sepsis-related mortalities. Abdominal
sepsis (AS) often caused by endotoxin producing microorganism with
increased intra-abdominal pressure aggravates cardiovascular load by
means of direct toxic influence and compartment syndrome devel-
opment. Current understanding of cardiovascular changes in AS
varies from ‘hyperdynamic circulation’ to cardiovascular failure and
shock.
Objectives: Hemodynamic and perfusion disorders are significant
burden, form pathogenesis and are found in almost all AS patients.
In connection with the above, the purpose of the study was to
determine changes of the functional state of the cardiovascular
system in AS.
Methods: The study included 17 patients with AS (group I), 15
patients after elective surgery for uncomplicated anterior abdominal
wall hernia and varicose veins of lower extremities (group II). The
control (group III) formed by 21 healthy volunteer. Following
hemodynamic parameters (systolic blood volume [SBV], minute
blood volume [MBV], mean dynamic pressure [MDP], systemic
peripheral vascular resistance [SVR], and autonomic nervous system
regulatory parameters) for 2–3 days after surgery were studied. The
study approved by the bioethics commission.
Results: Obtained data (table) confirms that any surgery significantly
impact parameters of central and peripheral hemodynamics. Group 2
changes indicate the active involvement of compensatory-adaptive
mechanisms and stimulation of the cardiovascular system; such
changes may not be considered pathological. In AS patients HR grew
significantly while SVR dropped (p\ 0.05). Influence of the sym-
pathetic autonomic nervous system in AS increases dramatically; the
Ke´rdo¨ index in 1 group patients was (+) 42.37 ± 7.61, while for the 2
and 3 groups it was moderately negative (-) 0.024 ± 0.006 and (-)
0.16 ± 0.03, respectively. Hildebrandt’s coefficient practically
unchanged in AS (4.32 ± 0.69 vs. 4.55 ± 0.71 in 2 group, and
4.10 ± 0.32 in control, p[0.05). Accordingly, the value of changes
of the autonomic nervous regulation of intersystem interaction
between the respiratory and cardiovascular systems in the pathogen-
esis of AS is insignificant.
Conclusions: Functional failure of the cardiovascular system
emphasizes abdominal sepsis of any severity. Changes of the func-
tional state of the cardiovascular system not only worsen the
prognosis, but also significantly burden the regenerative processes in
the peritoneal cavity and the healing of surgical wounds, increasing
the risk of postoperative complications.
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Longitudinal evaluation of plasma concentrations of presepsin
and clinical used biomarkers for infection in patients after severe
trauma
Koch C (1), Ruhrmann S (1), Po¨hlmann M (1), Weigand MA (2),
Uhle F (2), Sander M (1)
(1) Department of Anesthesiology and Intensive Care Medicine,
University Hospital of Giessen and Marburg, 35392 Giessen, Ger-
many, (2) Department of Anesthesiology, Heidelberg University
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Introduction: Due to better bleeding control, the high mortality of
patients after multiple trauma is based on the higher risk of the
development of subsequent infections. Thus, early onset of adequate
therapy is of particular importance for patients’ outcome after severe
trauma. However, early rapid diagnosis is often masked by the con-
sequences of sterile, damage-triggered immune response. Tissue
hypoperfusion during shock and subsequent cell death as well as
physically damaged cells and tissue result in the release of
immunogenic damage-associated molecular patterns (DAMPs), cap-
able of triggering a systemic inflammatory response syndrome
(SIRS).
Objectives: Concerning the value for the monitoring of progress and
therapy, biomarkers are seen as a supplemental approach, whereas the
acute phase proteins C-reactive protein (CRP), procalcitonin (PCT)
and the cytokine interleukin 6 (IL-6) are the most commonly used
sepsis biomarkers in daily clinical routine. New biomarkers like
soluble CD14 subtype (sCD14-ST, presepsin) and clot lysis index
after 60 min (CLI 60) are described to indicate patients with acute
septic diseases. While an increase of CRP, PCT and IL-6 may be
caused by non-infectious reasons, an increase of presepsin was pro-
posed to indicate a more specific infectious origin among different
cohorts of patients. Furthermore, Adamzik et al. proved a significantly
increased CLI60 in septic patients compared to postoperative patients
and healthy subjects. This study aimed to analyze the course of pre-
sepsin and CLI60 compared to clinically used biomarkers of acute
infections (CRP, PCT, IL-6) in a cohort of patients after severe
trauma.
Methods: Between January 2015 to February 2016, we included 50
patients with severe trauma (Injury Severity Score[16). They were
observed for seven consecutive days after ICU admission and
screened for clinical routine data, signs of infection, and inflammatory
biomarkers CLI60, sCD14-ST (presepsin), CRP, PCT and IL-6.
Results: Regarding the well establishes biomarkers CRP and PCT, we
observed trauma-associated alterations, which were not correlated to
the clinical development of SIRS (PCT: no-SIRS vs. SIRS p = 0.50).
Presepsin was elevated at ICU admission. Elevation of Presepsin, IL-
6 and CLI60 in the clinical course correlated with the development of
SIRS (presepsin: no-SIRS vs. SIRS p = 0.03; IL-6: no-SIRS vs. SIRS
p = 0.03; CLI60: no-SIRS vs. SIRS p = 0.03).
Conclusions: Our study systematically investigates both the kinetic
of clinically established biomarkers of inflammation and infection as
well as presepsin and CLI for after trauma. Both markers were proven
to be not affected by the early immune reaction after trauma as well as
over the next seven days, making them a valuable option as
biomarkers for infection in this clinical setting worthy of further
evaluation.
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Optimal ferritin value to diagnose hemophagocytic
lymphohistiocytosis in intensive care units
Lachmann G (1), La Rose´e P (2), Brunkhorst FM (3), Schenk T (4),
Spies C (1)
(1) Department of Anesthesiology and Operative Intensive Care
Medicine, Charite´ - Universita¨tsmedizin Berlin, (2) Klinik fu¨r Innere
Medizin II, Schwarzwald-Baar-Klinikum, (3) Center for Clinical
Studies and Department of Anesthesiology and Intensive Care Med-
icine, Universita¨tsklinikum Jena, (4) Klinik fu¨r Innere Medizin II,
Abteilung Ha¨matologie und internistische Onkologie, Univer-
sita¨tsklinikum Jena.
Introduction: Hyperferritinemia is one of the diagnostic markers of
hemophagocytic lymphohistiocytosis (HLH), a rare life-threatening
hyperinflammatory syndrome with fatal outcome. The HLH-2004
diagnostic criteria comprise a threshold of ferritin C500 lg/L, which,
however, is at low sensitivity and specificity in adults.
Objectives: Therefore, our aim is to determine the most predictive
ferritin value in adult HLH patients in the ICU.
Methods: This retrospective analysis approved by the ethics com-
mittee (EA1/176/16) was performed at the university hospital
Charite´-Universita¨tsmedizin Berlin, Campus Charite´ Mitte and
Campus Virchow-Klinikum, Germany. We included 258 patients of at
least 18 years old and hyperferritinemia according to the HLH-2004
diagnostic criteria, who were admitted to our ICUs between 2006 and
2014. If more than one ferritin value was available, we analyzed the
highest. Statistical analyses were performed using non-parametric
statistical tests, logistic regressions and ROC analyses.
Results: 9 out of the 258 patients were suffering from adult HLH. 73
out of the 258 patients died (28.3%). Ferritin was significant higher in
adult HLH patients compared to non-HLH patients (median 1,266 vs.
15,920 lg/L; p\ 0.001). This association remained significant after
adjustment for age and gender (p = 0.002). ROC analyses revealed
100.0% sensitivity and 83.1% specificity for a ferritin of 3,095 lg/L
(AUC 94.6%, p\ 0.001, CI 0.901–0.992).
Conclusions: A ferritin value of 3,095 lg/L was best predictive for
ICU patients suffering from adult HLH in our cohort. Inclusion of
ferritin into the routine lab-panel in critically ill patients is warranted.
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AlertsNet 2.0—a Thuringia-wide population-based surveillance of
bloodstream infections
Schmitz RPH (1), Rißner F (2), Kortegast-Winterwerb M (1),
Kesselmeier M (3), Jakob M (1), Weczerek C (1), Brunkhorst FM (4)
(1) Center for Sepsis Control and Care (CSCC), Jena University
Hospital, (2) Center for Clinical Studies Jena (ZKS), Jena University
Hospital, (3) Research Group Clinical Epidemiology (CSCC), Jena
University Hospital, (4) Department of Anesthesiology and Intensive
Care Medicine, CSCC, ZKS, Jena University Hospital.
Introduction: Blood culture (BC) testing is recommended as a
standard of care in international sepsis guidelines and has been shown
to reduce intensive care unit stay, antibiotic use, and costs in hospi-
talized patients. The Thuringian registry AlertsNet (
www.alertsnet.org), started in 2014, aims at quality assurance in BC
diagnostics in the whole German federal state of Thuringia and
connects hospitals and microbiological laboratories within an elec-
tronic registry for immediate integration and evaluation of BC
findings. Population-based data are aspired within the next years.
Objectives: Data of the second turn of funding are presented.
Methods: Data from 21 hospitals with 8 associated labs were inclu-
ded in this analysis. Microbiological data of all BCs taken in the
participating hospitals as well as clinical data from patients with
clinically relevant positive BCs collected from August 2015 to
August 2016 were analyzed using standard measures of descriptive
statistics.
Results: In total, 55,642 BC sets have been taken in the participating
hospitals representing 16,461 patients. After excluding negative BCs
(46,437; 83.5%) as well as contaminants (2111; 3.8%) and after
excluding positive BCs of the same patient taken within 96 h, a total
of 7094 clinically relevant BC sets (12.8%) were identified
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representing 3752 patients of which 1540 (41%) clinical data sets
were available. Of these 1540 patients, 40.8% had a nosocomial
bloodstream infection, while the remaining 59.2% were community
acquired. Disease severity within 96 h after BC sampling ranged from
infection without organ dysfunction (61.7%) to sepsis (29.5%) and
septic shock (18.2%). The overall hospital mortality rate was 20.6%.
55.4% of patients with infection without organ dysfunction died,
17.2% of patients with sepsis, and 8.8% of patients with septic shock.
Most common sites of infection were urogenital (29.7%), respiratory
(22.0%), and abdominal/gastrointestinal sites (17.8%).
In 3,752 patients, Enterobacteriaceae, Staphylococcus aureus , and
Enterococcus spp. belonged to the most frequently isolated pathogens
([50%). The most commonly anti-infective drugs given after first BC
sampling in 4,431 episodes of empirical antibiotic treatment were
Piperacillin/Tazobactam, Ciprofloxacin, and Meropenem.
Conclusions: The Thuringia-wide registry AlertsNet provides data on
BC positive patients with a wide clinical range of bloodstream
infections. Distribution of pathogens and underlying foci resembled
the experience of previous population-based studies in other
countries.
Acknowledgement: AlertsNet was funded by the German Ministry of
Health (BMG, Grant IIA5-2512FSB114) and by the Thuringian
Ministry for Social Affairs, Health and Family (TMSFG). AlertsNet
2.0 is supported by the German Federal Ministry of Education and
Research (BMBF, grant 01EO1502) and by the Thuringian Ministry
for Social Affairs, Health Care, Women and Family (TMASGFF,
grant 44-0793/29-1-37527/2015).
035
Infection 2017
Calprotectin and calgranulin C as novel biomarkers of bacterial
infection
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Sˇtefan M (1), Holub M (1)
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Introduction: Calprotectin (S100A8/9 protein) and calgranulin C
(S100A12 protein) are calcium-binding proteins belonging to a group
of danger associated molecular patterns (DAMPs). These proteins are
stored in human epithelial cells, keratinocytes, monocytes (Mo), and
neutrophils; caprotectin comprises approximately 45% of neutrophil
cytosol content. After neutrophil death or activation, calprotectin and
calgranulin C are released to extracellular space. Elevated serum
levels of caprotectin and calgranulin C were found in children with
acute otitis media, and in adults with tuberculosis or septic shock.
Although these studies indicate that calprotectin and calgranulin C
have potential as biomarkers of infectious diseases, their serum levels
have not been analyzed in adults with common infectious diseases.
Objectives: Therefore, the aim of our study was to analyze calpro-
tectin and calgranulin C serum levels in adult patients with
community-acquired infectious disease. We also evaluated effect of
antimicrobial therapy on the kinetics of these proteins and association
with clinical course, etiology and source of the infection.
Methods: Adult patients (age range 18–80 years) admitted to the
department of infectious diseases with probable severe bacterial or
viral infections were enrolled in this prospective study. Blood samples
were collected on day 1, 3, 5 and 7 after the admission. Beside routine
laboratory analyses of blood count and clinical chemistry serum
levels of caprotectin and calgranulin C were measured using ELISA
test (Biovendor, Brno, Czech Republic).
Results: We enrolled 43 patients with bacterial infection (median age
53 years), 15 patients with viral infection (median age 31) and 25
healthy controls (median age 53 years). The most common diagnosis
in bacterial infection group was genitourinary tract infection (n = 18)
followed by lower respiratory tract infection (n = 11) and gastroin-
testinal infection (n = 4). Calprotectin and calgranulin C serum levels
were significantly higher (p\ 0.05) in patients with bacterial infec-
tion in comparison to viral infection and healthy controls.
Furthermore, both proteins decreased significantly (p[0.05) during 7
days of antibiotic therapy, which was reflected by uneventful
recovery.
Conclusions: Our results suggest calprotectin and calgranulin C
serum levels as potential biomarkers of severe bacterial infection.
Moreover, serial measurements of these proteins in the blood might
be used for evaluation of the efficacy of antibiotic therapy.
References: Chan JK, Roth J, Oppenheim JJ, Tracey KJ, Vogl T,
Feldmann M, Horwood N, Nanchahal J. Alarmins: awaiting a clinical
response. J Clin Invest 2012;122(8):2711–9. doi:10.1172/JCI62423.
Acknowledgement: The study is supported by grants AZV
15-30786A and SVV260369.
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Diagnostic and prognostic value of monocyte chemotactic protein
1 in patients with sepsis and septic shock
Barre M (1), Behnes M (1), Hamed S (1), Lang S (1), Akin I (1),
Bertsch T (2), Borggrefe M (1), Hoffmann U (1)
(1) First Department of Medicine, University Medical Centre Man-
nheim (UMM), Faculty of Medicine Mannheim, University of
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Laboratory Medicine and Transfusion Medicine, General Hospital
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Introduction: Sepsis and septic shock represent complex disease
syndromes with a significant impact on patients´ outcomes. Monocyte
Chemotactic Protein 1 (MCP1) is a pro-inflammatory acute-phase
protein, which has been rarely investigated in sepsis and septic shock.
Objectives: This study evaluates the diagnostic and prognostic value
of MCP-1 in patients with sepsis or septic shock being within the first
week of intensive care treatment.
Methods: Patients with sepsis and septic shock according to Sepsis-3
criteria were included, when treated on an internal intensive care unit
(ICU). 60 controls with no evidence for sepsis/septic shock were also
included. Blood samples were taken on day 1, 3 and 8 of ICU
treatment. Biomarker measurements were performed by ELIS for
MCP-1 (Quantikine ELISA), as well as for PCT, IL-6 and C-reac-
tive protein (CRP). All-cause mortality was followed up at 30 days
and 6 months.
Results: Of a total of 136 patients, 43 (32%) suffered from sepsis and
93 (68%) suffered from septic shock. Highest MCP-1 levels were
found in patients with septic shock (median = 973.6pg/ml, IQR
608.4–2646.3pg/ml), followed by sepsis (median = 498.2pg/ml, IQR
378.4–903.6pg/ml) and controls (median = 350.6pg/ml, IQR
295.7–495.16pg/ml) (p = 0.001). MCP-1 was significantly higher in
non-survivors compared to survivors both at 30 days (non-survivors:
n = 68, median = 1074.1pg/ml, IQR 535.9–2373.2 pg/ml; survivors
n = 68, median = 663.7pg/ml, IQR 460–1204.3pg/ml; p = 0.02)
and 6 months (non-survivors: n = 87, median = 946.9pg/ml, IQR
540.3–2619.5pg/ml; survivors: n = 49, median = 577.1pg/ml, IQR
388.8–1136.2pg/ml; p = 0.047). Patients with MCP-1 levels within
the 4th quartile were up to 3 times more likely to die within 6 months
compared to patients with lower levels (HR = 2.1–3.3).
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Conclusions: Levels of MCP-1 may discriminate sepsis and septic
shock according to new sepsis-3 criteria and may provide prognostic
value both for short- and mid-term all-cause mortality in these
patients.
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Blood cultures at sepsis onset—guideline compliance and its
impact on pathogen detection in a German cohort
Thomas-Ru¨ddel DO (1), Matha¨us-Kra¨mer C (2), Schwarzkopf D (2),
Ru¨ddel H (1), Bloos F (1), Reinhardt K (1)
(1) Center for Sepsis Control and Care (CSCC) and Department of
Anaesthesiology and Intensive Care Therapy, Jena University
Hospital, (2) Center for Sepsis Control and Care (CSCC), Jena
University Hospital.
Introduction: Current guidelines recommend drawing at least two
sets of blood cultures (BC) before starting antimicrobial therapy (AT)
in patients with suspected sepsis or septic shock (1).
Objectives: To determine factors associated with pathogen detection
from BC and with guideline compliance regarding BC.
Methods: We conducted a four year multicenter cluster randomized
quality improvement study aiming at shorter time to AT and better
BC diagnostics including ICU patients with sepsis (all with organ
dysfunction) (2). The number of BC sets taken before or after the
initiation of AT was recorded and results were classified on site as
positive, contaminated or negative. Chi Square test was used to
examine categorical variables.
Results: Of 6561 patients 2687 (41%) had at least two sets of BC
drawn before starting AT (fully compliant), 2608 (40%) had only one
set drawn or BC were drawn after the start of AT (partly compliant)
and 1266 (19%) patients had no BC drawn at sepsis onset (non-
compliant). Compliance was highest in emergency departments and
low in operating theaters (Figure 1, p\ 0.001). The number of sets
drawn (p = 0.015) and the timing of BC draw before or after the start
of AT (p\ 0.001) were significantly associated with pathogen
detection rates (Figure 2).
In a binary logistic regression model, the number of sets (odds ratio
1.15 per set, 95% confidence interval 1.06–1.24), BC draw before AT
(OR 2.24, 95% CI 1.96-2.55) and procalcitonin concentrations (OR
2.05 per 10-fold increase, 95% CI 1.89–2.23) were independently
associated with pathogen detection from BC. The quality improve-
ment efforts were associated with a significant improvement in the
number of cases with at least two BC sets drawn (from 68 to 84%,
p\ 0.001), a slight reduction of patients without blood cultures
drawn (from 21 to 18%) but with no improvement in the proportion of
blood cultures drawn before starting AT (from 52% to 48%)
(p = 0.047).
Conclusions: Blood cultures drawn at the onset of severe sepsis have
a high rate of pathogen detection, especially when guideline recom-
mendations are fully followed. However, compliance with
recommendations is low and differs between areas of care. While we
were able to increase the proportion of cases with at least 2 BC sets
drawn, our quality improvement trial had no influence on the timing
of BC draw. Further quality improvement trials should especially
focus on this topic and on areas of care with low guideline
compliance.
Reference: (1) Dellinger RP et al. Intensive Care Med 2013
(2) Bloos F et al. Intensive Care Med 2017
Acknowledgements: The study was funded by the German Federal
Ministry of Education and Research via the integrated research and
treatment center ‘‘Center for Sepsis Control and Care’’ (FKZ
01EO1002).
055
Infection 2017
Accelerating time to pathogen-adapted antibiotic treatment
through culture-independent antimicrobial susceptibility testing
in patients suffering from sepsis
Karrasch M (1), Bender M (1), Geraci J (1), Brunkhorst FM (2),
Lo¨ffler B (1)
(1) Jena University Hospital, Institute of Medical Microbiology, (2)
Jena University Hospital, Center for Clinical Studies, Center of
Sepsis Control and Care (CSCC), Department of Anaesthesiology and
Intensive Care Medicine.
Introduction: Accurate and fast pathogen identification and con-
secutive antimicrobial susceptibility testing (AST) is of vital
importance for patient outcome in patients suffering from sepsis.
Objectives: superiority of time-to-result generation by culture-inde-
pendent AST when compared to gold standard.
Methods: The Accelerate PhenoTM system is a new, fully automated,
culture-independent diagnostic method for both pathogen identifica-
tion (ID) and antimicrobial susceptibility testing (AST). We analyzed
positive blood cultures from critically ill patients with new onset of
sepsis according to the new sepsis guidelines, using both conventional
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standard methods (VITEK, MALDI-TOF) and Accelerate PhenoTM
system. ID/AST results of the Accelerate PhenoTM system were not
reported to treating physicians as part of our internal evaluation
process.
Results: Accelerate PhenoTM system correctly detected 74 pathogens
[Gram-negative (GN) (n = 27), Gram-positive (GP) (n = 47)] straight
out of 84 positive blood culture bottles. Gram-negative (GN) pathogens
were identified as E. coli (n = 15; concordance rate 100%), K. pneu-
monia (n = 7; 71.4%), S. marcescens (n = 3; 100%), E. cloacae
(n = 2; 50%), P. mirabilis (n = 1; 100%) and P. aeruginosa (n = 1;
33%). Gram-positive pathogens were identified as CNS (n = 24;
82.6%), S. aureus (n = 15; 88.2%), E. faecium (n = 6; 100%) and E.
faecalis (n = 2; 100%). The Accelerate PhenoTM system generated a
GN-AST result in 70.4% (19 of 27 samples) and a GP-AST result in
61.7% (29 of 47 samples) when compared to routine AST. Growth
control, analysis and mechanical failure led to reduced results in
comparison to conventional ID/AST. Accelerate PhenoTM delivered
correct MIC-results for most of the panel antibiotics [e.g. meropenem:
83.3%, gentamicin: 88.9%, ertapenem: 100%].
Conclusions: The use of the Accelerate PhenoTM system significantly
improved time-to-ID/AST and would have led to a reduced time-to-
treatment in patients suffering from sepsis if results would have been
reported. The system currently has some weakness in the detection of
polymicrobial and streptococcal infections but due to the short hands-
on-time, culture-independence and fast generation of results, it rep-
resents a promising new diagnostic method for the consecutive
antibiotic treatment of septic patients.
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Two characteristic cytokine secretion and monocyte surface
marker expression patterns are associated with the clinical
outcome in critically ill patients with Pseudomonas aeruginosa
induced sepsis
Weiss M (1), Riedel CU (2), Barth E (1), Bracht H (1), Georgieff M
(1), Essig A (3), Henne-Bruns D (4), Sedlag A (2)
(1) Clinic of Anesthesiology, University Hospital Medical School
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Ulm, (3) Institut fu¨r Medizinische Mikrobiologie und Hygiene,
University Hospital Medical School Ulm, (4) Department of General
and Visceral Surgery, University Hospital Medical School Ulm.
Introduction: Critically ill patients with sepsis due to Pseudomonas
aeruginosa (PSA) infections often reveal a prolonged stay and worse
outcome.
Objectives: The present study was performed to find out whether
these patients on a surgical intensive care unit with sepsis due to PSA
with beneficial and worse outcome differ in serum cytokine concen-
trations and ex-vivo secretion, and in monocyte intracellular and
surface receptor expression.
Methods: IL-8 serum concentrations and ex vivo secretion after LPS
stimulation were determined by ELISA. Surface markers CD163
(hemoglobin scavenger receptor; clearance of hemoglobin, adhesion
to endothelial cells, tolerance induction, tissue regeneration; soluble
form: antiinflammation), CD206 (receptor for mannose on surface of
microorganisms), CXCR1 (IL-8a chemokine receptor), CXCR2 (IL-
8b chemokine receptor) and IFN-c receptor as well as intracellular
levels of IFN-c of monocytes of patients with PSA sepsis and of
healthy controls were analyzed by flow cytometry.
Results: 22 healthy controls and 20 surgical patients with sepsis/
septic shock with underlying PSA infections were monitored. Com-
pared to patients with low severity of disease SAPS II scores, patients
with high SAPS II scores revealed significantly higher serum con-
centrations of TNF-a (p\ 0.05) and sCD163 (p\ 0.01), but lower
concentrations of IL-8 (p\0.05). In line with high IL-8 or low IL-8
concentrations in serum (965 ± 139 vs. 232 ± 15 pg/ml) as well as
in culture after LPS stimulation (2838 ± 259 vs. 1097 ± 356 pg/ml),
expression of surface markers IFN-c, CXCR1, CXCR2 and CD163
was high or low, respectively, however, were always above those of
the healthy control group (p\ 0.05). In contrast, CD206 expression
was higher on IL-8 low monocytes (3657 ± 279 MFI) than on IL-8
high cells (17 ± 6 MFI) (p\0.001). The IL-8 low group manifested
markedly higher severity of disease (SAPS II 34 ± 8) than the IL-8
high group (SAPS II 17 ± 6) (p\ 0.001), and worse outcome.
Conclusions: Patients with sepsis due to PSA, with low TNF-a and
sCD163 but high IL-8 serum concntrations, and a IFN-chi, CXCR1hi,
CXCR2hi, CD163hi, CD206lo monocyte marker profile are expected to
have low severity of disease (SAPS II) and take a beneficial course. On
the other hand, high TNF-a and sCD163 but low IL-8 serum concen-
trations, and a IFN-clo, CXCR1lo, CXCR2lo, CD163lo, CD206hi
marker pattern of monocytes may indicate patients with sepsis due to
PSA with high severity of disaese and worse clinical outcome.
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Introduction: Blood cultures (BC) are the gold standard for detection
of bacteremia in patients with suspected infections. However, a
positive detection succeeds only in a limited number of patients. To
predict BC results several studies found Procalcitonin (PCT) as one
possible biomarker in patients with infections and suspected infec-
tions presenting in the Emergency Department (ED). (Laukemann
et al. 2015)1.
Objectives: To predict BC results by PCT-levels in intensive care
patients with suspected infections.
Methods: In a prospective clinical observational study (bedside vs.
standard microbiological BC Diagnostics - BEMIDIA, ClinicalTri-
als.gov Identifier: NCT03000049) all consecutive ICU patients with
clinical suspicion of infection and indication for blood culture sam-
pling were included between November 2016 and April 2017.
Samples for three BC pairs and Point-of-Care (POC) –PCT mea-
surement were taken simultaneously. BCs were incubated in an
automated detection system (BD BACTECTM blood culture system,
BD Diagnostic Systems, Sparks, MD, USA). Pathogen identification
was performed according to routine laboratory procedures. PCT-
measurement was performed using a point-of-care device (Samsung
IB BRAHMS PCT, C&T Corporation, Seoul, South Korea).
Patients were classified into two groups according to their PCT
levels\0.1 and[0.1 ng/ml.
Results: 121 patients with PCT measurments were included in this
analysis. 28 patients (23%) of the samples resulted in a positive blood
culture and a microbiological pathogen detection. 81 patients were
treated with anti-infectives at the time of blood sampling. 18 patients
(15%) had a PCT level less than 0.1 ng/ml. In these patients 11% of
blood cultures were positive (95%Confidence Interval (CI)
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0.02–0.36). 103 patients had a PCT level[0.1 ng/ml while 25% BC
(95% CI 0.17–0.35) were positive. Sensitivity and specificity of a cut-
off by 0,1ng/ml for the POC-PCT-measurement were 93% (95% CI
0.75–0.98) and 17% (95% CI 0.10–0.27), respectively. The positive
predictive value (PPV) of a cut-off by 0.1 ng/ml for blood cultures
was 25% (95% CI 0.17–0.34) and the negative predictive value
(NPV) 89% (95% CI 0.64–0.98).
Conclusions: Compared with patients in the ED (Lit.) where with a
cut off of PCT\0.1 ng/ml NPV was 99.6% (PPV 12%) the results of
this study in ICU patients showed a lesser NPV of 89%.
PCT levels of ICU patients therefore show minor advantage to predict
positive BC. So BCs will be still required under these conditions. One
possible explanation is that most patients were already treated with
antibiotics at the time of blood sampling. Furthermore surgeries or
malignomas can increase PCT levels.
Reference: 1 Laukemann, S. et al. Can We Reduce Negative Blood
Cultures With Clinical Scores and Blood Markers ? Results From an
Observational Cohort Study. 94, 1–10 (2015).
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Introduction: Studies in animals and humans have demonstrated that
immune responses are highly gender-specific. Females have a more
active baseline immune system. As a consequence, they exhibit a
higher incidence of autoimmune diseases, a more robust response to
vaccination, and a lower incidence of severe sepsis. However, the
regulatory mechanisms behind, in particular in the critically ill are
still unclear and appear complex.
Objectives: In this study, we aim to identify and synthesize evidence
for the influence of gender on the transcriptome of immune cells in
age and severity synchronized sepsis trauma patients throughout the
course of the acute phase.
Methods: Publically available expression data was analyzed from a
cohort of 75 men and 47 women age-matched (age [ 18 and \50
years) critically ill trauma patients. Whole blood gene expression was
measured from the time of hospitalization to 28 days at various time
points. SOFA scores were used to synchronize the severity course of
the patients. Transcription profiles were then mapped to the adjusted
severity course and binned in such a way that acute, pre-acute and post-
acute phase can be distinguished. Within each bin, transcription profiles
of male versus female patients were compared to identify significantly
distinct gene-sets. Identified gene-sets from all bins were then clustered
into major groups of cellular processes using the k-means algorithm.
Results: A synchronization of samples according to their SOFA
scores in time showed higher severity course in men in all bins (early,
acute and post-acute). The maximum-SOFA score was significantly
(p value\0.001) higher in men in spite of having similar injury scores
as women at admission. In total, 321 gender-affected gene-sets were
found modulated during the studied course of the illness. After
eliminating small and heterogeneous clusters of gene-sets, we
identified 8 large clusters representing the major molecular mecha-
nisms that differ in regulation across gender. During the post-acute
phase, women showed an immediate lymphocytic response. In turn,
men exhibited higher gene regulation of mitochondrial functions and
DNA damage response during the pre-acute and acute phase. The
early up regulation of genes for respiration may be due to oxidative
damage in men and a self-regulatory mechanism to compensate this
but may need further therapeutic support, by e.g. antioxidants.
Conclusions: Our longitudinal gene expression analyses by adjusting
age and severity scores have highlighted underlying gender-specific
mechanisms. These altered mechanisms of immune- and recovery-
responses may aid in understanding and delivering gender-specific
point of care.
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Simple and rapid ciprofloxacin AST and MIC determination
within 2 h using Raman spectroscopy
Kirchhoff J (1,2), Glaser U (1,2), Bohnert J (3), Pletz MW (1,4), Popp
J (1,2,5,6), Neugebauer U (1,2,5,6)
(1) Center for Sepsis Control and Care, Jena University Hospital,
Germany, (2), Leibniz Institute of Photonic Technology, Jena, Ger-
many, (3) Institute of Medical Microbiology, Jena University
Hospital, Germany, (4) Center for Infectious Diseases and Infection’s
Control, Jena University Hospital, Germany, (5) Institute of Physical
Chemistry and Abbe Center of Photonics, University Jena, Germany,
(6), Research Campus InfectoGnostics Jena, Germany.
Introduction: Antibiotic resistant bacteria, especially multi-resistant
Gram negative bacteria (MRGN) gained an acute health care problem
over the past years. Therefore, rapid antimicrobial susceptibility
testing (AST) is urgently to avoid both, inappropriate under-treatment
resulting in increased mortality in patients with sepsis and the
unnecessary use of broad spectrum antibiotics fostering further spread
of MRGN. Determination of the minimal inhibitory concentration
(MIC) is recommended to tailor and optimize antibiotic selection and
dosage. Here, we present a simple and fast spectroscopic procedure to
identify antibiotic susceptibilities and furthermore to determine the
MIC within 2 h.
Objectives: Our aim is to develop a simple and fast diagnostic tool
based on Raman spectroscopy, allowing isolation of the pathogen
from patients’ material, identification of the pathogen and subsequent
AST and MIC determination within a few hours.
Methods: Micro-Raman spectroscopy was applied to detect cipro-
floxacin-induced changes in bacteria exposed to a range of several
ciprofloxacin concentrations around the EUCAST breakpoint after only
90 min incubation time. The bacteria were captured directly in sus-
pension using a dielectrophoresis chip, which is placed under the
Raman microscope [1]. The spectroscopic MIC test was established
using two Escherichia coli strains (AG100 and 3-AG100) and validated
with 13 clinical isolates collected from patients with sepsis. Principal
component analysis (PCA) was applied to define spectral ciprofloxacin
effect marker bands. Classification as sensitive, intermediate or resis-
tant was done according to EUCAST clinical breakpoints. To verify the
MIC results, the spectral MICs were compared with MICs obtained by
broth microdilution, Vitek-2 system and Etest.
Results: Raman spectra indicated a concentration-dependent killing
effect induced by ciprofloxacin after 90 min of treatment. PCA
identified two marker bands defined at 1460 and 1485 cm-1 that
designate growth or inhibition. The ratios of the intensities of these
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two bands show a clear concentration dependent effect and allow
reading out the MIC at a defined threshold. The Raman-90-min AST
results of the clinical E. coli isolates are in good agreement with the
reference methods.
Conclusions: We present a Raman spectroscopy-based method for
determination of the MIC within 2 h total analysis time using the
clinical relevant example of E. coli and the fluoroquinolone drug
ciprofloxacin. Only minimal sample preparation is required and short
cultivation of 90 min is sufficient. These findings mark a major step
towards the completion of a novel spectroscopy-based diagnostic tool.
References: [1] Schro¨der et al., Anal Chem, 2013, 85 (22), 10717–24
Acknowledgements: Financial support by the BMBF via the Inte-
grated Research and Treatment Center ‘‘Center for Sepsis Control and
Care’’ (FKZ 01EO1502) and the Carl Zeiss Foundation is highly
acknowledged.
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glycocalyx by emergency room and intensive care unit nurses—
the GlycoNurse study
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Pavensta¨dt H (1), Ku¨mpers P (1)
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(2), Centre for Clinical Trials Mu¨nster, (3) Department of Physiology,
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Introduction: Deterioration of the endothelial glycocalyx (eGC), a
protective carbohydrate-rich layer lining the luminal surface of the
endothelium, plays a key role in vascular barrier dysfunction and
eventually organ-failure in systemic inflammatory response syndrome
and sepsis. Early detection of glycocalyx damage could thus become
an important goal in critical care.
Objectives: This study was designed to determine the feasibility and
reproducibility of quantitative, real-time glycocalyx measurements
performed by trained nurses in the emergency room (ER) and
intensive care unit (ICU).
Methods: The observational study included 70 patients admitted to
the ER or ICU of a university hospital. The nurse in charge of the
patient and a physician performed sublingual microcirculatory mea-
surements using sidestream dark field (SDF) imaging.
GlycoCheckTM software for automated data acquisition and analysis
was used to analyze the perfused boundary region (PBR), an inverse
parameter of endothelial glycocalyx dimensions in vessels with
diameters of between 5 and 25 lm.
Results: There were no significant differences in the PBR values
obtained by the nurses when compared to those reported by the
physician (and which was regarded as the ‘‘gold standard’’ mea-
surement). Intraclass correlation coefficient analysis showed excellent
reproducibility between the nurses’ and physician’s PBRs (0.75
[(95% CI: 0.52–0.87]). The mean difference between the two PBRs
(i.e., the bias) was 0.007 ± 0.25 lm. The nurses’ PBR assessment
had a 90% sensitivity (95% CI: 60–99%) and 90% specificity (95%
CI: 80–93%) to identify a severely impaired glycocalyx.
Conclusions: ER and ICU nurses can reliably measure glycocalyx
dimensions by non-invasive assessment of the PBR. This assessment
could become part of standard monitoring and contribute to clinical
decision-making and resuscitation protocols in clinical trials and daily
practice.
Acknowledgement: AR designed the study, performed the mea-
surements, analyzed the data, prepared the figures, and drafted the
manuscript: AL, HV, JS, and HP contributed to the design of the
study, discussed the findings and revised the manuscript; PK had the
initial idea, supervised the study and contributed to the manuscript.
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Dramatic increase in the frequency of blood cultures and a
significant decrease of bloodstream infections—an observational
Study on 729 Intensive Care Units in Germany (2006, 2015)
Salm F (1), Schwab F (1), Behnke M (1), Brunkhorst FM (2),
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Introduction: Early and sufficient diagnostic to identify the causative
pathogen is prerequisite for a timely therapy start and a targeted antibiotic
treatment and essential for the patient outcome. Blood cultures are the
most important diagnostic to detect a bloodstream infections.
Objectives: Aim of the study was to investigate the development of
the frequency of blood cultures and the rate of primary bloodstream
infections in a 10 year period (2006 to 2015) and to study the asso-
ciation between both parameters on intensive care units in Germany.
Methods: Intensive care units participating in the German hospital
infection surveillance system (KISS) were included in the analysis.
Bloodstream infection were defined according the Center for Disease
Control and Prevention. Univariable and multivariable analysis were
performed using generalized linear models (GLM).
Results: Overall, 2,427,921 patient days from 644,575 patients on
729 intensive care units were analyzed. On the 90 intensive care units
reporting data 2006 and 2015, the frequency of blood cultures per
1000 patient days increased doubled from 57.8 (interquartile range
[IQR] 29.8–101.2) to 128.2 (IQR 71.6–183.2). In the same time the
mean bloodstream infection rate decreased by half from 2 (IQR 0–5;
2006) per 1000 patient days to 1 (IQR 0–3; 2015).
Nevertheless, taking a closer look at the intensive care units stratified
by the frequency of blood cultures, wards with 200–249 compared to
wards with 0–49 blood cultures per 1000 patient days, those with
200–249 had a 1.9 higher risk for bloodstream infections (incidence
of bloodstream infections 0.44 versus 0.24).
Conclusions: In conclusion this investigation underlines the impor-
tance of a confidential feedback system within a surveillance system.
We cannot just compare rates. Rates of bloodstream infections are
significantly determined upon the frequency of blood culture. The risk
of this surveillance bias must be taken always into account when
surveillance data are used.
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The gut microbiota disturbances in ICU patients with nosocomial
pneumonia
Chernevskaya E (1), Beloborodova N (1), Bedova A (1), Pautova A
(1), Klimenko N (2), Tyakht A (3), Gusarov V (4)
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(1) Laboratory of human metabolism in critical states, Federal
Research and Clinical Center of Intensive Care Medicine and
Rehabilitology, Moscow, Russia, (2), Novosibirsk State University,
Novosibirsk, Russia, (3), ITMO University, Saint-Petersburg, Russia,
(4), Pirogov National Medical and Surgical Center, Moscow, Russia.
Introduction: Individual gut microbiota is temporally stable, but under
conditions of environmental changes in the intense-care unit (ICU), there
are rapid dramatic disturbances and temporary dynamic changes in the
microbial community composition. The analysis of 16S rRNA sequences
in microbial populations using NGS gives a rapid overview of the
microbial community diversity. Metabolic activity of microbes can be
assessed by measurement of aromatic microbial metabolite levels
(AMM)—which are associated with the severity and mortality of ICU
patients. System response of the host organism to microbial load is
assessed using biomarkers like procalcitonin (PCT) and presepsin (Ps).
Objectives: The purpose of our study is to assess the qualitative and
quantitative parameters describing host reaction and gut microbes
activity in patients with nosocomial pneumonia for better under-
standing pathophysiology of infection process in critically ill patients.
Methods: In a pilot prospective study, 5 patients with nosocomial
pneumonia admitted to ICUs were observed on days 1, 3, 7–9 after
the diagnosis of pneumonia. 16S rRNA metagenomic sequencing of
fecal sample was performed using Ion PGM System, with Ion PGM
Hi-QTM sequencing chemistry (318TM Chip). DNA was extracted
from endotracheal aspirate (EA) and fecal samples for the quantitative
detection of nosocomial bacteria were analyzed using RT-PCR (IQ5,
BIORAD); blood PCT and Ps were measured. After liquid-liquid
extraction from serum and fecal samples, 9 phenylcarboxylic acids
(AMM) were measured using GC-MS (Trace1310-ISQ, Thermo).
Results: The loss of species biodiversity of gut microbiota in ICU
patients is reflected in a change of AMM profiles in fecal samples.
According to metagenomic analysis, the major microbial families
were Enterobacteriaceae, Enterococcaceae, Streptococcaceae, Sta-
phylococcaceae, Bacteroidaceae (Fig. 1, Tab. 1). The following
correlations with serum AMM were revealed: the total concentration
of 9 AMM correlated with PCT (Spearman‘s correlation coeffi-
cient = 0.580), homovanillic acid - with PCT and Ps (rs = 0.810 and
0.709, respectively), phenyllactic acid - with presepsin (rs = 0.77),
p-hydroxyphenylacetic acid - with total DNA of bacteria and DNA of
Enterobacteriacea in EA (rs = 0.635 and 0.724, p\ 0.01).
Conclusions: The biodiversity reduction in the gut microbiota is
likely conduct to the change in the qualitative profile of AMM in the
feces and their serum quantitative content that correlate with the host
response (biomarkers level) in ICU patients with nosocomial pneu-
monia. Experiments with extended cohort will lead to a better
understanding of the host-microbe interaction.
Supported by Russian Science Foundation Grant 15-15-00110
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Changes in gastrointestinal microbiome patterns predict higher
probability of postoperative complications
Schmitt FCF (1), Brenner T (1), Uhle F (1), Hackert T (2), Hofer S
(3), Dalpke AH (4), Weigand MA (1), Boutin S (5)
(1) Department of Anesthesiology, Heidelberg University Hospital,
(2) Department of General and Transplant Surgery, Heidelberg
University Hospital, (3) Department of Anesthesiology, Kaiser-
slautern Westpfalz Hospital, (4) Department of Infectious Diseases,
Medical Microbiology and Hygiene, Heidelberg University Hospital,
(5) Translational Lung Research Center Heidelberg, German Center
for Lung Research.
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Introduction: The development of postoperative complications is of
great relevance in daily clinical practice and the gastrointestinal
microbiome seems to play an important role by preventing pathogens
from crossing the intestinal barrier.
Objectives: This study aims to examine changes in the gastroin-
testinal microbiome and evaluate its impact on the postoperative
course following major abdominal surgery.
Methods: In total, 116 stool samples of 32 patients, undergoing
pancreatic surgery, were analyzed via 16S-rRNA gene next-genera-
tion sequencing. One preoperative sample per patient was taken in
order to determine the baseline microbiome without exposition to
surgical stress and antibiotic use. At least two further samples within
the first 10 days were taken in order to observe the longitudinal
process. Whenever complications occurred, further samples were
taken.
Results: We were able to allocate the samples to three different
enterotypes (A, B and C) based on the structure of the microbiome.
Enterotype B showed an increase of Akkermansia, Enterobacteriaceae
and Bacteroidales as well as a decrease of Lachnospiraceae, Pre-
votella and Bacteroides. Patients being colonized by Enterotype B at
least once during the observation period showed a significantly higher
risk to suffer from postoperative complications (A vs B: odds
ratio = 4.96, p value\0.01, B vs C: odds ratio = 0.34, p value =
0.019).
Conclusions: Within the presented investigation we were able to
show for the first time, that there is a clear association between the
structure of the gastrointestinal microbiome and the rate of postop-
erative complications.
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Acute fibrinolysis shutdown occurs early in septic shock and is
associated with increased mortality
Schmitt FCF (1), Manolov V (1), Uhle F (1), Bruckner T (2),
Scho¨chl H (3), Weigand MA (1), Hofer S (4), Brenner T (1)
(1) Department of Anesthesiology, Heidelberg University Hospital,
(2) Institute of Medical Biometry and Informatics, University of
Heidelberg, (3) Department of Anesthesiology and Intensive Care
Medicine, AUVA Trauma Centre Salzburg, (4) Clinic for Anesthesi-
ology, Intensive Care and Emergency Medicine I, Westpfalz Hospital
Kaiserslautern.
Introduction: In the pathogenesis of sepsis, inflammation-induced
changes in coagulation are essential for the host defense against
infectious agents. However, an overwhelming procoagulatory
response may lead to a situation in which coagulation itself con-
tributes to the worsening of the disease. Acute fibrinolysis shutdown
has recently been described to be an early biomarker for the identi-
fication of patients suffering from sepsis, although the underlying
pathomechanisms, the specific temporal kinetics as well as its out-
come relevance in humans remain to be determined.
Objectives: The aims of this study were therefore to evaluate the pro-
as well as anticoagulatory responses in different inflammatory settings
using whole blood thromboelastometry (TEM) in parallel with routine
coagulation tests. A special focus was on the pathophysiology,
kinetics as well as outcome relevance of fibrinolysis shutdown in
patients suffering from septic shock.
Methods: In total, 90 patients (30 patients with septic shock, 30
surgical controls following major abdominal surgery and 30 healthy
volunteers) were enrolled. Blood samples from patients with septic
shock were collected at the time of sepsis diagnosis as well as 3, 6, 12,
24, 48 h and 7 d later. Samples from surgical patients were collected
prior to the surgical procedure as well as 3, 6, 12, 24, 48 and 7d after
the end of surgery. Blood samples from healthy volunteers were
collected once. Besides TEM, routine coagulation tests were per-
formed. Moreover, plasma concentrations of tissue plasminogen
activator (total tPA, free tPA) and plasminogen activator inhibitor
(PAI)-1 were measured using enzyme linked immunosorbent assays
(ELISA).
Results: As assessed by significantly increased plasma levels of
d-dimers, the coagulation system was shown to be activated in
patients with septic shock in comparison to both control groups.
Exceedingly, an inhibition of anticoagulatory mechanisms could be
observed in septic patients as assessed by significantly decreased
plasma concentrations of protein C, protein S and antithrombin (AT)
III, which was paralleled by significantly increased plasma levels of
thrombin-AT complexes. Moreover, fibrinolysis shut down occurred
early in the course of the disease. Most interestingly, significant
increases in total and free tPA in septic patients had no effect on
thromboelastometrical lysis indices (LI30min, LI45min, LI60 min).
Contrariwise, PAI-1 increased significantly already at sepsis onset,
which was paralleled by significantly increased LIs in patients suf-
fering from septic shock in comparison to both control groups. This
effect persisted throughout the 7d observation period and was most
pronounced in non-surviving septic patients.
Conclusions: As assessed by TEM, early inhibition of plasminogen
activation led to acute fibrinolysis shut down with improved clot
stability and was associated with increased mortality in patients suf-
fering from septic shock.
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The molecular face of hosts’ blood transcriptome during early
sepsis—insights from a large scale meta-analysis of microarray
data
Schaack D (1), Siegler BH (1), Tamulyte S (1), Weigand MA (1),
Uhle F (1)
Department of Anesthesiology, Heidelberg University Hospita.
Introduction: Sepsis is defined as a life-threatening condition,
resulting from a dysregulated and harmful response of the hosts’
immune system to infection. Apart from this, the (over-)compensating
mechanisms counterbalancing the inflammatory response have been
proven to render the host susceptible to further infections and increase
mortality. To date, various disparate studies have characterized the
pathophysiological complexity of sepsis with microarray-based tran-
scriptome data of circulating immune cells, while frequently being
restricted to a moderate number of patients in focus of particular
infections or clinical diagnoses.
Objectives: Our study aims to unravel the heterogeneity of immune
response in early sepsis and to elucidate the complexity of biological
processes behind it.
Methods: Following stringent assessment of appropriate microarray-
based studies, raw expression values from 14 selected data series
provided from public high-throughput repositories were processed
and annotated. In a subsequent conservative merging approach, a
meta-dataset was created comprising 949 patients with sepsis and 135
healthy controls, being described by expression values for 28,544
unambiguously mapped gene symbols. Parametric empirical Bayesian
methods were used for mandatory adjustments to accommodate for
batch effects emerging in the combined dataset. The number of
available genes was sequentially reduced to an informative subset of
5,000 genes with high variance. Residual expression data from septic
patients were then passed to hierarchical clustering analysis.
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Results: We identified two distinct clusters within the sepsis group
(655 vs. 294 septic patients), in direct comparison exhibiting only
moderate differences in gene expression. Comparing the both clusters
individually to healthy controls yielded strong expression changes of
genes involved in immune responses (T-cell receptor signaling,
antigen presentation, inflammasome). Both comparisons found a
similar set of regulated genes, with a stronger degree of dysregulation
occurring in the larger cluster and implicating a loss of monocyte and
T cell function, co-occurring with an activation of neutrophil
granulocytes.
Conclusions: We propose a consistent - but in its extent varying -
presence of immunosuppression, occurring as early in sepsis as its
clinical manifestation. While certain cell types possess contradictory
activation states, our finding underlines the urgent need for an early
host-directed therapy of sepsis side-by-side with antibiotics.
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Valuable LeukoDx64 score determination to follow antibiotic
treatment during intensive care
Denzinger M (1), Barth E (2), Bracht H (2), Weiss M (2),
Schneider EM (1)
(1) Division of Experimental Anesthesiology, University Hospital
Ulm, (2) Department of Anesthesiology, University Hospital Ulm.
Introduction: Flow cytometry (FACS) is used to determine immune
status of ICU patients by measuring expression rates of antigens like
receptors on the surface of leukocyte subpopulations. Up to now
FACS is a highly complex procedure with many steps and needs
standardized protocols and specially trained technicians. In our lab-
oratory FACS analysis of whole blood consists of nine steps and takes
up to 3 h. The Accellix LeukoDx provides results for one marker,
CD64 in 27 min and needs just one step by the user1.
Objectives: We asked first whether the LeukoDx64 results correlated
with flow cytometry and second, we asked whether CD64 is an earlier
marker for infections and sepsis than plasma biomarkers, PC-T and
CRP.
Methods: We compared the LeukoDx scores to the mean expression
densities of CD64 on the surface of granulocytes, in addition to other
surface markers related to leukocyte activation and HLA-DR. The
Accellix LeukoDx cartridge performed the LeukoDX ratio measure-
ments with 35ll of fresh EDTA-blood. Flow cytometry was
performed with antibodies directed against isotype controls, CD11b,
CD14, CD45, CD64, CD123, CD163. Analysis was done by a
FACScalibur cytometer and Cellquest (BD biosciences) and FloJo
software, for lymphocytes, monocytes and granulocytes. Individual
measurements as well as patients’ courses were determined by FACS
as well LeukoDx64 and were correlated using Graphpad prism vs. 7.0
for statistical evaluation.
Results: LeukoDx64 scores determined in 64 blood samples patients
ranged between 0.59 and 22.39, and flow cytometrically determined
expression densities on granulocytes ranged between 3.64 and 171.
After matching each LeukoDx score with the conventional flow
cytometry mean fluorescence intensities, Pearson correlation was
calculated and gave an r-value of 0.9492 (p = 0.0001). In follow-up
analyses, effective antibiotic treatment could be documented by a
rapid decline of both, the LeukoDx64 score as well as mean fluo-
rescence by conventional flow cytometry. Most importantly, the
changes observed by CD64 quantification were significantly more
sensitive than alterations in plasma biomarkers such as LBP
(lipopolysaccharide binding protein) and PC-T.
Conclusions: We conclude that the LeukoDx64 score has a very high
correlation with conventionally determined CD64 expression densi-
ties on granulocytes in patients with sepsis and septic shock before
and during antibiotic treatment. Moreover, CD64 expression on
granulocytes appears to be more sensitive to infection associated
inflammation than LBP and PC-T.
Reference: 1Sprung, C.L., Y. Sakr, J.L. Vincent, J.R. Le Gall, K.
Reinhart, V.M. Ranieri, H. Gerlach, J. Fielden, C.B. Groba, and D.
Payen. 2006. An evaluation of systemic inflammatory response syn-
drome signs in the Sepsis Occurrence In Acutely Ill Patients (SOAP)
study. Intensive Care Med. 32:421–7.
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Serum cholinesterase activity predicts length of the ICU stay
following polytrauma
Stein T (1), Zivkovic AR (2), Schmidt K (2), Mu¨nzberg M (3),
Brenner T (2), Weigand MA (2), Kleinschmidt S (1), Hofer S (4)
(1) BG Trauma Centre Ludwigshafen, Department of Anaesthesia,
Intensive Care Medicine and Pain Therapy, (2) Department of
Anesthesiology, Heidelberg University Hospital, (3) BG Trauma
Centre Ludwigshafen, Department of Trauma and Orthopaedic Sur-
gery, (4) Westpfalz Hospital, Kaiserslautern, Clinic for
Anesthesiology, Intensive Care and Emergency Medicine I.
Introduction: Severe traumatic injury (polytrauma) with resulting
systemic inflammatory response is associated with prolonged inten-
sive medical care and delayed patient recovery. The magnitude of the
associated systemic inflammation plays an important role in the
recovery following severe traumatic injury. Early detection of the
systemic inflammatory response might prove helpful in the effective
treatment of the polytrauma patients. Cholinergic activity has been
shown to play an important role in the inflammatory response. Serum
cholinesterase (butyrylcholinesterase; BChE) is the major acetyl-
choline hydrolyzing enzyme in blood. The activity of this enzyme has
been shown to correlate with extent of the acute inflammatory
response.
Objectives: Various biomarkers have been used in clinical and
experimental practice to predict the patient outcome. However, a
definitive prognostic tool for an early detection of the systemic
inflammation and prediction of the patient outcome remains to be
identified.
Here, we describe a correlation between the change in the BChE
activity and the early systemic inflammatory response upon severe
traumatic injury. Moreover, we assessed whether the BChE activity,
when measured in patients at the hospital admission following
polytrauma, could predict the patient outcome.
Methods: This observational clinical study was approved by the
Ethics Committee of the Medical Faculty of Heidelberg (Trial-Code
No. S-391/2015) and the Ethics Committee of the Rheinland-Pfalz
medical association, Mainz (Trial-Code No. 837.539.15/10307) and
was conducted in the Trauma Centre Ludwigshafen, Germany. All
patients or their legal designees gave written informed consent to the
work. The BChE activity was measured by using point-of-care-test
system (Securetec Detektions-Systeme AG, Neubiberg, Germany). In
addition, levels of the routine inflammation biomarkers, i.e. C-reac-
tive protein (CRP) and the white blood cell count (WBCC) were
measured during the initial treatment period. Measurements were
performed at the admission, followed by 12, 24 and 48-h time points.
Injury Severity Score (ISS) was used to assess the trauma severity.
Results: The observed reduction in the BChE activity was in accor-
dance with the change in the CRP concentration and the WBCC. The
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BChE activity measured at the hospital admission negatively corre-
lated with the length of the ICU stay in patients with polytrauma
(r = -0.5, Spearman’s rank correlation coefficient). A correlation
between the ISS and the length of the ICU stay further confirmed our
finding (r = 0.7, Spearman’s rank correlation coefficient).
Conclusions: Our results suggest that the BCHE activity might be
used as an early indicator for the magnitude of the systemic inflam-
matory response following polytrauma. Moreover, we show that the
BChE activity, measured at the hospital admission, might predict the
patient outcome and therefore prove useful in early identification of
the high-risk patients.
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Assessment of feasibility of using NLR as one of the markers of
purulonecrotic complications development in patients with
diabetic foot syndrome
Fuss J (1), Voloboyeva A (2)
(1) Physical rehabilitation, D.Halycky Lviv National Medical
University, (2) Intensive care, Central Regional Hospital in
Pustomyty.
Introduction: Diabetes mellitus (DM) belongs to a group of meta-
bolic disorders, the principal sign of which is high blood sugar level
resulting from abnormal secretion and/or insulin efficiency. Diabetic
foot syndrome (DFS) is one of the major complications of DM
(5–10%) with a high rate of radical treatment-amputations. The lower
limb amputation is performed in 0.2–4.8% of the DFS patients
worldwide that is, on average, 20–30 times higher than in overall
population [1].
Despite the progress in the diagnostics and treatment of DM, the DFS
incidence rates are still high, being a significant indicator of inade-
quate control over the DM progression [2, 3]. Despite the
achievements in modern medicine, i.e. advanced diagnostic tech-
niques and continuous improvement of surgeries, the number of
patients with purulonecrotic complications of DFS is growing each
year [4].
Objectives: to assess the feasibility of using NLR as one of the
markers of purulonecrotic complications in patients with diabetic foot
syndrome.
Methods: The clinical material consisted of 118 patients who were
divided into two groups. The first group included 59 patients with
DFS and ulcerative soft tissue lesions. The second group comprised
59 patients with DFS without lesions. The average age of the patients
was from 35 to 63 years old: man—43 (36.5%) and women—75
(63.5%). The research was conducted from March 2014 to November
2016. The patients of both groups participated in the following lab-
oratory tests: complete blood count (WBC, neutrophil count,
lymphocyte count, NLR), C-reactive protein (CRP) levels were
recorded. The study has not included active infection, leukocytosis,
malignancy, steroid use without any reason.
Results: At the hospital stage the study comprised a set of standard
and additional research methods. The standard ones included general
clinical research methods, assessment of foot lesion depth and of
purulonecrotic lesion using the wound exudate study. The additional
methods included the specification of purulonecrotic lesion depth and
nature of the wound process.
As a result of the conducted studies, we received the following data
(Table 1).
Variables Group 1 Group 2 p
CRP 1.3 ± 1.4 0.5 ± 0.3 \0.001
WBC 10.1 ± 1.7 6.9 ± 1.9 0.236
Neutrophil percent (%) 65.3 ± 9.8 51.4 ± 8.8 \0.001
Lymphocyte percent (%) 22.6 ± 7.9 37.8 ± 8.9 \0.001
NLR 4.4 ± 3.8 1.5 ± 0.8 0.001
White blood cell counts, neutrophil counts, neutrophil% and the
neutrophil lymphocyte ratio (NLR) were significantly higher in the
first group compared to that in the second group.
NLR can be considered to be one of the markers of purulonecrotic
complications development in patients with diabetic foot syndrome.
Conclusions: In this research, patients from both groups had analyzed
NLR level as inflammatory marker. Determining NLR in the presence
of high levels of diabetic foot ulcers is not a local inflammation alone
but also showed that there is a systemic inflammatory response. In
patients with diabetic foot other purulent complications of diabetes
can be seen much more and using NLR has been suggested as a cheap
and accessible inflammatory markers for developing and following of
purulent complication.
Reference: 1. Navarro, J.F. and Mora, C (2005) Role of inflammation
on diabetic complications. Nephrol. Dial. Transplant.20, 2601–2604.
2. Tamhane UU, Aneja S, Montgomery D, Rogers EK, Eagle KA,
Gurm HS: Association between admission neutrophil to lymphocyte
ratio and outcomes in patients with acute coronary syndrome. Am J
Cardiol 2008, 102(6):653–7.
3. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ: Neutrophil-
lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg
Oncol 2005, 91(3):181 4.
4. Imtiaz, Fauzia, et al. ‘‘Neutrophil lymphocyte ratio as a measure of
systemic inflammation in prevalent chronic diseases in Asian popu-
lation.’’ Int Arch Med 5.1 (2012): 2.
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Detection of Staphylococcus aureus Bacteremia by fully
automated Multiplex PCR (Curetis Unyvero)
Simon S (1), Scheer C (1), Kuhn SO (1), Bohnert J (2),
Hahnenkamp A (1), Rehberg S (1), Hahnenkamp K (1),
Gru¨ndling M (1)
(1) Department of Anaesthesiology, University Medicine Greifswald,
(2) Friedrich Loeffler Institute of Medical Microbiology, University
Medicine Greifswald.
Introduction: In order to be able to treat infections in a more focused
and faster way, rapid and correct microbiological diagnostics are
needed. The gold standard for the diagnosis of bacteremia is the
classic microbiological blood culture (BC) diagnostic. This requires at
least 24-48 h to get the final results. In comparison, the Curetis
Unyvero System (Curetis GmbH, Holzgerlingen, Germany) poten-
tially detects various microorganisms and resistance markers within
4.5 h.
Objectives: The present study was performed to verify the reliability
of the results of the Curetis Unyvero System analysis compared to the
gold standard of BC diagnosis.
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Methods: In a prospective clinical trial (Bedside vs. Standard
Microbiological BC Diagnostics - BEMIDIA, ClinicalTrials.gov
Identifier: NCT03000049), 51 positive BC samples (196 samples with
three BC pairs from 154 ICU-patients) were analyzed simultaneously
by Curetis Unyvero System and by classic microbiology proceeding.
Previously all BC samples were incubated in an automated detection
system (BD BACTECTM blood culture system, BD Diagnostic
Systems, Sparks, MD, USA).
The positive BC samples were lysed by the Unyvero L4 lysator within
30 min. Afterwards BC sample and Unyvero M1 Master Mix were
inserted into the Blood Culture Cartridge and analyzed in the Unyvero
A50 Analyzer.
With the cartridge 29 different gram-positive can be detected, 24
gram-negative and 8 fungi as well as Corynebacterium Spp.,
Mycobacterium Spp. and Propionibacterium Acnes. Simultaneously
16 different resistance markers were analyzed as well. The results of
the automated multiplex PCR (Curetis Unyvero) were compared with
the results of a classic microbiological proceeding.
Results: 51 (26.02%) BC incubated in BACTEC were positive for
bacteremia and 17 of those (8.67%) for Staphylococcus aureus . 15
(7.65%) of the Staphylococcus aureus positive BC were identified in
classical microbiology as well as in the Curetis Unyvero System. In
one sample the Curetis Unyvero System found a Methicillin Resistant
Staphylococcus Aureus (MRSA) and the resistance pattern mecA
even though classical microbiology was negative for Staphylococcus
aureus . There was no MRSA detected in any of the patient´s
microbiology samples, not even in the routinely performed nasal
MRSA-PCR screening. In a second sample we found Staphylococcus
aureus with classical microbiology but not with Curetis Unyvero
System.
Conclusions: Our first results show a correspondence with the results
gathered through microbiological analysis of Staphylococcus aureus
bacteremia within ICU-patients. More data are necessary to analyze
the benefit of Curetis Unyvero System in patients with other blood-
stream infections than Staphylococcus aureus bacteremia and to find
the clinical benefit of this rapid germ detection in positive blood
cultures.
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Serum cholinesterase activity predicts length of the ICU stay
following polytrauma
Stein T (1), Zivkovic AR (2), Schmidt K (2), Mu¨nzberg M (3),
Brenner T (2), Weigand MA (2), Kleinschmidt S (1), Hofer S (4)
(1) Department of Anaesthesia, Intensive Care Medicine and Pain
Therapy, BG Trauma Centre Ludwigshafen, (2) Department of
Anesthesiology, Heidelberg University Hospital, (3) Department of
Trauma and Orthopaedic Surgery, BG Trauma Centre Ludwigshafen,
(4) Clinic for Anesthesiology, Intensive Care and Emergency Medi-
cine I, Westpfalz Hospital, Kaiserslautern.
Introduction: Severe traumatic injury (polytrauma) with resulting
systemic inflammatory response is associated with prolonged intensive
medical care and delayed patient recovery. The magnitude of the
associated systemic inflammation plays an important role in the
recovery following severe traumatic injury. Early detection of the
systemic inflammatory response might prove helpful in the effective
treatment of the polytrauma patients. Cholinergic activity has been
shown to play an important role in the inflammatory response. Serum
cholinesterase (butyrylcholinesterase; BChE) is the major acetylcholine
hydrolyzing enzyme in blood. The activity of this enzyme has been
shown to correlate with extent of the acute inflammatory response.
Objectives: Various biomarkers have been used in clinical and
experimental practice to predict the patient outcome. However, a
definitive prognostic tool for an early detection of the systemic
inflammation and prediction of the patient outcome remains to be
identified.
Here, we describe a correlation between the change in the BChE
activity and the early systemic inflammatory response upon severe
traumatic injury. Moreover, we assessed whether the BChE activity,
when measured in patients at the hospital admission following
polytrauma, could predict the patient outcome.
Methods: This observational clinical study was approved by the
Ethics Committee of the Medical Faculty of Heidelberg (Trial-Code
No. S-391/2015) and the Ethics Committee of the Rheinland-Pfalz
medical association, Mainz (Trial-Code No. 837.539.15/10307) and
was conducted in the Trauma Centre Ludwigshafen, Germany. All
patients or their legal designees gave written informed consent to the
work. The BChE activity was measured by using point-of-care-test
system (Securetec Detektions-Systeme AG, Neubiberg, Germany). In
addition, levels of the routine inflammation biomarkers, i.e. C-reac-
tive protein (CRP) and the white blood cell count (WBCC) were
measured during the initial treatment period. Measurements were
performed at the admission, followed by 12, 24 and 48-h time points.
Injury Severity Score (ISS) was used to assess the trauma severity.
Results: The observed reduction in the BChE activity was in accor-
dance with the change in the CRP concentration and the WBCC. The
BChE activity measured at the hospital admission negatively corre-
lated with the length of the ICU stay in patients with polytrauma
(r = -0.5, Spearman’s rank correlation coefficient). A correlation
between the ISS and the length of the ICU stay further confirmed our
finding (r = 0.7, Spearman’s rank correlation coefficient).
Conclusions: Our results suggest that the BCHE activity might be
used as an early indicator for the magnitude of the systemic inflam-
matory response following polytrauma. Moreover, we show that the
BChE activity, measured at the hospital admission, might predict the
patient outcome and therefore prove useful in early identification of
the high-risk patients.
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Early detection of ESBL by Accelerate PhenoTM system—a case
report
Kuschnertschuk M (1), Scheer C (1), Kuhn SO (1), Bohnert J (2),
Hahnenkamp A (1), Rehberg S (1), Hahnenkamp K (1), Gru¨ndling M
(1)
(1) Department of Anaesthesiology and Intensive Care Medicine,
Department of Medicine University Greifswald, (2) Friedrich Loeffler
Institute of Medical Microbiology, Department of Medicine Univer-
sity Greifswald.
Introduction: To treat infections with multiresistant bacteria, rapid
and correct microbiological diagnostics are needed. The gold standard
for the diagnosis of bacteremia are the classic microbiological (CM)
blood culture diagnostics. After positivity the CM cultivation needs
24–48 h for a final pathogen result. In comparison, the Accelerate
PhenoTM system (APS, Accelerate Diagnostics, Inc., Tucson, Ari-
zona, USA) detects various microorganisms, resistance patterns and
minimal inhibitory concentration (MIC) within 6 h after positivity.
Objectives: To demonstrate a case of rapid detection of Extended
Spectrum Beta-Lactamase (ESBL) Klebsiella pneumoniae in a posi-
tive blood culture (BC) with consequences of antimicrobial therapy.
Methods: In a prospective clinical trial (Bedside vs. Standard
Microbiological BC Diagnostics - BEMIDIA, ClinicalTrials.gov
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Identifier: NCT03000049), positive BC samples are analyzed simul-
taneously by APS and by CM. The BC samples were incubated in an
automated detection system (BD BACTECTM blood culture system,
BD Diagnostic Systems, Sparks, MD, USA).
The positive BC sample were put in the APS. After the lysis of the
samples in flowcells a gel electrofiltration follows. A current is
applied so that interfering material will be absorbed leaving only the
pathogens for analysis. A fully automated fluoresence in-situ
hybridisation leads to the identification of the pathogens within 90
min. Detected bacteria is cultivated in a given concentration of
antibiotics and time-lapse imagine detects the antibiotic susceptibility
and MIC within 6 h.
Results: A male, 51 year old patient was transferred from a reha-
bilitation clinic to the hospital. 16 days later the patient showed a
reduced vigilance, a high PCT of[10 ng/l and a positive urin status
with [400 leukocytes/mikrolitre. BCs were taken and with the
probable cause of urosepsis a calculated therapy with piperacillin-
tazobactam was started, considering a past colonisation with Pseu-
domonas aeruginosa. The following day the BC became positive
(09:30am, +0 h after positivity) and samples were sent to CM diag-
nostics and simultaneously the APS started. 90 min after positivity
(11:03am, +1,5h) the APS identified Klebsiella pneumoniae. One and
a half hour later (12:22 am, +3h) the CM result (MALDI-TOF mass
spectrometry) came as well. Seven hours after positivity (04:21pm,
+7h) the APS presented the resistogram identifying 3MRGN, ESBL
and the therapy was adjusted to meropenem. The patient could be
transferred the same day with improved vigilance. The final CM
results arrived two days after positivity confirming the resistogram of
the APS (08:00, +41,5h)
Conclusions: The APS can shorten the time to identify pathogens and
to start an adequate therapy. Especially in infected patients with
multiresistant bacteria the earlier detection is suitable to save lives,
because of the faster adjusted antibiotic therapy.
Clinical Sepsis Research: Therapy
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The septic patient with new-onset atrial fibrillation—how to
treat?
Keller M (1), Meierhenrich R (1)
Klinik fu¨r Ana¨sthesie und Intensivmedizin, Diakonie-Klinikum
Stuttgart.
Introduction: Atrial fibrillation (AF) is the most common arrhythmia
which occurs during sepsis or septic shock and is promoted by sys-
temic inflammation and atrial remodeling. Especially the occurrence
of new-onset AF with no history of preexisting ‘‘typical’’ AF is
associated with increased morbidity and mortality. It can further lead
to hemodynamic failure and secondary thromboembolic complica-
tions such as stroke. Yet, there are no specific guidelines on treatment
of septic patients with new-onset AF and its ideal management cur-
rently remains unclear.
Objectives: To investigate the state-of-the-art on anti-arrhythmic and
stroke-preventive therapeutic strategies specifically for patients with
new-onset AF during sepsis.
Methods: A systematic review of the literature was conducted on
MEDLINE using various search terms. Abstracts of the listed publi-
cations were systematically analyzed and included if relevance and
quality matched our inclusion criteria. We manually added current
versions of major guidelines focusing on AF management to
investigate their current treatment approaches for new-onset AF, AF
during sepsis or AF due to other inflammatory causes.
Results: 1 meta-analysis, 3 reviews and 11 studies were included. AF
management guidelines of the European Society of Cardiology, the
American Heart Association and the American Association for Tho-
racic Surgery were investigated. The Surviving Sepsis Campaign
guidelines for clinical sepsis management were also included.
The current standards determine that the necessity of immediate
electric cardioversion is dependent on hemodynamic stability. Elec-
trical cardioversion alone seems to be ineffective and should most
likely be combined with amiodarone. Evidence on a pReference of
rhythm or rate control in hemodynamically stable patients is poor.
Systemic anticoagulation for stroke prevention is crucial but it seems
that typical scoring systems such as CHA2DS2-VASc score fail to
identify septic patients at risk. According to studies and guidelines,
anticoagulation in new-onset AF - especially during and after car-
dioversion - should only be administered to patients at high risk for
stroke.
Conclusions: While adequate antibiotic therapy and if necessary
surgical intervention as a causal approach to eliminate the inflam-
matory mechanisms responsible for new-onset AF during sepsis form
the basis of the treatment strategy, exact knowledge on specific
treatment options of new-onset AF in the septic patient is lacking and
further prospective treatment studies are required. Stroke-preventive
anticoagulation should only be performed in patients at high throm-
boembolic risk, while the exact risk factors associated with stroke
during sepsis are currently unknown. Even though there is no definite
data on follow-up of patients with new-onset AF during sepsis, rou-
tine long-term cardiology examinations after such an episode are
recommended.
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Death in ICU—an evaluation from Malawi
Pollach G, Pollach F
Anaesthesia and Intensive Care, University of Malawi.
Introduction: Information on survival rates in sub-Saharan African
ICUs (outside the Republic of South Africa) is scarce. Even rarer are
studies on longterm developments of survival and mortality rates.
These data are needed as basis to study death rates of sepsis.
Objectives: To investigate the survival rates on our ICU in one of the
poorest countries on earth over a period of around 10 years.
Methods: Audits, studies, publications, presentations and hospital
data from the largest Malawian hospital and it´s ICU were retrieved,
collected and analysed for the years 2004 to 2014.
Results: Early small studies from 2004 and 2005 showed mortality
rates of 54% and 41%. Our first own survey from October 2006 to
October 2007 showed a mortality of 40%. In the second from
September 2009 to August 2010 we found a mortality on our ICU of
37.9%, followed by the third during the period from September 2010
to August 2011 with 34%. From June 2011 to June 2013 this could be
reduced in the fourth to 29.8%. Our fifth and last study from
September 2013 to mid-November 2014 showed a further reduction to
23.6%.
Our hospital budget was reduced (2007 to 2014) from around 1.7
million to 1.37 million US $ by 19.4%. The pressure on our ICU was
further pronounced due to the admission of more HIV-reactive
patients with and without sepsis thanks to the change of AIDS from
an acutely deadly disease towards a treatable condition with the
availability of antiretroviral substances payed for by the Global Fund.
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Nevertheless from our first to our last study the above numbers
represent a reduction of 59% in eight years.
Conclusions: Even in ressource poor countries it is possible- despite
rising medical and economical constraints- to reduce the mortality in
the intensive care units to a level which is finally acceptable.
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Parallel treatment with anti-infectious drugs in an African ICU
Pollach G (1), Mndolo S (2), Namboya F (1)
(1) Anaesthesia and Intensive Care, University of Malawi, (2) Queen
Elizabeth Central Hospital, Ministry of Health.
Introduction: Information on interactions and sideeffects of multiple
anti-infectious (a-i) therapy in Africa is rare. To shed light on this we
performed an audit in the ICU of Malawis largest hospital.
Objectives: To find basic information on multiple a-i-therapy in an
African critical care unit.
Methods: From 1.1.-29.2.2014 we surveyed retrospectively in our
ICU numbers and types of a-i substances, mortality, signs of infection
and social challenges related to HIV-therapy during the first day of
admission in our mainly surgical ICU.
Results: Overall 53 patients received 119 anti-infectious drugs (2.24
substances per patient). Patients who died received 3 substances per
person. Only 2 patients did not receive any a-i drug (3.7%) and 6
patients (9.4%) received 5 or more a-i substances parallel. 1 of these
multi-drug receivers died (16.6%). Overall mortality was 11.3%. Both
patients without a-i drugs survived. Ceftriaxon was most widely used
(83%) followed by Metronidazol (60.4%).
In 28 cases an infection was suspected or proven (52.8%). Mean
temperature was 36.9 degrees Celsius. Four patients (7.4%) were
treated with antimalarial, -tuberculotic or -retroviral drugs (ARVs)
independant of the reason for admission. Two of them died (50%).
We found these data underestimating the number of patients on
parallel treatment because the surgical population in our hospital is
40% HIV-reactive and 50% of Malawians in need of ARVs are
treated (no discrimination against the admission of reactive surgical
patients). Different medical opinions on when a patient should receive
ARVs in ICU and social reasons like the spouse who brings ARVs
secretly at night for her husband to avoid stigma were discovered.
Conclusions: Too many a-i substances are given without good rea-
sons. A difficult clientel are patients receiving already anti-
tuberculotic or -retroviral therapy before they are acutely treated for
infections or sepsis.
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Daily goals for septic and non-septic patients in a tropical
intensive care unit and causes for failure to achieve them
Namboya F (1), Katunga D (1), Mbeta E (1), Mbweza R (1),
Kumbwemba E (1), Pietruck C (1), Pollach G (1)
Anaesthesia and Intensive Care, University of Malawi.
Introduction: Queens Hospital is the largest referal center in Malawi
([250,000 in-patients/year). Our 4–5 intensive care beds (all ages and
departments) are a precious resource for all patients, especially
including our many septic patients. Unnecessary challenges in orga-
nization, communication, coordination, interaction or problem-
awareness, which might lead to prolonged patient stays need to be
reduced.
Objectives: To assess documentation of daily goals during our ICU
ward rounds for septic and non-septic patients, the percentage of their
realization, the analysis of reasons inside and outside ICU leading to a
failure to achieve our goals. To assess the effectiveness of a checklist
for following audits.
Methods: We conducted an observational, descriptive, prospective
clinical audit and a re-audit in our ICU during 20 ward rounds in 20
days from 8th February 2016 to 4th March 2016. The audit-team was
part of the morning ICU ward-rounds, took notes and engaged the
ICU team during handover at 4 pm on why agreed goals from the
morning were not achieved. The re-audit used an adopted checklist
from John Hopkins and Mc Master University to improve the delivery
of the daily goals on ICU, including various sepsis-relevant questions.
The results were presented in general fora in the respective depart-
ments after the initial audit and the re-audit.
Results: Quantitatively our performance data for ICU showed for the
initial data collection 130 agreed and 110 documented goals (84.6%
documentation). For the re-audit we found 180 agreed (+138%) and
174 documented (+158%) goals. Documentation was reached in the
re-audit in 96.7% (including the sepsis relevant goals).
81.5% of the aims were achieved in the original audit and 86,1% in
the re-audit. Reasons, that goals were not achieved laid initially in
79.2% inside our ICU and 16.7% outside (4.1% lacking data). For the
re-audit we found 60% in our ICU and 40% outside. Reasons in ICU
were divided into patient factors, organization and resource factors
(initially: 16.7/54.2/8.3%; re-audit: 36/20/4%).
Qualitatively we identified a variety of reasons for the failure to
achieve our goals. No reagents for basic, sepsis relevant investigations
and therapies like the malaria rapid diagnostic test or electrolytes. The
availability for the signatory allowed to sign for a MRI to determine a
focus. The absence of blood in the blood bank or the absence of fever
reducing medication. Another focus for the non- achievement of goals
was lack of experience and expertise in the clinical setting and in
interdisciplinary communication.
Conclusions: In order to reduce poor documentation, the failure to
achieve our goals (especially in septic patients) and to reduce the
length of hospital stay we suggested the introduction of a checklist,
integrated meetings of all involved professional groups and regular
re-audits.
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Impact of endogenous IgGAM-levels on outcome in sepsis—
recent findings
Kindgen-Milles D (1), Dimski T (1), Dill H (2), Gockel U (2),
Briegel J (3)
(1) Department of Anaesthesiology, University Hospital Du¨sseldorf,
(2) Commercial Operation Deutschland, Biotest AG Dreieich, (3)
Department of Anaesthesiology, Hospital of the Ludwig Maximilian
University Munich.
Introduction: The main function of immunoglobulins (Ig) during the
immune response in sepsis is the clearance of pathogens, endotoxins,
DAMPs and PAMPs by activation/regulation of the complement
cascade [1]. It is known that in some patients the immunological
response to sepsis is impaired and increased Ig production does not
occur. This might be due to apoptotic depletion of memory B-cells [2,
3]. The prognosis of patients with sepsis depends on several factors
such as load and virulence of the pathogen, effective antimicrobial
therapy, and obviously also on age-dependant inefficiency of Ig
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production [4]. In this context, IgM plays a major protective role, and
in patients with decreased IgM levels mortality is extremely high [5].
However, whether adjunct treatment with exogenous IgM-enriched
preparations improves survival in these patients is still under inves-
tigation and a matter of controversy [6].
Objectives: To summarize the available data on the effect of
endogenous IgGAM levels on the clinical outcome of patients with
severe sepsis or septic shock and to present data on the effect of
adjunct therapy with IgM in such patients. This information may help
to identify target groups for adjunct treatment of sepsis with intra-
venous IgGAM.
Methods: We searched PubMed entries up to June 2017 and sum-
marized the relevant literature in a narrative review.
Results: We found 12 studies on this topic. In general, the
potential effects of supplementation with Ig preparations depend
on several factors, including severity of sepsis and efficacy of
general therapy per se. With regard to IgM therapy, Ig levels
should be assessed directly after admission of patients with severe
sepsis or septic shock to the ICU. In such patients, decreased IgM
concentrations may predict a higher mortality [7]. Consequently,
these patients are a target group for treatment with exogenous IgM
preparations. If a decision to supplement IgM is made, the time
between diagnosis and IgM administration is a significant predictor
of mortality risk, and treatment within \23 h after diagnosis is
most beneficial to reduce mortality. The duration of therapy should
be at least 72 h to achieve a sustained effect [6, 8]. However,
before this therapy is initiated, the general prognosis has to be
taken into account and this therapy should not be given to a patient
whose condition makes it futile. In summary, the response of
patients to treatment with IgGAM can probably be predicted on the
basis of the above criteria.
Conclusions: Sepsis and septic shock are serious diseases with a high
mortality even if standard therapy according to recent guidelines is
applied. In patients with an impaired immune response, as detected by
decreased levels of endogenous immunoglobulins (i.e. IgM levels),
early adjunct therapy with an IgM-containing solution may improve
survival. However, an early start and sustained application for 72 h
seem mandatory.
References: 1. Ehrenstein, M.R. and C.A. Notley, The importance of
natural IgM: scavenger, protector and regulator. Nat Rev Immunol,
2010. 10(11): p. 778-86.
2. Giamarellos-Bourboulis, E.J., et al., Kinetics of circulating
immunoglobulin M in sepsis: relationship with final outcome. Crit
Care, 2013. 17(5): p. R247.
3. Shankar-Hari, M., et al., Activation-Associated Accelerated
Apoptosis of Memory B Cells in Critically Ill Patients With Sepsis.
Crit Care Med, 2017. 45(5): p. 875-882.
4. Suzuki, K., et al., Reduced Immunocompetent B Cells and
Increased Secondary Infection in Elderly Patients With Severe Sepsis.
Shock, 2016. 46(3): p. 270–8.
5. Kreymann, K.G., et al., Use of polyclonal immunoglobulins as
adjunctive therapy for sepsis or septic shock. Crit Care Med, 2007.
35(12): p. 2677–85.
6. Z. Molnar, A.N.a.F.E., Immunoglobuloins in Sepsis: Which
Patients will benefit the most? . Annual Update in Intensive Care and
Emergency Medicine, 2013.
7. Martin-Loeches, I., et al., The protective association of endogenous
immunoglobulins against sepsis mortality is restricted to patients with
moderate organ failure. Ann Intensive Care, 2017. 7(1): p. 44.
8. Berlot, G., et al., Relationship between the timing of administration
of IgM and IgA enriched immunoglobulins in patients with severe
sepsis and septic shock and the outcome: a retrospective analysis.
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Number needed to treat and cost per life saved of adjunctive igm-
enriched immunoglobulin treatment of sepsis in Germany
Barlozek M (1), Nowak A (3), Ruebesam T (1), Gockel U (2)
(1) Commercial Development, Biotest AG, (2) Commercial Opera-
tions Germany, Biotest AG, (3) Klinik fu¨r Ana¨sthesiologie und
Intensivmedizin, Notfallmedizin und Schmerztherapie, Sta¨dtisches
Klinikum Dresden.
Introduction: Sepsis is a life-threatening clinical syndrome defined
by a systemic inflammatory response to infection. In Germany, the
expected number of newly diagnosed cases with severe sepsis
amounts to 76–110 per 100,000 adult inhabitants. Despite the
development of new antibiotics, mortality of patients with severe
sepsis or septic shock in German ICUs remains high with about
34.4–55.2%. Adjunctive treatment with IgM-enriched immunoglob-
ulins is one of the sepsis management strategies according to German
guidelines.
Objectives: This research aims to investigate the number needed to
treat (NNT) of IgM-enriched immunoglobulins in adult sepsis and
compare it with other, widespread treatment strategies. The NNT will
additionally be used to calculate the cost per life saved.
Methods: A number needed to treat model was developed by
obtaining effectiveness data from a systematic literature review
including the latest meta-analysis and subsequent trials, when avail-
able. The main outcome was mortality. Additionally, a cost per life
saved model was developed for Germany using the list price of IgM-
enriched immunoglobulins according to the public price list in Ger-
many (Lauertaxe).
Results: Based on the latest Cochrane meta-analysis, the NNT of
IgM-enriched immunoglobulin treatment in sepsis is 8. This was
compared with a number of other treatments and their NNTs: rapid
defibrillation for cardiac arrest (2,5), prophylactic antibiotics for
reducing ICU respiratory tract infections (18), tranexamic acid for
severe trauma (67), statins for heart disease prevention (83) and blood
pressure medicines for hypertension (125). However, sepsis treatment
developed during the last 10 years and when taking only the most
recent studies including real-world data into account, the NNT for
IgM-enriched immunoglobulins for adult sepsis patients is reduced to
3,93. The average treatment costs in Germany are 4106€. Therefore,
the cost per life saved ranges between 16114€ and 32844€.
Conclusions: The findings suggest that the treatment of septic
patients with IgM-enriched immunoglobulins is effective in reducing
mortality compared to other therapies. Considering international cost-
effectiveness thresholds, Pentaglobin represents a cost-effective use
of health care resources. Therefore, IGM-enriched immunoglobulins
can be recommended as adjunctive treatment of patients with sepsis.
Acknowledgements: This analysis was sponsored by Biotest AG,
Dreieich, Germany.
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Clinical and microbiological characteristics of Staphylococcus
aureus bacteremia in the Military University Hospital Prague
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(1)
(1) Department of Infectious Diseases, First Faculty of Medicine,
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Introduction: Staphylococcus aureus bacteremia (SAB) is the most
common bloodstream infection with incidence of 15–40 cases per
100,000 population. Mortality of SAB caused by methicillin-sensitive
(MSSA) and methicillin-resistant (MRSA) S. aureus ranges between
20–40%. Previous studies documented the importance of infectious
diseases (ID) expert consultations in the management of SAB and
compliance to evidence-based guidelines in diagnosis and therapy.
Objectives: The aim of this study was to characterize a cohort of
patients with SAB hospitalized during a two year period and evaluate
the quality of SAB management in a tertiary care hospital.
Methods: A total of 65 patients with SAB hospitalized at all
departments of the Military University Hospital Prague in 2015–2016
were retrospectively evaluated based on positive results of blood
culture testing. Clinical and laboratory parameters were analysed and
compliance of SAB management to current guidelines was evaluated.
Results: The mean age of patients was 65 years (range 20–94 years),
with 42 men and 23 women with the mean hospital stay of 23 days
(median 16 days). In 60 patients (92%), MSSA was detected and 5
cases of SAB (8%) were caused by MRSA. The mortality of 28% was
documented in the study cohort, 23 and 80% in the MSSA and MRSA
patients, respectively. Source of infection was found in 83% of SAB
cases with catheter-related infections being the most common cause
in 20% of patients followed by SAB due to surgery-related infections,
skin and soft tissue infections, lung infections (all 14%), infective
endocarditis (12%), bone infections (5%) and port infections (5%).
The most common empirical antibiotic therapy included aminopeni-
cillins and third generation cephalosporins. Upon SAB detection, only
45% of patients with MSSA etiology were switched to appropriate
targeted antibiotic therapy. However, all patients with SAB due to
MRSA received adequate antibiotics. Follow up blood cultures were
properly collected only in 42% of patients and ID consultations were
performed only in 23 (35%) patients. Interestingly, mortality in a
group of 23 patients who were consulted by an ID physician was only
17%.
Conclusions: The management of patient with SAB must include
recommended diagnostic and therapeutical interventions. It is nec-
essary to rapidly detect and possibly remove infectious focus,
promptly administer effective antibiotic therapy based on microbio-
logical results, obtain follow up blood cultures and indicate
appropriate duration of SAB treatment. Our retrospective study doc-
ument a lack of compliance to these rules in clinical practice and
support the importance of ID consults to improve the SAB
management.
References: 1. Vogel M, Schmitz RP, Hagel S, et al. Infectious
disease consultation for Staphylococcus aureus bacteremia—a sys-
tematic review and meta-analysis. J Infect. 2016 Jan;72(1):19–28.
doi: 10.1016/j.jinf.2015.09.037.
Acknowledgements: The study was supported by a project MO 1012,
SVV 260369 and UNCE 204022.
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Therapeutic plasma exchange as rescue therapy in refractory
septic shock
David S (1), Knaup H (1), Haller H (1), Hoeper MM (2), Kielstein JT
(3)
(1) Medicine; Nephrology and Hypertension, Hannover Medical
School, (2) Medicine; Pulmonology, Hannover Medical School, (3)
Nieren- und Hochdruckerkrankungen, Klinikum Braunschweig.
Introduction: Sepsis is a life-threatening dysregulated host response
to infection. Given the injurious role of (1) the overwhelming immune
response and (2) the consumption of protective plasmatic factors (e.g.
vWF cleaving proteases—ADAMTS13 etc.) we hypothesize that
early therapeutic plasma exchange (TPE) in severely ill individuals
might be beneficial. TPE combines two aspects in one procedure: (1)
removal of harmful circulating molecules and (2) replacement of
protective plasma proteins.
Objectives: To investigate surrogate endpoints and feasibility of an
add-on TPE strategy in early septic shock patients.
Methods: We have included 17 septic shock patients (onset\12 h)
requiring high doses of noradrenaline ([0.4 g/kg/min). TPE was
performed within 4 h. Clinical and chemical data were obtained
longitudinally besides the evaluation of 28-day mortality. Plasma
samples before and after TPE were obtained for stimulation of human
umbilical vein endothelial cells (HUVECs) ex vivo to analyze their
phenotype with regard to permeability (fluorescent immunocyto-
chemistry and transendothelial electrical resistance (TER)).
Results: Mean ADAMTS13 activity was 36 ± 18%. The 28-day
mortality in this study was found 24.3% lower (64.7%) as the pre-
dicted mortality (88.95%) by APACHE II score (37.6 ± 4). TPE
resulted in hemodynamic stabilization as indicated by mean arterial
pressure (63 ± 11 vs. 71 ± 9 mmHg, p = 0.002) and lower vaso-
pressor requirement (NA 0.84 ± 0.4 vs. 0.55 ± 0.2 ug/kg/min,
p = 0.0006). Fluid balance was also positively affected probably by
reduced capillary leakage. This is supported by ex vivo stimulation of
HUVECs with septic plasma where plasma before TPE induced
severe alteration of cellular architecture including a disassembly of
adherens junction (VE-cadherin IF) and a dramatic increase in per-
meability (TER, Figure). The same patients’ plasma after TPE did not
induce this typical septic phenotype.
Conclusions: This pilot study supports our hypothesis that early TPE
in highly unstable patients might be beneficial with regard to hemo-
dynamic stability, microcirculatory perfusion and overall outcome. A
national multicenter randomized trial powered for mortality is highly
desirable. Funding applications are currently under review.
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A mirror: sepsis management audit in emergency department
(step 1.)
Szedla´k M (1), Melegh B (1), Nagy L (1), Nagyunyomi-Se´nyi K (1),
Pada´nyi K (1), Ro´nay A (1), Szigili A (1), So´lya K (1)
Emergency Department, Medical Centre, Hungarian Defence Forces,
Budapest, Hungary.
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Introduction: Besides the growing patient flow, the timely recogni-
tion and adequate urgent care of septic patients, who do not always
show specific symptoms, is one of the greatest challenges for emer-
gency care staff. In addition to this challenge there is the fact that the
incidence is rising(1) and the recognition could be difficult.
Objectives: We investigated what kind of indicators could charac-
terize the management of sepsis in the Emergency Department (ED)
of Central Hungary with the highest patient flow.
Methods: A sepsis care audit was performed in the ED of our adult
care hospital. We examined the first 1000 patient who entered our ED
from 1st January 2017. The data of septic patients was separated from
the total cases. Sepsis was defined by verified infection plus SOFA
score C2. We investigated the incidences, the basic demographic
data, the achievement of the Sepsis Six and the crucial time data as
treatment indicators.
Result: The 1000 patients have been admitted within seven and a
half days. In 163 cases acute infection was verified and in 63 cases
sepsis was diagnosed (Figure 1). 46% of septic patients were
women, 54% were men. The median age was 74 years, 82.5% of
patients were over 60 years old. 14% of patients required vasoactive
circulatory support and there was need for intensive care in 19% of
the cases. Two patients died in the ED. During primary emergency
care, Sepsis Six elements were totally ignored in 9 cases, while in 4
cases all requirements were completely fulfilled (Figure 2a and 2b),
however, meeting all criteria did not show correlation with the
SOFA score. Total of 25 patients (40%) received antimicrobial
treatment in the ED, 75% in the intensive care subgroup. The
median wait time from admission to medical examination was 25.5
min, which showed inverse correlation with the SOFA score
describing the actual condition. The median time to the initiation of
antimicrobial treatment (in those cases when it was administered)
was 248 and 480 min in the intensive care subgroup (Figure 3).
Septic patients had 580 min-long median turnaround time in the ED
that showed linear relationship with the SOFA score (Figure 4).
Those patients who needed to wait for admission to the ICU spent
the longest time in the ED.
Conclusion: While epidemiological and demographic data seem to be
similar to international data(2), there is a significant lag in emergency
health care indicators compared to standards(3). The short wait time of
patients with need of intensive care, with their late antimicrobial
therapy reflects the deficiency in conceptual thinking, while the
sporadicity of the fully implemented Sepsis Six package and its
independence from the SOFA score demonstrates the lack of
knowledge of treatment standards. There is a need for system inter-
vention designed to improve conceptual thinking relating sepsis, early
recognition and standardized, provider-independent care.
References.
1. DF Gaieski, JM Edwards, MJ Kallan, et al.: Benchmarking the
incidence and mortality of severe sepsis in the United States. Crit
Care Med. 2013;41(5):1167-1174.
2. CDC/NCHS, National Hospital Discharge Survey, 2008 (
https://www.cdc.gov/nchs/products/databriefs/db62.htm)
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Campaign: international guidelines for management of sepsis and
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‘‘Sepsis Project’’: Complex Intervention Package to Improve
Sepsis Management in Emergency Department (Step 2.)
Szedla´k M (1), A´braha´m B (1), Hetzman L (1), Kianek E (1), Kiss A
(1), Nagy-Toldi A (1), Orosz F (1), Sarnyai A´ (1)
Emergency Department, Medical Centre, Hungarian Defence Forces,
Budapest, Hungary.
Introduction: Sepsis is an emergency condition in which the delay in
treatment worsens outcomes(1-3). According to the international
guideline, antimicrobial therapy should be initiated within 1 h after
recognition of sepsis(4). This goal presents a challenge to the loaded
Emergency Departments.
Objectives: As part of a complex program called Sepsis Project, we
audited the sepsis care in the ED with the highest patient flow of
Central Hungary. Based on the results, we started to implement an
intervention package with the purpose to facilitate the treatment of
sepsis according to international standards.
Methods: 1. Education. A mandatory training day organized for ED’s
healthcare providers (doctors and nurses), consisted of three main
elements: theoretical lecture, micro-skill practice and situation prac-
tice (Table 1). The purpose of the education was to introduce the
Sepsis-3 definition, to promote early recognition, to present the
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elements of the treatment, to describe the 2016 international guide-
line, thereby to improve the treatment following standards, to increase
the survival rate of septic patients (Figure 1.). 2. Sepsis screening
tool. We started to use a special document in the ED. The purpose of
this tool is to facilitate the recognition of septic patients according to
PIRO principles during the triage process and to lead the real-time
management of the septic patients based on decision support (Fig-
ure 2a and 2b). 3. Re-audit. We plan to justify the improvement in the
quality of treatment arising from the implementation of the inter-
vention package by comparing the results of the re-audit with the
previous one. 4. Organized cooperation. This program in our
department is not unique, the whole project is part of a program
launched by the Hungarian Emergency Sepsis Network, set up at the
beginning of 2017, which aims to assess and improve the quality of
the primary care of septic patients in the Hungarian ED-s.
Result. 24 residents and specialists and 36 professional workers
have participated in the education. The implementation of the
complex intervention package is ongoing and the training of the
entire staff requires additional occasions. We are looking forward
to see improvement in the recognition at triage, in the achieve-
ment of Sepsis Six and in the timing of the antimicrobial
treatment initiation. The objective justification for these measur-
able changes is the planned task of a subsequent re-audit (‘‘Step
3’’). The Hungarian Emergency Sepsis Network has begun with
the collaboration of 5 Hungarian ED-s. Since then more than 20
hospitals have joined the program from several parts of the
country.
Conclusion: Comprehensive interactive education organized for
emergency care staff and the use of a tool during treatment to support
recognition and therapeutic decision are expected to improve the
quality of septic patient’s care.
References.
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Succesful treatment with Cytosorb in a case of septic shock,
ARDS, multiorgan failure and purpura fulminans due to
Acinetobacter baumannii pneumonia
Kogelmann K (1), Scheller M (1), Jarczak D (2), Dru¨ner M (1)
(1) Ana¨sthesiologie und Intensivmedizin, Klinikum Emden, (2)
Intensivmedizin, Universita¨tsklinikum Hamburg Eppendorf.
Introduction: In several studies and in in-vitro data is demonstrated
that treatment with an extracorporal cytokine adsorber (CytoSorb)
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may be useful in patients with septic multiple organ failure or other
critical diseases due to an excess of cytokines. This therapy has
meanwhile been used in over 500 hospitals worldwide, more than
23000 applications, is well tolerated and safe. Purpura fulminans is a
rare disease with thrombosis and tissue necrosis caused by protein C
deficiency. Data on this life threatening disease are rare, treatment
guidelines have not been established.
Objectives: We treated a patient with septic shock, ARDS, multior-
gan failure and purpura fulminans due to community acquired
Acinetobacter baumannii pneumonia with ECMO, protein C and
Cytosorb.
The Patient without any chronic diseases beside alcohol abuse (male,
47 years old) has been admitted to our ward from another hospital,
ventilated and in septic shock. At admission APACHE II 38, heart
rate 133 bpm, MAP 60/Norepinephrine 2.8 mg/h, fever 38.5 C,
severe ARDS (paO2/fiO2 95).
Methods: Initial protocol treatment (lung protective ventilation,
volume resuscitation) failed; we treated therefore with ECMO (X-
Lung, Novalung), CVVHD (Fresenius multifiltrate) and as adjunc-
tive therapy with Cytosorb haemadsorption (7 applications). In
initial treatment we changed the adsorber every 12 h, from day 3 we
changed every 24 h. Adsorber was used with CVVHD (Citrat anti-
coagulation) in pre-filter position, blood flow 150 ml/min. Protein C
3000 IE was applicated.
Results: ECMO could be weaned after 10 days (paO2/fiO2 308), after
7 cycles of Cytosorb therapy we reached shock reversal (Nore-
pinephrine 0.5 mg/h, MAP 85) and catecholamines could be
terminated several days later. After application of 3000 IE protein C
tissue necrosis stopped immediately and plasma protein c levels
normalized (from 26% up to 83%). SOFA decreased from 15 to 10,
SAPS 2 from 58 to 43, other laboratory and physiological data are
shown in table 1. After 10 days we started weaning from ventilator,
patient was awake and vigilant, but ventilation had to be continued
because of severe Critical ill PNP and tetraparesis. In the next 4
weeks patient developed stable clinical conditions. Catecholamine
demand even as intermittent dialysis could be finished, skin necrosis
went better, no surgical intervention was necessary of it. Only ven-
tilation had to be continued because of the persistent tetraparesis
caused by CIP. After 57 days of ICU treatment we transferred our
patient in good clinical conditions to a rehabilitation Center.
Conclusions: We reached complete shock reversal after 7 applica-
tions of Cytosorb therapy even as complete restitution of the purpura.
Treatment with CytoSorb adsorber in a patient with sepsis acquired
purpura fulminans had shown great effect, been safe and without any
side effects
Reference: Protein C zymogen in severe sepsis: a double-blinded,
placebo-controlled, randomized study. Pappalardo F et al, Intensive
Care Med. 2016
Purpura fulminans in sepsis. Betrosian AP et al, Am J Med Sci. 2006
Hemoadsorption by CytoSorb in septic patients: a case series,
Kogelmann K et al, Critical Care 2017
Surviving sepsis campaign guidelines for management of severe
sepsis and septic shock. Dellinger RP et al Intensive Care Med. 2004
Hemoadsorption in infection-associated rhabdomyolysis. Suefke S
et al, Ther Apher Dial. 2016
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Assessment of some factors associated with death in patients from
necrotizing fasciitis
Avdoshin I (1), Chernyshev O (2), Petrov A (3), Shatil M (2),
Akinchits L (2), Sulima V (2), Bubnova N (1)
(1) Medical department, Saint-Petersburg State University, Saint-
Petersburg, Russia, (2) Department of Surgical Infections and Sepsis,
City Hospital of St. George, Saint-Petersburg, Russia, (3) Fabrika
Biopolymerov LLC.
Introduction: Necrotizing fasciitis (NF) is life-threatening disease
among surgical infections. It characterized as rapid necrosis of fascia,
soft tissues, sepsis, septic shock and still high mortality rate. The
prognostic factors associated with death from NF need to be analyzed.
Objectives: To assess some factors associated with death from NF.
Methods: The medical cases of 55 patients with NF who admitted to
the department of surgical infections and sepsis were analyzed retro-
spectively. Demographic, Co-morbidity, clinical data and laboratory
tests were compared between patients who survived and did not.
Results: 55 patients with NF divided into Group 1 (survived)—54.5%
and Group 2 (died from NF)—45.5%. Two groups had no differences
between gender data and wound location (p = 0.068). Group 2
characterized with greater amount of Septic shock cases 68.4 and
31.6% in Group 1 (p = 0.074). Patients in group 2 had average age
70.6 and in group 1 50.4 (p = 0.049). Time from disease’s onset and
admitted to hospital in group 1 was about 7.9 h and in Group 2–72.8 h
(p = 0.045). Patients in Group 1 had average 3,4 debridement com-
pared with 1.9 in group 2 (p = 0.049). Average length of stay in ICU
was 14.2 days in group 1 which was significantly greater (p = 0.035)
than patients in group 2 who spent 7.3 days. SOFA scores were 6.3 in
Group 1 and 15.8 in Group 2 (p = 0.048). Laboratory values were
similar in both groups (Hb, WBC, PLT, MPV, PWD, creatinine, total
bilirubin, glucose level, Alt) and showed no statistically significant
differences between groups (p = 0.089).
Conclusions: In this study patients who died from NF were older age
group, late admitted to the hospital. Also this group characterized
with majority of septic shock and statistically significant SOFA
scores. The earliest disease’s onset, aggressive surgical treatment
(Debridement) showed better outcome in Group 1. We found no
correlations between prolonged stay in ICU and risk of death.
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Effects of time to source control on 28-day-mortality in patients
with severe sepsis or septic shock
Ru¨ddel H (1), Schwarzkopf D (2), Thomas-Ru¨ddel DO (1),
Mattha¨us-Kra¨mer CT (2), Reinhart K (1), Bloos F (1),
for the MEDUSA study group
(1) Dept. of Anesthesiology and Intensive Care Medicine and Center
for Sepsis Control and Care (CSCC), Jena University Hospital, Jena,
Germany, (2) Center for Sepsis Control and Care (CSCCC), Jena
University Hospital, Jena, Germany.
Introduction: Guidelines recommend timely source control in
patients with (severe) sepsis and/or septic shock. Yet, only in the
recent SSC guideline source control is recommended ‘‘as soon as
possible’’ [1]. The former SSC- as well as the German S2k guidelines
recommended source control within 12 or 6 h, respectively, yet
Abstracts S49
123
without indicating any underlying data or level of evidence [2, 3]. The
current SSC recommendation is based on results of the observational
phase of our MEDUSA trial, showing a significant effect of timely
and successful source control on mortality [4].
Objectives: To investigate the effects of time to source control and
success of source control on survival in patients with severe sepsis or
septic shock.
Methods: Secondary analysis of the MEDUSA study [4], a cluster
randomized controlled trial including patients with severe sepsis or
septic shock treated on the ICU. Time-to-source control and success
of source control were abstracted from patient records by intensive
care clinicians. We analyzed the effect on 28-day-mortality over both
intervention phases of the MEDUSA trial [5]. Analyses: Uni- and
multivariate generalized hierarchical linear models controlling for
clustering of data.
Results: 2496 of a total of 6576 patients received surgical focus
sanitation. Delay of source control of more than 6 h was observed in
767 (31%) patients, source control was unsuccessful in 351 (14%)
patients. Mortality increased with delay (B6h: 28%,[6h: 38%) and
non-success of source control (success: 25%, non-success: 65%).
Controlled for risk-factors, delay of source control had an effect on
source control being unsuccessful (OR = 1.65 [95% CI 1.24–2.18], p
B 0.001). Both delay of source control and unsuccessful source
control had an effect on survival (OR = 1.38 [1.09–1.75] and
OR = 6.23[4.55–8.55], respectively, both p B 0.007). Time to source
control had an effect on 28-day-mortality both among patients where
source control was judged to be successful and patients where it was
judged to be unsuccessful (OR = 1.31 and OR = 1.76 respectively,
both p B 0.045).
Conclusions: Time to source control in patients with severe sepsis or
septic shock has significant effects on success of source control and
survival. Therefore, capacities for diagnosis and intervention should
be provided at all times in any institution caring for patients at risk of
sepsis with a surgical focus.
Reference: 1. Rhodes et al (2016). Surviving Sepsis Campaign:
International Guidelines for Management of Sepsis and Septic Shock:
2016. Intensive Care Med. 2017 Mar;43(3):304-37
2. Dellinger et al (2012) Surviving Sepsis Campaign: international
guidelines for management of severe sepsis and septic shock, 2012.
Intensive Care Med. 2013 Feb;39(2):165-22
3. Reinhart et al (2010) Prevention, diagnosis, therapy and follow-up
care of sepsis. Ger Med Sci 2010;8:doc14
4. Bloos et al (2014) Impact of compliance with infection manage-
ment guidelines on outcome in patients with severe sepsis: a
prospective observational multi-center study. Crit Care 18(2):1
5. Bloos et al (2017). Effect of a multifaceted educational intervention
for anti-infectious measures on sepsis mortality—a cluster random-
ized trial. Intensive Care Med 2017 – Epub ahead of print
Acknowledgements: The study was funded by the German Federal
Ministry of Education and Research via the integrated research and
treatment center ‘‘Center for Sepsis Control and Care’’ (FKZ
01EO1002).
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Effects of a multimodal intervention using change-management
methods on guideline adherence and 28-day mortality: results of a
prospective controlled multicenter study
Schwarzkopf D (1), Ru¨ddel H (2), Mattha¨us-Kra¨mer CT (1),
Thomas-Ru¨ddel DO (2), Reinhart K (2), Bloos F (2),
for the MEDUSA study group
(1) Center for Sepsis Control and Care, Jena University Hospital, (2)
Department for Anesthesiology and Intensive Care and Center for
Sepsis Control and Care, Jena University Hospital.
Introduction: Early antimicrobial treatment (AT) is an essential part
of guidelines on treatment of sepsis [1]. Several quality improvement
(QI) initiatives were able to increase guideline adherence and to
reduce sepsis-related mortality but used uncontrolled before-after
designs [2].
Objectives: To investigate the effects of applying change-man-
agement methods to improve the quality of antimicrobial therapy
and decrease sepsis-related mortality in a prospective controlled
trial.
Methods: Secondary analysis of the MEDUSA study [3], a cluster
randomized controlled trial including patients with severe sepsis or
septic shock treated on the ICU. Hospitals were randomized into an
intervention and a control group in study phase 1. After two years,
hospitals switched groups for study phase 2. Intervention: Audit and
feedback of quality indicators, change-management methods (local
QI teams, change-facilitation by study team); Control in phase 1:
Standard medical education; in phase 2: Feedback. Analyses: Dif-
ferences between study phase and surveillance phase regarding study
outcomes were compared between groups (difference-in-differences
[d-i-d] design). Generalized hierarchical linear models controlling for
clustering of data; Test of d-i-d by interaction effects between study
phase and study group.
Results: 40 hospitals participated in the trial including 4182 patients
in the intervention phase and 2394 patients in the surveillance phase.
Baseline characteristics showed substantial differences between
groups because of randomization failure (median SAPS-II group 1:
50, group 2: 46). Percentage of patients receiving antimicrobial
therapy within 1 h did not change in group 1 and increased in group 2
(38 vs. 40%, clustering-adjusted OR [95% CI] = 0.96[0.8–1.1], and
34 vs. 42%, OR = 1.3[1.1–1.6] respectively, d-i-d: p = 0.016). Per-
centage of patients with de-escalation of AT within 5 days showed a
similar development (OR = 1.1[0.9–1.3] and OR = 1.6[1.3–2], d-i-
d: p = 0.012). Percentage of at least 2 sets of blood cultures taken
increased in both groups (OR = 1.4[1.2-1.7] and OR = 1.7[1.4-2],
d-i-d: p = 0.138). There was no d-i-d in 28-day mortality (35 vs.
34%, OR = 0.95 [0.8–1.1] and 27 vs. 28%, OR = 1.1 [0.9–1.3], d-i-
d: p = 0.313), which stayed true when controlling for risk-factors (d-
i-d: p = 0.636).
Conclusions: This is the first controlled trial showing an effect of QI
interventions on time to first antimicrobial therapy. However, these
changes in guideline compliance were obviously not marked enough
to result in improved patient survival.
Reference: 1. Dellinger et al (2012). Crit Care Med, 41: 580–637
2. Damiani et al (2015).PLOS ONE, 10: e0125827
3. Bloos et al (2017). Intensive Care Med, published ahead of print.
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SMARTDOSE—Simultaneous determination of multiple
antibiotics by LC-MS/MS in plasma, tissue, and breath
condensate for personalized antibiotic treatment
Wichmann C (1), Bremer-Streck S (1), Kiehntopf M (1), Kiehntopf M
(2)
(1) Department of Clinical Chemistry and Laboratory Medicine, Jena
University Hospital, (2), Integrated Research and Treatment Center,
Center for Sepsis Control and Care (CSCC).
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Introduction: Adequate antibiotic treatment is the prerequisite for
successful treatment of systemic infections. Increased scientific evi-
dence shows that a fixed dosage regimen can lead to insufficient and
ineffective antibiotic therapy. Thus, personalized therapy regimes by
Therapeutic Drug Monitoring are necessary.
Objectives: The aim of this study was to develop and validate a
reproducible and robust method for quantification of antimicrobials
by using liquid chromatography with mass spectrometric detection
(LC-MS/MS) in different biological specimens (plasma, tissue,
exhaled breath condensate).
Methods: The method was developed for simultaneous quantification
of nine antimicrobials (Aciclovir, Ampicillin, Cefuroxime, Cipro-
floxacin, Meropenem, Metronidazole, Piperacillin, Rifampicin,
Tazobactam) in lithium-heparin plasma, entailed a single method for
sample preparation, enabling quick processing of the samples fol-
lowed by an LC-MS method with a chromatographic run time of 10
min. The method was validated for sensitivity, specificity, linearity,
accuracy, precision, dilution integrity according to the guidelines for
bioanalytical method validation of the European Medicines Agency.
This new method was also applied for determination of antimicrobial
concentration in other materials, e.g. tissue, exhaled breath.
Results: All calibration curves were linear over a range of 1–100 mg/
l, and if necessary, samples can be diluted 2- or 5-fold. Furthermore,
the accuracy was between 85.1 and 114.9% for all analytes, and the
within- and between-run precision were\16.5% for the lower limit of
quantification and \14.8% for the middle level and upper limit of
quantification. Preliminary data show a possible application of the
newly established quantification method also for other materials than
plasma, e.g. tissue, exhaled breath. Further validation for this other
materials is in preparation.
Conclusions: A short analysis time, small amount of plasma needed,
high specificity, and accuracy make the LC-MS/MS method devel-
oped in this study appropriate and practical for therapeutic drug
monitoring of antimicrobials in routine analysis.
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Glu-plasminogen—a life-saving drug for patients with organ
failure?
Karges H
Marburg.
Introduction: A functioning fibrinolytic system is the prerequisite for
the patency of blood vessels. For this, the balance between the central
protein of the fibrinolytic system Plasminogen (Plg) and the main
Plasmin Inhibitor Alpha2-Antiplasmin (APL) has to be warranted.
Under certain circumstances (e.g. severe septicaemia), however, the
APL level of the patients plasma exceeds the Plg level markedly,
leading to persistent clots in the capillaries and thus to organ failure
(e.g. the kidney) and finally in severe cases to the death of the
patients. In Germany die annually up to 70,000 patients due to these
problems. Those are about 50% of the affected persons.
Objectives: Since the components of the fibrinolytic system—Plg and
APL—are normally not considered in the diagnosis and treatment of
those patients, we tried to see if the substitution of plasma compo-
nents including Glu-Plasminogen could improve the survival of those
patients, and also looked for the effect of the substitution of Glu-
Plasminogen in patients with acute renal failure.
Methods: Citrated plasma was used for the determination of the
proteins Plg, APL and ATIII using the respective Berichrome testkits
of Behringwerke, Marburg. Glu-Plasminogen was obtained by affinity
chromatography from Cohn I fraction supernatant of plasma
fractionation.
Results: In a small open clinical study, 14 patients with severe sep-
ticaemia and septic shock, were treated additionally to the
conventional treatment with plasma components including Glu-Plas-
minogen. The control group—19 patients—obtained only the con-
ventional treatment for septic patients. In the control group 9 patients
died (47%), whereas in the group which was additionally treated with
plasma proteins including Glu-Plasminogen only 3 patients died
(21%).
A further study including patients with acute renal failure showed also
very positive effects of the substitution of Glu-Plasminogen. Kidneys
opened in close time relation to the substitution of Plg and the cre-
atinine clearance normalysed.
Conclusions: Our results show the very positive effect of the sub-
stitution of Glu-Plasminogen to balance the higher level of APL in
patients with multi organ failure. The acute death rate of these
patients could be reduced by more than 50%. If these results could be
verified in a double blind clinical trial, this approach to treat patients
with multi organ failure using plasma proteins including Glu-Plas-
minogen would save about 30,000 patients annually alone in
Germany from acute death. Thus, this approach would be the most
promising method to save the lives of those patients.
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The influence of comorbidities on mortality in medical intensive
care patients with severe sepsis and septic shock
Fro¨hlich H (1), Thomas-Ru¨ddel D (2), Schwarzkopf D (2), Riessen R
(1)
(1) Medical ICU, Department of Medicine, University Hospital
Tu¨bingen, Tu¨bingen, Germany, (2) The Integrated Research and
Treatment Center for Sepsis Control and Care, University Hospital
Jena, Jena, Germany.
Introduction: Despite all improvements in sepsis care hospital
mortality of patients with severe sepsis and septic shock is still in the
range of 30–50%. It is known that certain comorbidities predispose to
sepsis and are associated with a high mortality.
Objectives: The aim of the study was to investigate the relevance of
comorbidities as a contributing or leading cause of death in sepsis
patients.
Methods: Retrospective analysis of 235 patients with severe sepsis/
septic shock, age[18 years and no treatment restrictions admitted to
the Medical ICU of the University Hospital Tu¨bingen, Germany, from
12/2010 to 05/2015. Comorbidities were assessed by the Charlson
Comorbidity Score (CCS), which was also modified to assess dif-
ferent severities of comorbidities (Charlson Score of the Severity of
Comorbidities, CSSC). In addition, SAPS 2, SOFA, Sepsis Severity
Score (SSS) and KNAUS score was determined for all patients.
Finally, 4 different raters (PhD student, medical intensive care
attending, anesthesiologist and medical specialists for the dominating
comorbidity) reviewed the medical documentation of each non-sur-
vivor to subjectively grade the contribution of the comorbidities to
mortality into 4 categories.
Results: Hospital mortality was 33.2%(78/235). Mean SOFA score
was 11.0 (CI 10.1–11.8) in non-survivors and 8.4 (CI 7.9–9.0) in
survivors. Standardized mortality ratio was 0.73 based on the SAPS 2
and 0.65 based on the SSS. Frequency and severity of comorbidities
are shown in Fig. 1. Mortality rate ranged from 15.6% in patients with
low CSSC (0–1, n = 24) to 56.3% in patients with very high CSSC
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(C10, n = 22). Mean CSSC among the non-survivors was 5.7 (CI
5.0–6.4) and in survivors 4.8 (CI 4.3–5.2). Age \50 years was
associated with a lower mortality (21.6%). An immunosuppression
had 40% of all patients and 50% of non-survivors. Mortality was
highest in patients with severe chronic pulmonary disease/pulmonary
hypertension (52.9%, n = 9/17), severe malignant diseases (48.6%,
n = 17/35) and severe liver disease (47.6%, n = 10/21). Only 5.1%
of non-survivors had a normal health status (KNAUS A) before
hospital admission, whereas 41.0% were bedridden (KNAUS D).
Sepsis was subjectively rated as solely responsible for death on
average in 7.7%, sepsis as the leading cause of death with relevant
comorbidities present in 31.4%, sepsis and relevant comorbidities
equally contributing in 32.7% and comorbidities as the leading cause
of death in 28.2% of fatal cases. Gradings of the 4 individual raters
are shown in Tab. 1.
Conclusions: Significant comorbidities were very common in our
cohort of medical ICU patients with severe sepsis and septic shock
and were subjectively perceived as a major contributor or the leading
cause of death in the majority of patients.
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Comparison of procalcitonin and C-reactive protein levels and
blood culture results in septic patients
Nejtek T (1), Pru˚cha M (2), Moravec J (1), Moravec M (1), Zazula R
(1)
(1) Department of Anaesthesiology and Intensive Care, First Faculty
of Medicine of Charles University and Thomayer Hospital Prague,
Czech Republic, (2) Department of Fiochemistry, Haematology and
Immunology, Na Homolce Hospital Prague, Czech Republic.
Introduction: Procalcitonin (PCT) and C-reactive protein (CRP) are
the most commonly used biomarkers in the sepsis diagnosis. How-
ever, their reliability is limited and the results should always be
interpreted in the context of specific clinical situation. Dynamic of
individual parameters in time is more important than their absolute
values.
Clinical benefit of PCT monitoring lies in its ability to serve as
negative predictive marker of sepsis and bacteremia and can suggest
success or failure of initiated therapy.
Objectives: The objective of this study was to compare blood culture
at the time of clinical diagnosis of severe sepsis (T0) with the pro-
calcitonin and C-reactive protein serum levels at the time T0 and after
24 h.
Methods: During the years 2013 to 2016 95 blood cultures were
examined in ICU patients with diagnosis of severe sepsis. Simulta-
neously, samples were sent for laboratory evaluation of PCT and CRP
serum levels. After 24 h the control levels of procalcitonin (DPCT)
and C-reactive protein (DCRP) were examined.
Data were divided into 5 groups: BC- (negative blood culture), BC+
(positive blood culture)—bacteremia, BC+G+ (only gram-positive
blood culture), BC+G- (only gram-negative blood culture) and
BC+PM (polymicrobial positive blood culture).
Basic statistic methods were used for analysis of collected data.
Non parametric Kruskal-Wallis and Wilcoxon tests were applied to
assess difference between cases in time or between individual groups.
Results: Out of total 95 blood samples were 57(60%) in BC-,
38(40%) in BC+ of which 24(63%) BC+G+, 8(21%) BC+G- and
6(16%) BC+PM (not further evaluated in this work). Respective
values of PCT, DPCT, CRP and DCRP are shown in Table 1.
In the BC-group was found a significant increase of CRP levels after
24 h. Concentration of PCT C 2.0 ng/ml was found in 23(40%) and
PCT C10 ng/ml in 10(18%) of all samples. PCT levels together with
DPCT\0.2 ng/ml were found in 3(8%) samples.
Comparison of the PCT and CRP level changes within the 24-h
interval is shown in charts 1 and 2. Significant differences of PCT,
CRP, DPCT and DCRP levels between BC+ and BC- groups were not
observed. There was a significant difference in concentrations of PCT
as well as DPCT between BC+G+ and BC+G-. Neither the CRP nor
DCRP reached statistically significant values in the above mentioned
subgroups.
Conclusions: In our study we have failed to prove significant dif-
ference in PCT levels from bacteremic and non-bacteremic septic
patients.
Significant difference in PCT and DPCT levels was noticed between
gram-positive and gram-negative bacteremia groups with higher PCT
a DPCT in gram negative bacteremia.
Negative predictive cut-off value of PCT for ruling out bacteremia
based on our data was found to be PCT\0,2ng/ml
Acknowledgement: Supported by Ministry of Health, Czech
Republic—conceptual development of research organization (Tho-
mayer Hospital-TN, 00064190).
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The role of enterococci in the treatment of patients with severe
sepsis and septic shock
Sonnwald P (1), Fuchs C (1), Scheer C (1), Kuhn SO (1), Rehberg S
(1), Hahnenkamp K (1), Bohnert J (2), Gru¨ndling M (1)
(1) Klinik fu¨r Ana¨sthesiologie, Universita¨t Greifswald, (2) Institut fu¨r
Mikrobiologie, Universita¨t Greifswald.
Introduction: Enterococci belong to the most common pathogens
involved in hospital-associated infections and frequently cause
bloodstream infections1. Furthermore, enterococci are important
pathogens in gram-positive sepsis and intraabdominal infection that
may cause endocarditis and should be treated in multimorbid
patients2. Whether a detection of enterococci from abdominal drai-
nages or intraabdominal swabs (in absence of a positive blood
culture) should be treated with antibiotics is still the subject of con-
troversial discussions. Several studies failed to show a benefit of an
empiric antibiotic therapy including enterococci species3.
Objectives: The aim of the study was to evaluate whether enterocci
effective antibiotics (Vancomycin, Teicoplanin, Tigecycline, Line-
zolid, Daptomycin and Aminoglycosides) may influence 90-day
mortality in patients with intraabdominal enterococcal findings and
severe sepsis or septic shock but without enterococcal positive blood
cultures.
Methods: This retrospective monocentric observational study is
based on data from the surgical intensive care unit of the University
Hospital Greifswald from 2010 to 2013. The local ethics committee
approved the study. Patients with severe sepsis and septic shock, who
have received an abdominal swab during this period were included.
Patients with positive detection of enterococci in blood cultures were
excluded. The primary endpoint was 90-day mortality.
Patients were stratified into four groups according to the adminis-
tration of enterococci effective antibiotics:
Gr. 1 (n = 70): pos. abdominal enterococci findings and administra-
tion of enterococci effective antibiotics
Gr. 2 (n = 55): pos. abd. enteroc. findings without administration of
enterococci effective antibiotics .
Gr. 3 (n = 49): neg. abd. enteroc. findings and admin. of enterococci
effective antibiotics
Gr. 4 (n = 91): neg. abd. enteroc. findings without admin. of ente-
rococci effective antibiotics
Results: 265 patients were included (group 1 n = 70; group 2
n = 55, group 3 n = 49, group 4 n = 91). In all, 125 patients (47%)
were tested positive of enterococci. 90-day mortality was reduced to
35% (25/70) in group 1 compared to 53% (29/55) in group 2 (OR:
2.01; 95% CI: 0.98–4.13; p-value: 0.06) but failed to demonstrate
statistical significance.
53% (140/265) had no enterococci findings. In group 3 90-day mor-
tality was 59% (29/49) compared to 40% (36/91) in group 4 (OR:
0.45; 95% CI: 0.22–0.92; p-value: 0.03).
Conclusions: In our small observational study the administration of
enterococci effective antibiotics in septic patients with positive
intraabdominal enterococci findings did not significantly reduce
90-day mortality.
Conversely, 90-day mortality was significantly increased in entero-
cocci-negative septic patients that received enterococci effective
antibiotics.
Reference: 1Hidron et al. Infection Control and Hospital Epidemi-
ology (2008)
2Dougherty, S. The American Journal of Surgery (1984)
3 Teppler et al. Surgical infections (2002)
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CytoSorb—is anti-aging?
Denzinger M (1), Schneider EM (1), Bracht H (2), Barth E (2)
(1) Division of Experimental Anesthesiology, University Hospital
Ulm, (2) Department of Anesthesiology, University Hospital Ulm.
Introduction: RAGE, the receptor for advanced glycation end
products, binds to a broad repertoire of ligands including advanced
glycation endproducts (AGEs)1. Soluble RAGE (sRAGE) may
interfere with RAGE-ligand induced inflammation2 such as increased
expression of cytokines, chemokines, and adhesion molecules.
Results of previous studies also emphasized the role of RAGE in
murine models of sepsis by focussing on the anti-inflammatory role of
IL-103.
Objectives: We here addressed changes of inflammatory biomarkers,
sRAGE, AGEs in patients with septic shock before and after Cyto-
Sorb treatment and asked for their correlation with immune
phenotypes and clinical parameters i.e. recovery from septic shock
and catecholamine dependency.
Methods: Inflammatory cytokines and soluble receptors were mea-
sured with validated ELISA techniques (Siemens Immulite1000),
sRAGE, AGE’s, oxidized DNA(oxoDNA) were quantified by ELISA
from MyBiosource Inc, CellCiolabs, CaymanChem. Leukocyte sub-
populations were investigated by FCM (FACScalibur,
BDBioSciences.com). Antibodies against CD antigens on T-, B-, and
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myeloid cells were used to characterize activation states as well as
immune inactivation.
Fiveteen patients were tested before and after CytoSorb treatment.
Two patients with an excellent clinical response and two patients with
an inferior clinical improvement after Cytosorb treatment were
studied in greater detail.
Results: Before CytoSorb treatment sRAGE concentrations ranged
between 372 and 4486 pg/ml (median 1336pg/ml). CytoSorb treat-
ment resulted in reduced sRAGE levels in 2/4 patients (median
387 pg/ml). A rapid hemodynamic improvement within 24 h after
CytoSorb treatment was seen in 2/4 patients all these rapidly
improving patients showed lowered sRAGE levels.
CytoSorb treatment also resulted in decreased AGE concentrations
in 3/4 patients (median before 2943 lg/ml to after 13.82 lg/ml).
Another RAGE-ligand oxoDNA showed a clear reduction (p = 0.14)
in 3/4 patients after CytoSorb (median before 10,108 pg/ml to after
5210 pg/ml). Accordingly inflammatory cytokines such as IL-6 and
sCD25(4/4); IL-8, IL-1bb and IL-10(3/4); were reduced after Cyto-
Sorb treatment.
When comparing CD11b mean expression densities on granulo-
cytes after CytoSorb treatment we observed a significantly reduced
expression in 3/4 patients. We also observed a decline of CD36
expression density on monocytes in 3/3 patients.
Conclusions: Plasma samples of CytoSorb treated patients which
were analyzed by our extended marker protocol verified that hemo-
dynamic improvement was related to decreased IL-6, sCD25, IL-8,
IL-1, IL-10 sRAGE, AGEs and oxoDNA. Leukocytes of patients who
improved clinically had decreased expression densities of CD11b, and
the scavenger receptor CD36 levels were found. The new observation
of CytoSorb to influence sRAGE and its receptors in patients
recovering from septic shock deserves more detailed investigations.
Reference: 1 J Transl Med. 2009
RAGE (Receptor for Advanced Glycation Endproducts), RAGE
Ligands, and their role in Cancer and Inflammation
Louis J Sparvero et al
2 J Surg Res. 2016
RAGE-mediated inflammation in patients with septic shock.
Hofer S et al
3 Infect Immun. 2017
RAGE-mediated suppression of interleukin-10 results in enhanced
mortality in a murine model of Acinetobacter baumannii sepsis.
Noto MJ et al
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Effect of an extended hemodynamic monitoring on therapeutic
interventions and mortality in patients with sepsis—results from
the VISEP-trial
Bloos F (1), Bogatsch H (2), Jelschen F (3), Meier-Hellmann A (4),
Loeffler M (2), Brunkhorst FM (1), Weyland A (3), SepNet Study
Group
(1) Dept. of Anesthesiology and Intensive Care Medicine, Jena
University Hospital, (2) Clinical Trial Centre Leipzig, University of
Leipzig, (3) Dept. of Anesthesiology, Intensive Care Medicine,
Emergency Medicine and Pain Therapy, University Hospital Olden-
burg, (4) Dept. of Anesthesiology, Intensive Care Medicine and Pain
Therapy, Helios Hospital Erfurt.
Introduction: Current guidelines recommend dynamic measures for
guiding hemodynamic stabilization in sepsis patients [1]. In general,
extended hemodynamic monitoring is only recommended in patients
not responding to initial resuscitation [2]. However, data about the
rational application of extended hemodynamic monitoring in sepsis
patients are limited.
Objectives: To retrospectively analyze data from the VISEP-trial [3]
regarding the association between application of extended hemody-
namic monitoring as well as therapeutic interventions and mortality.
Methods: The VISEP trial was a randomized multicenter bifactorial
trial involving 537 patients to investigate the effects of fluid resus-
citation with Ringer’s Lactate versus HES 10% and conventional
versus intensive insulin therapy. The use of extended hemodynamic
monitoring was not directed by the study protocol and was at the
discretion of the treating physician. Patients were included into this
analysis if hemodynamic monitoring with pulmonary artery catheter,
transpulmonary thermodilution or absence of such a monitoring
within 24 h after enrolment was documented.
Results: 526 patients—223 with (HEMO) and 303 patients without
(NO-HEMO) extended hemodynamic monitoring—were included
into this analysis. HEMO was associated with a higher APACHE-II
score (21.6 ± 6.8 vs. 19.1 ± 6.2, p\ 0.001) and a higher baseline
serum lactate (3.9 ± 3.4 vs. 2.7 ± 3.5 mmol/l, p\ 0.001). HEMO
was also associated with more therapeutic interventions (Table 1).
The 90-day mortality in the HEMO group was 45.3 versus 29.9% in
the NOHEMO group (p \ 0.001). When adding APACHE-II score
and total volume of fluid resuscitation to a multivariate analysis,
extended hemodynamic monitoring was independently associated
with a higher 90-day mortality (OR = 1.5 [95% CI: 1.005–2.248]).
Conclusions: Patients receiving extended hemodynamic monitoring
were sicker resulting in more aggressive fluid resuscitation and cat-
echolamine therapy. Extended hemodynamic monitoring was
independently associated with a higher mortality.
Reference: [1] Rhodes A, Evans LE, Alhazzani W et al. Intensive
Care Med 2017;43(3):304. [2] Cecconi M, De Backer D, Antonelli M
et al. Intensive Care Med 2014;40:1795. [3] Brunkhorst FM, Engel C,
Bloos F et al. N Engl J Med 2008;358:125.
Acknowledgements: The VISEP-trial was supported by a grant (01
KI 0106) from the German Federal Ministry of Education and
Research and by unrestricted grants from B. Braun, HemoCue, and
Novo Nordisk.
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Use of Decasan antiseptic for local treatment of different forms of
diabetic foot syndrome
Fuss J (1), Voloboyeva A (2)
(1) Physical rehabilitation, D.Halycky Lviv National Medical
University, (2) Intensive care, Central Regional Hospital in
Pustomyty.
Introduction: The development of purulonecrotic complications
(PNC) in diabetes mellitus can lead to amputation of lower limbs or
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even death [1, 2]. Diabetic ulcers, infected with Staphylococcus
aureus , increase the risk of death in 5 years [3]. As a result of
aggression and low sensitivity, the infected lesions of skin in diabetic
foot syndrome (DFS) tend to spread rapidly and require active sur-
gical treatment, which often ends with amputation. That is why the
role of local and general antimicrobial therapy cannot be overstated
[4, 5].
Objectives: to define the composition of microflora in patients with
different forms of DFS and the effect of chemical and biological
antiseptics on them.
Methods: The exudate, washing of the ulcer surface and fragments
of infected tissue served as materials for bacteriological study.
Primary cultures were reviewed in 48 h and then every two days.
The duration of cultivation with no growth was seven days. 210
bacteriological studies with identification of sensitivity to antibiotics
were conducted.
Results: The infection in patients with PNC of DFS is characterized
by its polyvalent nature caused by the presence of both aerobic and
anaerobic microorganisms. The most frequent were aerobic bacteria
Staphylococcus aureus and Staphylococcus epidermidis. The mixed
infections, such as S. aureus+Peptostreptococcus spp., S.
aureus+Peptococcus spp. and S. epirdermidis+Enterobacteria+Bac-
teria fragilis were also frequently observed. The frequency of
anaerobic bacteria was 65.7% in patients with neuropathic form of
DFS without pronounced inflammatory reaction and 94.5% with acute
advanced inflammation. The similar tendencies were observed in
patients with ischemic form of DFS and neuroischemic form of DFS,
where the frequency of anaerobic bacteria isolation with chronic
inflammatory process was observed in 68.4% and with acute
inflammation—in 98.9%. The bacterial content after the surgical
debridement of purulent focus in neuropathic form of DFS in the
course of comprehensive treatment during 2–3 days was reduced from
10.8 ± 0.2 to 3.8 ± 0.3. The relevance of the use of high-potent
antiseptics such as Octenisept and Decasan in the treatment of
purulent lesions of foot should be pointed out. When using Decasan
antiseptic for the treatment of foot phlegmon, rinsing with Decasan
solution + pad application during 20 min and applying gel into a
wound, the bacterial content was significantly reduced: upon the
initial data of CFU concentration 10.8 ± 0.32 in 5 days—7.3 ± 0.24,
in 10 days—5.9 ± 0.51, in 15 days—4.8 ± 0.72, in 21 days—
3.8 ± 0.36, while when using Decasan solution in 5 days—
9.7 ± 0.58, in 10 days—8.4 ± 0.73, in 15 days—7.3 ± 0.48, in 21
days—6.2 ± 0.61. The clinical course and prognosis were more
favourable when using Decasan.
Conclusions: The microbial landscape of PNC in DFS is distin-
guished by different multistrain composition and high antibiotic
resistance. The antiseptic for local application Decasan is an impor-
tant element of antimicrobial therapy of PNC in DFS.
Reference: 1. G. R. Jones and J. A. Lowes, ‘‘The systemic inflam-
matory response syndrome as a predictor of bacteraemia and outcome
from sepsis,’’ Monthly Journal of the Association of Physicians, vol.
89, no. 7, pp. 515–522, 1996.
2. D. W. Bates, K. Sands, E. Miller et al., ‘‘Predicting bacteremia in
patients with sepsis syndrome. Academic Medical Center Consortium
Sepsis Project Working Group,’’ Journal of Infectious Diseases, vol.
176, no. 6, pp. 1538–1551, 1997.
3. A. Dupuy, F. Philippart, Y. Pean et al., ‘‘Role of biomarkers in the
management of antibiotic therapy: an expert panel review. I: currently
available biomarkers for clinical use in acute infections,’’ Annals of
Intensive Care, vol. 3, no. 22, article 1, 2013.
4. R. S. Samraj,B.Zingarelli, andH.R.Wong, ‘‘Role of biomarkers in
sepsis care,’’ Shock, vol. 40, no. 5, pp. 358–365, 2013.
5. C. Pierrakos and J. L. Vincent, ‘‘Sepsis biomarkers: a review,’’
Critical Care, vol. 14, no. 1, article R15, 2010.
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Antibiotic resistance in sepsis patients in a Romanian hospital
Iacob SA (1), Mihalcut AC (2), Iacob DG (2), Ciobotaru AC (2),
Dobrita A (1), Mihalache I (2), Anghel AF (2)
(1) Infectious Department, Carol Davila University of Medicine and
Pharmacy, Bucharest, Romania, (2), National Institute of Infectious
Diseases, Matei Bals, Bucharest, Romania.
Introduction: Early antibiotic therapy in septic patients is usually
empirical and it is based on several risk factors including the site of
the infection, presumed etiology and local resistance pattern. Roma-
nia is currently listed as having one of the highest antibiotic resistance
rates in Europe, leading to a high use of carbapenems and van-
comycin as a first-choice regimen. Improving the knowledge about
the local antibiotic resistance could help improve the current empir-
ical regimens.
Objectives: Study on antimicrobial resistance in patients with sepsis
from a Romanian hospital
Methods: A retrospective observational study was conducted in adult
patients admitted with sepsis during Jan 2017- June 2017 in one of the
wards from Matei Bals Institute of Infectious Diseases, Bucharest,
Romania. The diagnosis of sepsis was established based on SOFA
criteria (Sepsis 3, 2016) and/or Sepsis 2 criteria (2001). Isolates were
identified and antibiotic sensitivities were performed using standard
microbiological procedures.
Results: A total of 140 microbiological samples were analysed. Half
of the blood cultures were positive (58.33%), most of cases for Gram-
negative germs (58%) followed by Gram-positives (35.71%).
Importantly most K. pneumoniae and E. coli strains were ESBL
producing bacteria (60 and 40% respectively). 28.37% of the Gram-
negative strains produced carbapenemases as well (80% in A. bau-
manni, 50% in P. aeruginosa and 36.84% in K. pneumoniae cases).
On the other hand 94.73% of S. aureus strains were MRSA van-
comycin sensitive. 72% of all strains were MDR. We recorded an
important increase in colymycin-resistant strains (71.62%), fluoro-
quinolones (56.64%) and gentamycin (49.12%) strains, but not
towards tygecycline yet (8.16%).
The Gram-negative strains were observed in 82.85% of all deceased
patients (ESBL positive strains 32% and carbapenemase producers
17.14%). Most frequent Gram-negative isolates were E. coli
(25.71%), P. aeruginosa (17.14%), K. pneumoniae and A. baumanii
(11.42%). The Gram-positive strains were observed in 31.42% of
deceased patients with a death rate due to MRSA of 17.14%.
Polymicrobial infections were recorded in 31.42% of the patients with
an unfavourable outcome.
Conclusions: In conclusion the use of vancomycin in settings with a
high incidence of MRSA remains a good choice. On the other hand
the increasing rates of ESBL and carbapenemase- producing Gram
negatives prompt the need for alternative regimens, such as tigecy-
cline. Nevertheless, the Pseudomonas and Acinetobacter strains
continue to have limited treatment options and a poor prognosis in
high-resistance areas.
Reference: ECDC. Antimicrobial resistance surveillance in Europe,
2012. 2013. http://ecdc.europa.eu/en/ publications/Publications/an-
timicrobial-resistance-surveillance-europe-2012.pdf.
Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/
ATS/SIS International Sepsis Definitions Conference. Crit Care Med
2003;31:1250-6.
Abraham E. New Definitions for Sepsis and Septic Shock Continuing
Evolution but With Much Still to Be Done. JAMA. 2016;315(8):757-
759. doi:10.1001/jama.2016.0290
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Clinical and Laboratory Standards Institute (CLSI). Performance
Standards for Antimicrobial Susceptibility Testing. 26th ed. CLSI
supplement M100S (ISBN 1-56238-923-8 [Print]; ISBN 1-56238-
924-6 [Electronic]). Clinical and Laboratory Standards Institute, 950
West Valley Road, Suite 2500, Wayne, Pennsylvania 19087 USA,
2016
120
Infection 2017
International registry on the use of the CytoSorb-adsorber in
ICU patients (NCT02312024)—preliminary results
Brunkhorst FM (1,2), Schein M, Braune A (1), Schumacher U (1) for
the Cytosorb Registry Study Group
(1) Center for Clinical Studies Jena (ZKS), Jena University Hospital,
(2) Dpt of Anaesthesiology and Intensive Care Medicine, Jena
University Hospital.
Introduction: Clinical registries are valuable tools for assessing the
effects of medical applications under real-life conditions.
Objectives: The aim of this registry is to record the use of CytoSorb
adsorber device in critically ill patients in as many cases as possible.
Methods: The objectives of the registry (http://www.cytosorb-
registry.org/) are collection of data on a broad scale, centralized,
structured and comprehensive documentation, and controlled data
exchange. The registry records all relevant information in the course
of product use, e.g. diagnosis, comorbidities, course of the condition,
treatment, concomitant medication, clinical laboratory parameters and
outcome (ClinicalTrials.gov Identifier: NCT02312024). Primary
endpoint is in-hospital mortality as compared to the mortality pre-
dicted by the APACHE-II and SAPS-II-Score, respectively.
Results: As of June 30, 2017, 142 centers from 24 countries were
participating in the registry and 345 patients were documented.
Data available from the start of the registry on May 18, 2015 to
November 24, 2016 were analyzed. At this time point 122 centers
from 22 countries participated in the registry, of whom 20 centers
from four countries provided data for a total of 198 patients.
Mean age was 60.3 ± 15.1 years, 135 (68.2%) were male. 192
(97.0%) had one to 5 Cytosorb adsorber applications. Sepsis/
septic shock was the most common indication for CytoSorb
treatment (135 patients). Mean APACHE-II score in this group
was 33.1 ± 8.4 [range 15–52]) with a predicted risk of death of
78%, whereas the observed mortality was 65%. There were no
significant decreases in the SOFA scores after treatment
(17.2 ± 4.8 [3–24]). However, IL-6 levels were markedly
reduced after treatment (median 5000 pg/ml before and 289 pg/ml
after treatment, respectively).
Conclusions: This third interim report demonstrates the feasibility of
the registry with excellent data quality and completeness from twenty
study centers. The results must be interpreted with caution, since the
numbers are still small, however the disease severity is remarkably
high and suggests that adsorber treatment might be used as an ulti-
mate treatment in life-threatening situations. There were no device-
associated side effects.
Longterm Outcome
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The malicious economics of sepsis: the long-term outcome is
significantly worse than immediate financial burden
Sydorchuk RI (1), Sydorchuk IR (2), Sydorchuk LP (2), Sydorchuk II
(3), Sydorchuk AR (2), Stepan VT (4), Vladychenko KA (4)
(1) General Surgery department, Bukovinian State Medical Univer-
sity, (2) Family Medicine Department, Bukovinian State Medical
University, (3) Microbiology Department, Bukovinian State Medical
University, (4) Urology department, Bukovinian State Medical
University.
Introduction: It is generally accepted that sepsis is an acute emer-
gency condition. Multiple reports warn about well-proved and
possible long-term morbidity and mortality. Other studies report no
significant changes in long-term health status between post-septic and
non-septic individuals. However, its long-term consequences remain
unidentified and unappreciated. While financial burden of sepsis is
extremely heavy, the total cost of mortalities, treatment, and dis-
abilities throughout the life is not yet estimated.
Objectives: The aim of the study is to determine the accumulative
financial effect of sepsis and its consequences during long-term
observation.
Methods: The study is based on local register of 836 septic patients
(mean age 53.61 ± 9.14 yrs) mutually created by several General
Surgery clinics in West Ukraine. Medical problems associated with
sepsis and included into the study covered cumulative acute and post-
acute mortality as well as long-term mortality; morbidities and
complications were selected based on intensive database search
(Cochrane, Embase, Medline, Web of Science, and Google Scholar).
Primarily unrelated medical conditions but with sepsis-associated
complications like trauma complicated by SIRS/MODS were inclu-
ded only from the time of complication occurrence. Chronic disease
expenses present at the time of initial sepsis were deducted. All fig-
ures converted to ‘conditional credits’ to avoid bias of rates’ changes
and inflation. Initial spending was taken as 100%. Calculations of
financial expenses related to sepsis were based on the ‘WHO Guide to
identifying the economic consequences of disease and injury’.
Results: The most common health problems after sepsis were mental
(cognitive, stroke, extreme weakness and fatigue, general body pains
or aches, difficulty moving around and/or sleeping), cardio-vascular
(heart failure, peripheral vascular, arrhythmias), infections,
immunosuppression and organ failure. Accumulated 10 yrs mortality
after sepsis due to sepsis-related causes reached 16.03% (acute
mortalities unrelated e.g. traumatic injuries excluded). General dis-
ease associated financial during 10 yrs of observation rose almost
sextuple, reaching dramatic 586.9 ± 48.16%. Among most common
post-septic medical conditions consuming financial resources were
different infectious/impaired immunity complications.
Conclusions: Some of the long-lasting effects of sepsis are obvious,
such as missing limbs or organ dysfunctions, like kidney failure or
cardiovascular problems. Other after effects of sepsis are less obvious,
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such as memory loss or the inability to do simple arithmetic. The after
care for septic patients is needed not only in the hospital environment,
but at home as part of community care. This makes sepsis a long-term
financial burden for both families and communities, backing the idea
of early beginning of post-sepsis rehabilitation and secondary
prophylaxis.
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The Mid-German Sepsis Cohort (MSC)—background, study
design and status quo
Scherag A (1), Hartog CS (1), Fleischmann C (1), Ouart D (1),
Hoffmann F (1), Kesselmeier M (1), Fiedler S (1), Reinhart for the
MSC team* and investigators# K (1)
Integrated Research and Treatment Center, Center for Sepsis Control
and Care (CSCC), Jena University Hospital, Jena, Germany.
Introduction: Patients with sepsis experience life-threatening organ
dysfunction caused by a dysregulated host response to infection
(Singer et al. 2016). Recent estimates of highly-variable population
incident rates from high-income countries ranged between 148 and
288 hospital-treated sepsis cases per 100,000 person-years depending
on disease severity (Fleischmann et al. 2016).
For survivors, however, sepsis is not over after the intensive care
therapy and a wide range of sepsis sequelae has been reported. Sepsis
has therefore been called a ‘‘hidden’’ healthcare disaster (Angus
2010). While these adverse and long-lasting post-discharge outcomes
are increasingly acknowledged, we lack a comprehensive assessment
of the nature, extent, and impact of sepsis sequelae. A systematic
review (Winters et al., 2010) that summarized the available evidence
until 02/2009 demonstrated that studies mainly focus on long-term
mortality and decreased quality of life. When we recently updated this
systematic review, we came to the same conclusions.
Objectives: We designed the Mid-German Sepsis Cohort (MSC) as a
patient cohort to better and more completely quantify mid- and long-
term functional disabilities resulting from sepsis (Scherag et al. 2017).
Methods: We include all ICU-treated patients with (severe) sepsis.
Recruitment is based on ICUs of six large hospitals in Thuringia,
Saxony-Anhalt and Saxony. After the initiation in 03/2016, we aim at
including 3000 patients during a period of 3 years to obtain a suffi-
ciently large sample of survivors discharged from the ICU to assess
the nature, extent, and impact as well as the time course of physical,
mental, and emotional outcomes over a period of up to 5 years.
Results: In addition to the medical background and study design
information, we provide an update on the number of already included
patients.
Conclusions: After recruitment is finished, we can expect the first
results of the MSC.
Acknowledgement: The MSC receives funding by the CSCC at the
Jena University Hospital and the Kurt-Goldstein Institute (KGI). The
CSCC is funded by the German Ministry of Education and Research
(BMBF No. 01EO1502). The Kurt-Goldstein-Institute is a research
institute of the Bavaria Rehabilitation Hospital Group in Kreischa/
Saxony, Germany (Rudolf Presl GmbH & Co. Klinik Bavaria Reha-
bilitations KG). The funders have/had no role in study design, data
collection and analysis, decision to publish.
*MSC team: Ko¨nig C, Sobbe V, Philipp M, Braune A, Eichhorn C,
Gampe C, Romeike H
#MSC Investigators: The authors and Bauer M, Kortgen A (all Jena
University Hospital), Schreiber T, Hu¨ter L (both Zentralklinik Bad
Berka), Oehmichen F (Bavaria Clinic Kreischa), Meier-Hellmann A
(Helios Clinic Erfurt), Petros S, Bercker S, Stehr S (all Univer-
sita¨tsklinikum Leipzig), Bucher M, Nuding S, Frantz S (all
Universita¨tsklinikum Halle (Saale)).
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Familial coping in the post discharge process after surviving
sepsis
Keßler R (1), zu Sayn-Wittgenstein F (2), Schnepp W (1)
(1) School of Nursing Science, Witten/Herdecke University, (2)
Faculty of Business Management and Social Sciences, Osnabru¨ck
University of Applied Sciences.
Introduction: Currently, little is known about the post discharge
process of survived sepsis. Recent studies have shown that survivors
commonly suffer from chronical diseases such as posttraumatic stress
disorder, and experience a reduction in health-related quality of life.
Also it is known that survivors often need help in coping with their
everyday lives and are dependent on the support of family members.
But at this stage, it is unclear how the survivors and family members
cope exactly. Questions that arise are: What post discharge challenges
do they have, what strategies do they use and which of these strategies
are successful to recover and return to everyday life?
Objectives: To examine and describe challenges and coping strate-
gies in the post discharge process in one family, in which one person
survived a sepsis.
Methods: The method used is the ‘‘case-reconstructive family
research’’, which encompasses serval methodological approaches,
such as grounded theory and phenomenology. The data collection
includes interviews, genograms and observations. Hermeneutic
analysis instruments are used for data analysis.
Results: This study investigates the case of Mr. and Mrs. Schnell as a
family. Mr. Schnell survived a sepsis at the age of 59. After Mr.
Schnell came home, he still depended on medical devices and was
confined to bed. Mrs. Schnell described the homecoming moment as
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the biggest challenge, because she did not know what to do, to give
her husband right medical support. Additionally, she described that no
physician was available and no information was given about how to
deal with this situation. To cope with this stressful situation, Mr. and
Mrs. Schnell designed a nurse-patient relationship in which Mrs.
Schnell became the absolute authority, even towards medical and
therapeutic professions. Mr. Schnell reported that it was tough to be
immobile, even more because the ability to walk had been an
imperative of his identity as a handicapped person. He worked very
hard to gain physical strength to keep the hope to walk again. These
strategies seemed successful, because Mr. and Mrs. Schnell said that
they are satisfied today. Conditions that contributed to their successful
coping might be Mr. Schnell’s resilient identity as a handicapped
person and Mrs. Schnell’s past as a nurse.
Conclusions: One major challenge for sepsis survivors and their
families is the homecoming moment. This event should be supported
by family members and professionals.
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Superior accuracy of mid-regional proadrenomedullin over C
reactive protein, procalcitonin and lactate for ICU mortality
prediction in septic patients
Badia Tejero AM (1), Martinez Sagasti F (2), Domingo Marı´n S (2),
Lo´pez Vergara L (2), Requesens Solera M (2), Giersig-Heredia C (2),
Ortega De Heredia D (3), Serrano I (4)
(1) Faculty of Medicine, Complutense University of Madrid, (2)
Intensive Care department, Hospital Clinico San Carlos, (3)
Department of laboratory medicine, Hospital Clinico San Carlos, (4)
Department of Statistics, Hospital Clinico San Carlos.
Introduction: Recently, studies of the potential usefulness of the
mid-regional proadrenomedullin (MR-proADM) as mortality predic-
tor in sepsis has provided interesting results [1, 2, 3, 4].
Objectives: The aim of our study was to evaluate the accuracy of
MR-proADM to predict ICU mortality in septic patients compared
with other more frequently used biomarkers, procalcitonin (PCT), C
reactive protein (CRP) and lactate, and APACHE II and SOFA scores.
Methods: This was a single-centre, prospective, observational,
cohort, blind study, enrolling septic patients admitted to the ICU of a
teaching tertiary hospital between November 2016 and April 2017.
The Institutional Review Board approved the study. Blood samples
for the determination of MR-proADM were taken within the first 18 h
of ICU admission, after obtaining informed consent. The rest of
biomarkers were analysed from the first blood sample taken upon ICU
admission as well as the APACHE II and SOFA scores. The accuracy
of the biomarkers and risk scores for ICU mortality was evaluated by
calculating the area under the receiver operating characteristic
(AUROC) curve. Survival was assessed by Kaplan Meier and COX
regression analysis.
Results: Thirty-three consecutive patients with sepsis (20.2%) or
septic shock (78.8%) were enrolled. The ICU mortality was 27.3%.
The mean age was 69.9 years (standard deviation [SD], 11.6) and
66.7% of patients were male. MR-proADM and lactate plasmatic
levels were both significantly higher in non-survivors: 16.89 nmol/L
(8.86–27.44) versus 3.83 nmol/L (1.04–8.86) (p \ 0.001) and 5.56
mmol/L (1.50–10.50) versus 2.35 mmol/L (0.50-9.10) (p = 0.007),
respectively. Non-surviving patients also had both a higher APACHE
II score (31 [24–35] vs 20.5 [10–42]) (p = 0.004) and SOFA score
(11 [8–14] vs 8 [1–15]) (p = 0.032). Although plasmatic levels of
CRP and PCT were higher in the patients who died, this effect was
not statistically significant (Table 1).
Conclusions: A unique determination of MR-proADM plasmatic
levels in septic patients measured within the first 18 h of admission in
the ICU has better accuracy for ICU mortality prediction than CRP,
PCT, lactate or APACHE II and SOFA scores.
References: 1. Andaluz-Ojeda D, Cicuendez R, Calvo D., Nogales L,
Mun˜oz M-F, Bueno P, Eiros J-M and Gandı´a F. Sustained value of
proadrenomedullin as mortality predictor in severe sepsis. J Infect
2015; 71:136–139.
2. Andaluz-Ojeda D., Nguyen H-B., Meunier-Beillard N., Cicue´ndez
R., Quenot J., Calvo D., Dargent A., Zarca E., Andre´s C., Nogales L.
et al. Superior accuracy of mid-regional proadrenomedullin for
mortality prediction in sepsis with varying levels of illness severity.
Ann. Intensive Care 2017; 7:15
3. Marino R, Struck J, Maisel A-S, Magrini L, Bergmann A and Di
Somma S. Plasma adrenomedullin is associated with short-term
mortality and vasopressor requirement in patients admitted with
sepsis. Crit Care 2014; 18:R34.
4. Valenzuela-Sanchez F, Valenzuela-Mendez B, Rodriguez-Gutier-
rez F, Estella-Garcı´a A and Gonza´lez-Garcı´a MA. New role of
biomarkers: mid-regional pro-adrenomedullin, the biomarker of organ
failure. Ann Transl Med 2016.
Acknowledgements: The authors would like to thank the ICU
nursery team and the lab staff for their contribution to this study
collecting and processing the samples. They also thank Irene Serrano
for helping with the statistical analysis and Dr Miguel Sa´nchez
Garcia, head of the ICU for his advice interpreting the results. Finally,
they would like to thank Thermo Fisher for providing the reagents for
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Internet-based cognitive-behavioural writing therapy for
reducing post-traumatic stress after intensive care for sepsis in
patients and their spouses (REPAIR): results of two pilot cases
Gawlytta R (1,4), Niemeyer H (2), Bo¨ttche M (3), Scherag A (1),
Knaevelsrud C (2), Rosendahl J (1,4)
(1) Integrated Research and Treatment Center, Center for Sepsis
Control and Care, Jena University Hospital, (2) Department of
Clinical Psychological Intervention, Freie Universita¨t Berlin, (3)
Berlin Center for Torture Victims, Zentrum U¨BERLEBEN, (4) Insti-
tute of Psychosocial Medicine and Psychotherapy, Jena University
Hospital.
Introduction: As consequence of sepsis and intensive care unit
treatment, a considerable number of patients and their spouses
develop symptoms of posttraumatic stress disorder (PTSD). Internet-
based cognitive-behavioural writing therapy (IB-CBWT) has proven
to be an effective treatment option for PTSD in various studies. This
therapeutic approach may allow to meet the specific needs of sepsis
survivors and their spouses and to overcome treatment barriers. In a
randomized-controlled trial (REPAIR) we currently examine the
feasibility, acceptance, safety, and efficacy of IB-CBWT for PTSD in
patients and their spouses after intensive care for sepsis.
Objectives: To get first information about feasibility, acceptance,
safety and efficacy, we aim to analyse the results of two pilot patient-
partner-dyads who received IB-CBWT.
Methods: In the REPAIR trial participating patient-partner-dyads are
assigned by random either to a treatment or a wait-list (WL) control
group. The treatment group receives IB-CBWT for PTSD. If both the
patient and the partner show increased PTSD symptom scores mea-
sured by PTSD Checklist for DSM-5 (PCL-5), both obtain IB-CBWT.
If only one of them is affected, the partner is actively involved in the
participant’s IB-CBWT. IB-CBWT is guided by an experienced
therapist and consists of two writing assignments per week over a
period of 5 weeks. After completion of each assignment, the partic-
ipants receive individual feedback from the therapist. Participants
assigned to WL control group obtain treatment after a 5-week waiting
period. The primary outcome is PTSD symptom severity in self-rated
PCL-5 at the end of treatment and waiting time, respectively. Two
patient-partner-dyads were treated as pilot cases before the main
study has started. After completion of the intervention they were
interviewed and asked for their experiences and evaluation regarding
their treatment participation.
Results: According to the initial PCL-5 scores, both the patient and
the partner of the first pilot dyad received IB-CBWT. In the second
pilot dyad only the sepsis patient was treated with IB-CBWT. We
obtained positive evidence regarding feasibility, acceptance and
safety of IB-CBWT. Neither dropouts nor adverse events occurred.
Furthermore, participants reported high satisfaction with the treatment
and the study modalities. According to their statements, participation
in the REPAIR trial was beneficial for both, the sepsis patients as well
as their partners.
Conclusions: The analysis of pilot cases is an important instrument in
psychotherapy research, especially with respect to the development of
therapy concepts. Because of the small sample size generalizability of
the results is limited. Nevertheless, results of the two pilot cases
reveal that IB-CBWT is a promising approach to treat patients and
their spouses suffering from PTSD symptoms after intensive care for
sepsis. The case results have to be replicated in the REPAIR trial’s
total sample.
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Sepsis induces long-term changes in the transcriptome and
epigenome of naı¨ve bone marrow monocytes
Bomans K (1), Schenz J (1), Weigand MA (1), Uhle F (1)
Department of Anesthesiology, Heidelberg University Hospital.
Introduction: The late phase of sepsis is often associated with a so-
called ‘‘sepsis-induced immunosuppression’’. This state is character-
ized by a persisting hypo-responsiveness of the host’s immune system
(also ‘‘compensatory anti-inflammatory response syndrome’’) to
counteract the pronounced initial pro-inflammatory response (‘‘sys-
temic inflammatory response syndrome’’). This overall
immunosuppressive state renders the host vulnerable for a persisting
or the occurrence of secondary, often opportunistic infections. As a
result, this condition increases mortality both within and even after
discharge from the hospital, raising it an important aspect of the
follow-up treatment of sepsis survivors.
Objectives: The mechanisms underlying the immunosuppressive
phenotype are yet unknown, but with respect to the longevity of it, the
involvement of epigenetic alterations in DNA methylation or histone
modifications of immune cells seem obvious. Our project aims to
unravel these underlying molecular mechanisms.
Methods: Polymicrobial abdominal sepsis was induced in 12 weeks
old C57BL7/6 mice using the cecal ligation and puncture (CLP)
model. Corresponding control animals only received a laparotomy
without intestinal perforation. Three months after insult, surviving
mice were euthanized, and Cd11b+ Ly6C+ monocytes were isolated
from bone marrow by magnetic activated cell sorting. Subsequently,
genome-wide distribution of the active histone mark H3K4me3 was
analyzed by ChIP-Seq and global gene expression by RNA-Seq. Also,
immune cell composition and functionality in blood, spleen, and
peritoneum were assessed by flow cytometry and ex vivo stimulation.
Results: Principal component analysis of global gene expression of
naı¨ve bone-marrow monocytes revealed a sustained deregulation of
certain genes after CLP conditions: 75 genes were differentially
expressed, with 2 down- and 73 genes up-regulated genes. Further-
more, an increase of H3K4me3 was observed in 77 promoter regions
of post-septic naı¨ve monocytes. No correlation between changes in
H3K4me3 and altered gene expression could be determined. Fur-
thermore, a robust change of immune cell abundance, especially of
the lymphoid lineage, in spleen and peritoneum was obvious.
Conclusions: Our results prove the remains of transcriptomic scars in
naı¨ve bone marrow monocytes even months after the insult, poten-
tially indicating an ab initio altered functional state of naı¨ve
monocytes. Interestingly, the increase in gene expression was not
associated with histone alterations, leaving the question of the
involved regulatory tier open for further research.
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Influence of paternal sepsis on behavior and stress response in
offspring
Zipperer S (1), Bomans K (1), Weigand MA (1), Uhle F (1)
Department of Anesthesiology, Heidelberg University Hospital,
Heidelberg.
Introduction: The hypothalamus-pituitary-adrenal (HPA) axis is a
central neuroendocrine circuit in the response of the body to stressful
situations like overwhelming immunological reactions during sepsis.
It is activated e.g. by pro-inflammatory cytokines, leading ultimately
to the release of steroids like e.g. cortisol or its murine paralogue
corticosterone from the adrenal glands. Several studies reported the
trans- and intergenerational heredity of parental adaptions to envi-
ronmental exposures onto the progeny. Especially, parental distress
has been proven to result in abnormal stress reactions and diminished
HPA axis responsiveness in descendants.
Objectives: We aimed to evaluate if also paternal sepsis induces
intergenerational changes of behavior and stress response in their
offspring.
Methods: C57BL7/6 male mice (12 weeks) were subjected to cecal
ligation and puncture (CLP), thereby inducing a polymicrobial peri-
tonitis. Control animals did only receive a laparotomy without
intestinal perforation. Six weeks after insult, each surviving male was
bred with two healthy females. The resulting offspring were grown up
to 15 weeks before behavioral assessment. All mice underwent a test
sequence in open field, elevated O-maze and T-maze (24 h rest
between each). To assess the acute stress reaction, animals were
immobilized for 15 min and euthanized. Subsequently, the concen-
tration of the stress-related hormones corticosterone, ACTH and
testosterone were determined in the blood plasma. Furthermore, gene
expression analysis of molecular components of the HPA axis organs
was performed by qPCR.
Results: Male offspring of post-septic fathers showed a mild increase
in exploratory behavior, observed by increased moving time and
distance in the open field test. No differences in behavior could be
found in the O-Maze test. In line, males (and not female offspring)
approached a foreign object introduced during the open field test more
often than the corresponding controls. Interestingly, female animals
were more exploratory, but also insecure during the elevated O-maze,
what resulted in several falls. After acute immobilization stress, male
CLP descendants showed no changes in the plasma ACTH and cor-
ticosterone, whereas a higher release of ACTH could be observed in
female sham descendants. Regarding basal gene expression, an ele-
vated expression of the CRH gene in CLP progenies of both genders
was observed. CRHR2 gene was solely reduced in male CLP
descendants. In contrast, POMC gene expression was only elevated in
CLP female offspring.
Conclusions: We can provide evidence for intergenerational inherited
alterations in molecular and behavioral aspects of sepsis progenies.
Remarkably, the phenotype seems to be sex-dependent, with male
CLP descendants to be more stress-resistant and less anxious than
control descendants.
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Quantitative virtual infection modeling of sepsis
Tille A (1), Lehnert T (1), Mosig A (2), Figge MT (1)
(1) Applied Systems Biology, Leibniz Institute for Natural Product
Research and Infection Biology - Hans Kno¨ll Institute, Jena, Ger-
many, (2) Institute of Biochemistry II, Jena University Hospital,
Germany.
Introduction: A systemic inflammatory response caused by a severe
infection is called sepsis and can result into organ dysfunction that
may lead to death. The immune response is a highly complex system
involving non-linear mechanisms. Because of the high complexity of
the biological data it is often difficult to unravel the mechanisms,
which are important to predict the outcome of the disease or to
suggest therapeutic options. A systems biology approach consisting of
a combination of mathematical models and quantitative biological
data promises deeper insights into the processes of the biological
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system. Here we investigate an infection model of a liver organoid.
The liver is a critical organ for host survival in the context of sepsis
and plays a central role in metabolic and immunological homeostasis.
Therefore, it is a key player in the host response against infections, as
well as in damage and repair.
Objectives: By deriving a virtual infection model of the liver orga-
noid and comparing the model to experimental data, we can
investigate potential immune response mechanisms and validate or
neglect these hypotheses. Furthermore we can predict possible out-
comes of an infection and propose new immune response mechanisms
that can be verified in experiment.
Methods: The virtual infection model is based on a set of biological
reactions describing the interplay of invading pathogens, immune
cells like macrophages and parenchymal cells like hepatocytes. The
model describes the temporal evolution of the cell concentrations and
is fitted to data of a liver organoid to determine the parameters of the
model.
Results: The virtual infection model can predict different outcomes
of the disease. Depending on the initial conditions and the rates of the
system, possible outcomes of the disease are clearance of the patho-
gens and immune homeostasis, clearance of the pathogens associated
with overwhelming inflammation or persistent pathogen populations.
By varying critical parameters, transitions between the different
outcomes can be observed.
Conclusions: The virtual infection model of a liver organoid gives
the opportunity to investigate the relative importance of various
immune response mechanisms. By identifying critical parameters of
the system, we will be able to propose further experiments and get
deeper insights into the processes of sepsis.
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Sepsis long-term mortality assessed by the Jena Sepsis Registry
Schmidt K (1), Gensichen J (2), Sakr YM (3), Bahr V (4),
Fleischmann C (3), Reinhart K (3), Vollmar HC (1),
Brunkhorst FM (3)
(1) Institute of General Practice, Jena University Hospital, (2)
Institute of General Practice, Ludwig-Maximilians-Universita¨t
Mu¨nchen, (3) Department of Anesthesiology and Intensive Care
Medicine, Jena University Hospital, (4) Center for Clinical Studies,
Jena University Hospital.
Introduction: Most existing sepsis registries are restricted to hospital
data. There is still few population-based data on long-term mortality
of survivors of sepsis and septic shock.
Objectives: To describe long-term mortality of sepsis and septic
shock in association to clinical and other factors.
Methods: All ICU patients of the Jena University Hospital between
2011 and 2015 were screened for severe sepsis or septic shock.
Clinical, microbiological, sociodemographic and process-of-care data
was extracted from patient ICU records. Follow-up data on mortality
was collected at the patients’ primary care providers at 6, 12, 24, 36
and 48 months after diagnosis. Primary outcome is all-cause mortality
at 6 months.
Results: N = 1976 patients were included meeting criteria for sepsis
or septic shock. Of these, 44.7% (N = 883) died in hospital. Six month
after diagnosis, mortality increased to 58.5% (N = 1156). N = 55
patients (2.8%) were lost to follow up. Six-month mortality was sig-
nificantly associated with age, APACHE II score, recent surgical
history, pneumonia, history of liver cirrhosis and nosocomial acquired
source of infection. Over time, mortality increased to 74.2% (N = 288)
at 48 months referring to N = 388 patients included in 2011.
Conclusions: The Jena Sepsis Registry provides observational long-
term data on mortality of sepsis and septic shock up to 48 months
after diagnosis. Even though validity is limited due to the mono-
centric design, the registry demonstrates feasibility indicated by high
enrolment and follow up rates.
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Long term effect of a sepsis aftercare intervention
Schmidt K (1), Worrack S (1), Brunkhorst FM (2), Freytag A (1),
Reinhart K (3), Scherag A (2), Schneider N (1), Gensichen J (4)
(1) Institute of General Practice, Jena University Hospital, (2) Center
of Clinical Studies, Jena University Hospital, (3) Department of
Anesthesiology and Intensive Care Medicine, Jena University
Hospital, (4) Institute of General Practice, Ludwig-Maximilians-
Universita¨t Mu¨nchen.
Introduction: Sepsis survivors face mental and physical long-term
sequelae. A structured sepsis aftercare intervention has been imple-
mented in primary care. The intervention group showed indications of
better functional outcomes than the control group at 6 and 12 months.
It is unknown if this result persists.
Objectives: To examine the functional long term outcomes of a
primary care-based case management intervention in sepsis aftercare
Methods: A 24-month follow-up of the SMOOTH study [1], a ran-
domized clinical trial, was performed 12 months after the 1-year
intervention. Patients with severe sepsis or septic shock treated at one
of nine ICU study centers were randomized to intervention and
control group. The intervention included training of patients and
treating primary care physicians (PCP), case management provided
by trained nurses and clinical decision support for PCPs by consulting
physicians. Usual care was provided by PCPs in the control group.
Data were collected by telephone interviews at 6, 12 and 24 month
using validated questionnaires assessing physical and musculoskeletal
functioning, activities of daily living among 28 other outcomes.
Results: 143 and 148 patients were randomized to the intervention
and control group, respectively. 186 of 291 (63.9%) patients partici-
pated 24-month follow up. Differences in functional outcomes
between intervention and control group at 6 and 12 months, as has
been reported before [1] did not sustain at 24 months.
Conclusions: By increased physical function across both groups at 24
month after ICU discharge, there was possibly no potential for
functional improvement by the intervention. In addition, possible
improvements at 6 and 12 months in the intervention group did not
sustain at 12 months after intervention termination.
Reference: 1: Schmidt, Konrad, et al. ‘‘Effect of a Primary Care
Management Intervention on Mental Health–Related Quality of Life
Among Survivors of Sepsis: A Randomized Clinical Trial.’’ Jama
315.24 (2016): 2703-2711.
Acknowledgement: SMOOTH Study Group
Sepsis Prevention
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Quality-management for sepsis treatment in African anaesthesia
through training of non-doctor anaesthetists
Pollach G (1), Namboya F (1), Mabedi D (2)
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(1) Anaesthesia and Intensive Care, University of Malawi, (2) Zomba
Central Hospital, Ministry of Health.
Introduction: Most anaesthesia and ICU-care for septic patients in
Malawi is given through Bachelors of Science and clinical officers in
Anaesthesia (BACOS). Quality-management needs to know the type
of their training, which chances for careers might be in reach and the
challenges they face.
Objectives: To investigate on the ground standard training, further
education and problems of quality-management for non-doctor
anaesthetists.
Methods: We evaluated the situation through semistructured inter-
views and questionnaires in the Ministry, the University of Malawi
and the relevant hospitals and compared informations with 10 years
experience in the country and the literature.
Results: Different types of non-physician anaesthetists dealing with
sepsis in Malawi were found. The anaesthetic clinical officer (around
120 in 4 central and more than 30 district or rural hospitals), their
trainees (32) and interns (16) and the Bachelors of Sciences in
Anaesthesia and Intensive Care (17) and ist trainees (12). Only very
occasionally we found a nurse or another profession providing
anaesthesia for sepsis. We found significant improvement in their
numbers of almost 100% from´ 07 (100) to´17 (197) due to intense
measures in training and the inauguration of a BSc. Nevertheless
numbers are far behind staff establishments (\25%). In May 2017 all
schools and training institutions for BACOS are working. Relations of
professional groups dealing with sepsis are complex and face chal-
lenges (age up to 75, working despite a major stroke, on-call numbers,
low salary, own HIV or malaria infection, low CME resources,\1%
study medicine, bad relations to ICU nurses, low standing in medical
community).
Conclusions: Training of non-doctors (for quantity and quality) is
crucial to reach the traditional development goals (sustainability,
empowerment, capacity building) in sepsis treatment too.
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Nationwide trends in infection and sepsis incidence and mortality
in Germany
Fleischmann C (1), Mikolajetz A (2), Schwarzkopf D (1),
Thomas-Ru¨ddel DO (2), Hartog CS (1), Reinhart K (2)
(1) Center for Sepsis Control and Care, Jena University Hospital, (2)
Department of Anesthesiology and Intensive Care Medicine, Jena
University Hospital.
Introduction: Over the last decade, sepsis incidence rates were found
to increase in multiple countries by up to 5.7% annually (1). Demo-
graphic change and an increase of invasive or immunosuppressive
measures may be important contributors, as well as an increased
sepsis awareness. The impact of changes in infectious disease inci-
dences is unknown in Germany.
Objectives: To assess trends in infection and sepsis incidence and
mortality between 2010 and 2014 based on administrative data in
Germany.
Methods: Patients with (1) infection, (2) infection and organ dys-
function, (3) infection and intensive care/organ support as well as (4)
sepsis were identified in a nation-wide database of hospital discharge
data (DRG statistics) between 2010 and 2014 using ICD-10 codes
used as primary and secondary discharge diagnoses and procedural
OPS codes. Sepsis was defined using explicit sepsis codes microbi-
ological and/or clinical sepsis codes). Severe sepsis and septic shock
were defined as ICD-10 R65.1 and R57.2, respectively. Organ
dysfunctions were identified by 27 ICD codes for cardiovascular,
respirator, central nervous, renal, metabolic, hematologic and hepatic
organ failure.
Results: In 2014, 4,035,853 patients with infectious diseases were
treated in German hospitals, of which 26% had at least one organ
dysfunction and 12% required intensive care, renal replacement
therapy or mechanical ventilation (Tab. 1). 299,464 patients had
sepsis, including 123,295 patients with severe sepsis and septic shock.
Hospital mortality was 5.6% in infection patients and increased if an
organ dysfunction or explicitly coded sepsis was present to 16.6 and
22.7%, respectively). Between 2010 and 2014, the age- and sex-ad-
justed incidence rate of hospitalized patients with infectious diseases
increased by a mean of 1.6% annually and the number of those with
organ failure or sepsis increased, too. The most substantial rise was
found in patients with severe sepsis (mean ?7.6% annually). Mor-
tality declined or remained relatively stable. However, the absolute
number of deaths from infectious diseases and sepsis increased over
time.
Conclusions: Although the number of hospitalized patients with
infections is growing, the numbers of those with infections compli-
cated by sepsis, organ dysfunction or requirement for intensive care is
rising. In contrast to sepsis, the latter are less prone to coding
incentives. These dynamics are independent from demographic
changes and confirm that sepsis must become a key priority for health
care authorities and health care providers on the national and inter-
national level as recently underlined by a WHO resolution on sepsis.
Further research is needed to understand the underlying mechanisms
of rising infection and sepsis rates in German hospitals.
Reference: Fleischmann et al. Hospital Incidence and Mortality Rates
of Sepsis. Dtsch Arztebl Int. 2016 Mar 11;113(10):159-66.
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Incidence of respiratory infections and sepsis in Germany
Mikolajetz A (1), Fleischmann C (2), Schwarzkopf D (2),
Thomas-Ru¨ddel DO (3), Reinhart K (3), Freytag A (4), Forstner C (5),
Vaccination60? Group
(1) Department of Anesthesiology and Intensive Care, Jena Univer-
sity Hospital, (2) Center for Sepsis Control and Care, Jena University
Hospital, (3) Department for Anesthesiology and Intensive Care and
Center for Sepsis Control and Care, Jena University Hospital, (4)
Institute for General Practice and Family Medicine, Jena University
Hospital, (5) Center for Infectious Diseases and Infection Control,
Jena University Hospital.
Introduction: Respiratory infections are a substantial health care
burden all over the world. Especially in elderly or immunocompro-
mised patients, infections may take a more complex progression and
lead to a sepsis.
Objectives: The aim of this study is to examine the incidence of
respiratory infections in general, and specifically the incidence of
pneumonia and influenza, and to determine the extent of severe
complications as sepsis in Germany.
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Methods: We retrospectively analyzed hospital discharge data from
the year 2014 by using the DRG (diagnosis related groups) statistics
of the German Federal Statistical Office (FSO), which contains nearly
complete data of all inpatient hospital treatments in Germany. The
cases were identified among primary and secondary discharge diag-
noses by ICD-10 codes: Influenza—J09, J10 or J11; pneumonia—
J12–J19 or U69.00!; sepsis—at least one of 29 microbiological and
clinical codes; severe sepsis—R65.1 or R57.2. We assessed inci-
dences (total number of cases, cases per 100,000 population) and
mortality and describe age, sex, comorbidity and treatment data of
patients.
Results: In 2014, 1,345,848 patients were hospitalized due to respi-
ratory infections, which made up 33.3% of all infectious disease cases
treated in German hospitals. About 50% of the respiratory infections
were coded as pneumonia, whereas only 0.4% of respiratory infec-
tions were coded as influenza. Patients with pneumonia had a
relatively high mortality of 15.7% and patients with influenza had a
relatively low mortality of 2.6% when compared to the overall
mortality of respiratory infections of 9.6%. 104,154 (7.7%) of patients
with respiratory infections had sepsis, most of which were patients
with pneumonia progressing into sepsis (88,939 cases; 6.6%).
Mortality of pneumonia and influenza increased to 33.7% and 23.3%
respectively, when accompanied by sepsis. In total, 34.8% of all
sepsis cases occurred with a respiratory infection. Incidences for both
respiratory infections and pneumonia increased with age, while
incidence for influenza was highest in children.
Conclusions: Results show considerable proportions of patients with
sepsis among patients with respiratory infections and a higher risk
with increasing age—especially for pneumonia. The incidence of
hospital-treated influenza is relatively low and underestimates the true
burden of disease, as most patients may be treated in the outpatient
setting (see RKI influenza report 2014 [1]). The results point out that a
reduction of respiratory infections, e.g. by increasing vaccine uptake
in the population, may be one way to achieve a substantial decrease in
sepsis incidence.
Reference: 1. Arbeitsgemeinschaft Influenza (2014). Bericht zur
Epidemiologie der Influenza in Deutschland Saison 2013/14.
Retrieved from: http://influenza.rki.de/Saisonberichte/2013.pdf
Acknowledgement: This work has been funded by the Federal
Ministry of Education and Research (BMBF, Germany) in the project
Impfen 60? within the funding programme,, Zwanzig20 – Partner-
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